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Over 90% of all cancer-related deaths result from metastasis, a multistep process 
that occurs in the blood or lymphatic vasculature under hydrodynamic forces. During 
metastasis, cancer cells leave the primary tumor, intravasate into the circulatory or 
lymphatic system, circulate until they are able to extravasate, and eventually take up 
residence in a secondary location of the body to form a metastatic tumor. In order to leave 
the vasculature during extravasation, circulating tumor cells utilize a highly orchestrated 
adhesion cascade that begins with rolling adhesion to endothelial cells under a high shear 
environment. This process is driven by interactions between endothelial-presented 
selectins and glycan epitopes on selectin ligands present on the circulating cell’s surface. 
These selectin-selectin ligand interactions have been implicated in cancer metastasis, 
however, an outstanding problem in the field is the lack of effective systems to study the 
role of wall shear stress and cellular molecular profiles in initiating and sustaining these 
interactions, and how this may lead to enhanced metastatic capacity of circulating tumor 
cells. As such, the overall objective of this thesis is to engineer microfluidic platforms to 
permit the analysis of selectin-mediated adhesion and interrogation of cellular 
characteristics underlying selectin-selectin ligand interactions between the endothelium 
and metastatic cell subsets that occur during cancer dissemination in a tumor 
microenvironment. My central hypothesis is that microfluidic systems can be engineered 
to mimic the hemodynamic forces of the circulatory system or hydrodynamic forces of the 
lymphatic system, which can be used to interrogate cellular characteristics associated with 
adhesion in flow or the effects of altered microenvironments on metastasis. 
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CHAPTER 1. INTRODUCTION 
1.1 Motivation 
Over 90% of all cancer-related deaths result from metastasis, a multistep process that 
can occur in either the lymphatics or in the blood vasculature, and these processes are 
related in that disseminated tumor cells move through the lumen of vessels under 
hydrodynamic forces. Cancer metastasis is initiated when a tumor cell leaves the primary 
tumor and intravasates into the circulatory or lymphatic system. The tumor cell can then 
circulate in the vasculature until it is able to extravasate, or leave the circulatory or 
lymphatic system, infiltrate a distant tissue, multiply, and  form a secondary, metastatic 
tumor.1,2 In order to travel to distant sites in the body during the process of metastatic 
cancer extravasation, circulating tumor cells utilize a highly orchestrated adhesion cascade 
that begins with rolling adhesion to (lymphatic) endothelial cells under a high shear 
environment, in a similar manner to leukocyte homing and extravasation.3–5 Importantly, 
this process is driven by interactions between endothelial-presented selectins and glycan 
epitopes on selectin ligands present on the circulating tumor cell’s surface. The interaction 
of selectins with their ligands slows a circulating tumor cell down and allows it to firmly 
adhere to (lymphatic) endothelial cells in the dynamic fluid flow environment of blood or 
lymphatic vessels, which can permit transmigration and the eventual formation of 
metastatic tumors.6–10  
In the context of hematogenous metastasis, selectin-mediated adhesion has been 
previously recapitulated in vitro to elucidate the selectin-mediated adhesive behavior of 
metastatic cancer cells in a controlled, physiologically relevant microenviroment.11–13 
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Furthermore, the use of such in vitro platforms has been extended to interrogate the 
correlation between short time-and length-scale selectin-mediated rolling adhesion and 
expression levels of selectin ligands, such as sLex and CEA, as well as selectin ligands that 
are also cancer stem cell markers, such as CD24 and CD44.12 However, these microfluidic 
systems are limited in that they are unable to correlate metastatic cancer cell expression of 
selectin ligands and cancer stem cell markers with long time- and length-scale adhesive 
propensity, and they do not permit the simultaneous juxtaposition of short and long time- 
and length-scale adhesive behavior of metastatic cancer cells. Furthermore, these systems 
fail to allow the separation, collection, and post-perfusion analysis of distinct subsets of 
metastatic cancer cells from a heterogenous population. Consequently, the exact cell-
intrinsic mediators facilitating long time- and length-scale selectin-mediated adhesion as it 
relates to hematogenous metastasis are widely unknown. Collectively, therefore, there is a 
need for the development of new, cell-sorting microfluidic systems that can be used to 
interrogate the role of wall shear stress and distinct cellular molecular profiles in initiating 
and sustaining selectin-mediated adhesion, particularly as it relates to enhanced 
hematogenous metastasis potential of different adhesive phenotype subsets of circulating 
tumor cells. Notably, the engineering of such novel systems that allow during perfusion 
and post-perfusion analysis of cell subsets with different adhesive propensities can be 
applied to identify molecular drug targets for development as anti-cancer metastasis 
therapeutics or can be used as a high-throughput method of identifying various biomarkers 
that distinguish circulating tumor cells from malignant phenotypes. 
Unlike hematogenous metastasis, which can be modeled with a constant wall shear 
stress, a cell which is metastasizing in the lymphatic vessels is exposed to a decreasing wall 
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shear stress as it moves from the entering afferent vessel toward the perimeter of the 
subcapsular sinus, the first point of entry into the lymph node for circulating tumor cells 
that have harnessed lymphatic vessels for transport.14,15 As a result, the hydrodynamic 
microenvironment under which selectin-mediated adhesion occurs is different in the 
lymphatics than in the blood vasculature, and, thus, the interrogation of biophysical and 
biomechanical mechanisms of lymphatic metastasis require a unique model system to 
recapitulate the distinctive fluid flow regime. Importantly, despite the central role the 
lymphatics play in metastasis, as lymph node status is a key indicator of cancer 
aggressiveness and patient prognosis, there is currently no in vitro system to interrogate 
the mechanisms of tumor cell recruitment and extravasation through selectin-mediated 
adhesion during lymphatic metastasis.16–19 Further complicating the investigation of 
lymphatic metastasis is tumor induced remodeling of the lymph node, such as dilation of 
the afferent lymphatic vessel and subcapsular sinus, which alters the fluid flow and wall 
shear stress that circulating tumor cells are exposed to.14,20–23 Taken together, due to the 
limited understanding of the process of lymphatic dissemination of circulating tumor cells, 
there exist a need to elucidate, on-chip in a high-throughput manner, the contribution of 
lymphatics in permitting cancer cell extravasation, and the role of the altered wall shear 
stress profile of the remodeled lymphatics in potentiating metastasis.  
In summary, an outstanding problem in the field are the lack of effective systems to 
interrogate the role of hydrodynamic forces and cellular molecular profiles in initiating and 
sustaining increased selectin-ligand interactions, and how this may lead to enhanced 
extravasation and metastatic propensity of circulating tumor cells. Significantly, the 
development of such systems to study and better understand the interactions between 
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metastatic cancer cell surface selectin ligands and selectins expressed in the blood 
vasculature and the elucidation of cellular adhesion in the lymphatic system under 
hydrodynamic flow provide critical insight into the role of selectin-mediated adhesion in 
cancer metastasis. Of clinical relevance, these insights can serve to aid in the development 
of targeted drug therapies to attenuate metastasis while minimally impacting normal cell 
processes.24,25 
As such, the overall objective of this proposal is to engineer microfluidic platforms 
that will enable the interrogation of the adhesive behavior of cells under physiologically 
relevant hydrodynamic forces. These microfluidics will establish systems to permit 
analysis of selectin-mediated adhesion and interrogation of cellular characteristics 
underlying selectin-selectin ligand interactions between the endothelium of the blood 
vasculature and metastatic cell subsets that occur during cancer dissemination in a tumor 
microenvironment and interrogate the role of lymphatic remodeling in the presence of a 
tumor in altering the adhesive behavior of circulating cells entering the lymph nodes. My 
central hypothesis is that microfluidic systems can be engineered to mimic the 
hemodynamic forces of the circulatory system or hydrodynamic forces of the lymphatic 
system, which can be implemented to interrogate cellular characteristics associated with 
adhesion in flow or the effects of altered microenvironments on metastasis. This hypothesis 
will be tested using in vitro fluidic models in the following specific aims. 
1.2 Specific Aims 
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Specific Aim 1: Develop an adhesion chromatography microfluidic that sorts cells 
based on their elution time from a selectin functionalized substrate of the flow channel 
to analyze attributes of cells with different adhesive phenotypes.  
The working hypothesis of this aim is that metastatic cancer cell subsets can be 
functionally coenriched based on their propensity to mediate adhesive interactions with 
selectins in flow. To this end, an integrated, parallel-plate microfluidic device was 
engineered to interrogate and fractionate cells based on their adhesivity to a substrate 
surface functionalized with adhesive ligand in a tightly controlled flow environment to 
elucidate associated cell-intrinsic pathways. Wall shear stress levels and endothelial 
presentation of E-selectin were modeled after the inflamed vasculature microenvironment 
in order to simulate in vitro conditions under which in vivo hematogenous metastasis 
occurs. Based on elution time from the flow channel, the collection of separate fractions of 
cells – non-interacting and interacting – at high yields and viabilities enabled multiple post-
perfusion analyses, including flow cytometry, in vivo metastasis modeling, and 
transcriptomic analysis. This platform enabled the interrogation of flow-regulated cell 
molecular profiles, such as (co)expression levels of natively expressed selectin ligands 
sLex, CD44, and carcinoembryonic antigen, and cancer stem cell marker CD24. This 
additionally revealed E-selectin adhesivity exhibited by metastatic human colon carcinoma 
cells to be a transient phenotype. Facile and rapid, this methodology for unbiased, label 
free sorting of large populations of cells based on their adhesion in flow represents a 
method of studying flow-regulated adhesion in vitro for the identification of molecular 
drug targets for development as anti-metastatic cancer therapeutics.26 These results are 
presented in Chapter 3. 
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Specific Aim 2: Uncouple short time- and length-scale velocity from long time- and 
length-scale average velocity by integrating a photoconversion system with a cell 
sorting adhesion chromatography platform.  
The working hypothesis is that an integrated photoconversion, cell sorting 
microfluidic platform can be designed to simultaneously quantify short and long time- and 
length-scale velocities of perfused cells, enabling the evaluation of whether short time- and 
length-scale metastatic cancer cell rolling velocities correspond to cell adhesion over long 
distances or time scales. To test this hypothesis, photoconvertable protein technology was 
incorporated with the cell sorting microfluidic system engineered in Aim 1. As such, an 
integrated photoconversion and cell sorting parallel-plate chromatography channel 
enabling the measurement of long and short time- and length-scale velocities of cells 
mediating adhesion in flow fields was engineered to study the mechanisms underlying 
adhesion to selectins by metastatic cancer cells. Through the facile enrichment of cells into 
subfractions of differing adhesive behaviors and a fluorescent velocity probe amenable to 
off-chip analysis, underlying, causal molecular profiles implicated in differing adhesive 
phenotypes of metastatic cancer cells could be interrogated. This analytical method 
revealed selectin-mediated rolling adhesion to be strongly associated with expression of 
selectin ligands, correlations that vary with ligand type and rolling velocity magnitude. 
Discrete selectin ligand expression profiles were also found to underlie persistent versus 
non-persistent adhesion on selectins, suggestive of divergent regulatory mechanisms. This 
integrated cell sorting and photoconversion microfluidic platform thus enables in vitro 
analysis and comparisons of adhesive phenotypes as they relate to mechanisms of cancer 
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cell metastasis in the context of selectin mediated adhesion, revealing new insights into 
potential cancer dissemination pathways.27 These results are presented in Chapter 4. 
Specific Aim 3: Engineer a lymph node “sinus-on-a-chip” adhesion microfluidic to 
explore the effects of WSS magnitude and dissipation on adhesion of cells, 
particularly as it relates to lymphatic remodeling in the presence of a tumor or 
inflammation.  
The working hypothesis is that the structural changes within the sinus and afferent vessel 
that occur in the presence of a tumor or in states of inflammation alters the theoretical 
position at which cells can optimally interact within the lymph node subcapsular sinus, and 
these effects are further influenced by upregulation of presented adhesion receptors. To test 
this hypothesis, a lymph node “sinus-on-a-chip” adhesion microfluidic device that 
recapitulates the hemodynamic microenvironment of the lymph node subcapsular sinus 
was engineered to interrogate the effects of lymph node remodeling on cellular adhesion 
in fluid flow relevant to lymphatic metastasis and immune cell homing. Wall shear stress 
levels within the microfluidic channel analytically estimated and modelled after both 
quiescent and diseased/inflamed lymph nodes were recapitulated using this adhesion 
analysis device, enabling the assessment of wall shear stress magnitude and dissipation on 
human monocytic and metastatic cancer cell line adhesion. This methodology revealed the 
potential for structural changes within the lymph node sinus and afferent lymphatic vessel 
to reposition adhesive cells within the lymph node sinus microenvironment, effects 
dependent on adhesive molecule presentation context.  Our results indicate that biophysical 
changes including wall shear stress magnitude, dissipation rate and cell transit time in flow 
as well as biochemical changes such as adhesion receptor expression within the sinus 
 8 
lumen and the presence of lymph-borne cells synergistically contribute to the extent of 
adhesion. Given the tight orchestration of chemotactic cues within lymph nodes to drive 
optimal adaptive immune responses, these findings implicate lymph node remodeling to 
regulate the location at which cells can optimally interact and/or within the subcapsular 
sinus and therefore potential mechanism of lymph node invasion. These results are 
presented in Chapter 5. 
1.3 Significance 
The innovation of the work presented herein is in creating microfluidic adhesion 
chromatography systems that recapitulate the hydrodynamic forces and microenvironment 
of the areas in which metastatic extravasation occurs. While a wide distribution of adhesive 
phenotypes of cells has been observed upon recapitulation of the selectin-mediated 
adhesion process in vitro, the direct relationship between endogenous expression of 
selectin ligands on metastatic cells and their rolling adhesion behavior over selectins in 
both the blood vasculature and lymphatics is poorly understood.11,12,24 By establishing 
models to study cancer extravasation in vitro, this research develops systems to permit 
future interrogation of the effects of selectin ligand presentation on cell adhesion 
biomechanics to selectins in flow, and elucidate the poorly understood role of the 
lymphatics, particularly the effect of lymphatic remodeling in response to a tumor, in 
potentiating cancer metastasis. In the future, the knowledge gained by using these 
platforms may inform the development of therapeutic strategies that utilize the unique 
expression of glycan epitopes on selectin ligands of circulating tumor cell surfaces to 
develop targeted therapies that inhibit metastasis.24,25,28,29 Individually, each specific aim 
has contributed to the field of bioengineering in the following ways: 
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Specific Aim 1. Capacity to sort subsets of cells based on their adhesive phenotype in a 
physiologically relevant blood vasculature microenvironment.  
Previously, there did not exist a system to sort, collect, and enrich subsets of cells 
based on their adhesion propensity to a selectin-functionalized substrate of a microfluidic 
device in a high-throughput manner. Therefore, in Specific Aim 1, we engineered a flow-
based device that functions as an adhesive chromatography platform. This system, based 
on a widely used parallel-plate flow chamber, leverages time-averaged velocities of cells 
perfused as a pulse in a controlled flow field as a proxy for overall adhesion propensity to 
a substrate surface functionalized with adhesive ligands. The high-throughput nature of the 
cell adhesion chromatography system permits the analysis of a large number of cells 
simultaneously in an environment that, used herein, recapitulates the physiological flow of 
the circulatory system. Using the microfluidic analysis platform to study the behavior of 
cancer cells in the vascular microenvironment, and therefore relating the phenotypic 
characteristics of a cancer cell with their adhesive potential, can inform novel biomarkers 
to distinguish lowly adhesive from highly adhesive cancer cells and identify molecular 
pathways that can be targeted with therapeutics to prevent cancer metastasis.27 
Specific Aim 2. Integration of a cell sorting microfluidic and a photoconversion platform 
to interrogate drivers of adhesion persistence. 
Previously, the photoconversion platform has been used to elucidate phenotypes 
underlying varying adhesive propensities at a single cell level based on short time- and 
length-scales, and the cell sorting platform has been used interrogate phenotypic 
differences underlying varying adhesive propensities at a large, cell subset level based on 
average velocity.12,26 However, the correlation between these two readouts has not been 
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extensively explored or distinguished. Therefore, by combining these two platforms, we 
engineered an integrated system that is capable of isolating and identifying subsets of cells 
with different adhesive behaviors to enable associated cellular phenotypes to be discerned. 
Separating cells based on biophysical characteristics is a broadly used technique for 
probing mechanisms underlying multiple disease types, and this platform improves upon 
former methods by enabling both quantification of rolling adhesion velocities and 
assessment of their qualities, e.g. persistent versus non-persistent.11–13,26 Our results 
demonstrating divergent molecular profiles associated with various adhesive phenotypes 
suggests the potential for this system to be applied to identify druggable targets on distinct 
subsets of circulating cancer cells (tumor initiating, for example) or provide nuance to the 
utility of various biomarkers in distinguishing circulating cells with distinct malignant 
phenotypes.27  
Specific Aim 3. Development of a “lymph node sinus-on-a-chip” to interrogate the role of 
lymphatic transport in lymphatic metastasis. 
While many in vivo models to study lymph node metastasis exist, there have been 
few studies that explore lymphatic metastasis in the context of cell adhesion in vitro, 
particularly as it relates to selectin-mediated adhesion and the resulting wall shear stress 
profile of remodeled lymphatics. There currently does not exist an effective system to 
model lymphatic flow from the afferent lymphatic vessel into the subcapsular sinus, which 
is the primary route of tumor infiltration into the lymphatics. Therefore, the exact 
mechanisms of tumor cell recruitment and extravasation through the lymphatics remains 
poorly understood. As such, we engineered an adhesion microfluidic “lymph node sinus-
on-a-chip” platform to visualize and quantify the adhesive behavior of cells on a surface-
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functionalized substrate. This platform permitted, for the first time, the interrogation of 
cancer cell metastasis as it first occurs in the lymphatics from the afferent vessel into the 
subcapsular sinus, and the role of the altered wall shear stress profile of remodeled 
lymphatics on altering the adhesive propensity of cells to further promote adhesion and 
extravasation. The development of a system to interrogate the pathways and intricacies of 
immune cell homing to the lymph nodes and lymphatic metastasis in the context of 
hydrodynamic forces will allow for the elucidation of the biomechanical, biophysical, and 
biochemical processes and regulation of circulating cell adhesion and extravasation 
through the lymph nodes, which can better explain the poorly understood process of 
lymphatic metastasis and begin to inform therapeutics that are directed at preventing 




CHAPTER 2. BACKGROUND AND LITERATURE REVIEW  
2.1 Cell Adhesion in the Vasculature 
2.1.1 Cell Adhesion under Hydrodynamic Flow 
In order to disseminate into distant tissues in the body, circulating tumor cells that 
have intravasated into a blood or lymphatic vessel must engage in a multistep adhesion 
cascade that slows them down amidst fluid flow, permitting them to leave the vessel and 
infiltrate tissues at sites far removed from the primary tumor, multiply, and form metastatic 
tumors.3,30,31 Importantly, these circulating tumor cells that have intravasated into the 
vasculature are exposed to hydrodynamic forces as they move through vessels (Figure 
2.1).7,32 
 
Figure 2.1 Hydrodynamic Forces Acting on Cells in the Vasculature. Cells moving 
through the vasculature are exposed to normal, shear, and tensile forces due to fluid 
flow.33 
One hydrodynamic force that has a significant effect on the adhesion of circulating 
tumor cells is wall shear stress, or the tangential force acting at the interface between blood 
or lymphatic fluid flow and endothelial cells lining the vessel, which ranges from 1-6 
dyn/cm2 in healthy veins to 10-70 dyn/cm2 in healthy arteries.34–36 Therefore, escaping the 
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bloodstream or lymphatic system and forming secondary tumors requires that circulating 
tumor cells overcome the dispersive forces of fluid flow, including wall shear stress, by 
utilizing a highly orchestrated adhesion process that begins with rolling adhesion on the 
vascular endothelium under a high shear environment.3,37 This process is driven by 
interactions between endothelial-presented selectins and glycan epitopes on selectin 
ligands present on the metastatic cell’s surface.8,9,38–41 Due to the fast binding kinetics of 
these interactions, which yields a high bond turnover rate, the interaction of selectins with 
their ligands decreases the forward velocity of the cells.42–45 Notably, the slower velocity 
of rolling cells enables the formation of integrin-cell adhesion molecule (CAM) bonds, 
which have a slower kinetic rate than selectin-selectin ligand bonds and allows the rolling 
cells to firmly adhere to the vessel wall.11,46–48 This firm adhesion is required before a 
circulating tumor cell can transmigrate across the endothelium for tissue infiltration and 
the formation of metastatic tumors.33,46,49 When selectin-mediated adhesion is recapitulated 
in vitro, a cell exhibiting rolling adhesion is defined as the cell moving with a translation 
velocity less than a free flowing, non-interacting cell, and a firmly adherent cell is defined 
as a cell that is not moving (Figure 2.2).11,13,33 
Notably, this multistep adhesion process is employed not only in cancer metastasis, 
but also in numerous other physiological and pathophysiological conditions, including the 
recruitment of leukocytes to sites of inflammation and the homing of stem cells.50–52 
Consequently, a better understanding of the interactions between metastatic cancer cell 
surface glycan epitopes and selectins as mediated by biomechanical forces from blood or 
lymphatic flow will aid in the development of targeted drug therapies to attenuate 
metastasis while minimally impacting normal cell processes. 
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Figure 2.2 Selectin Mediated Adhesion in the Vasculature. (A) Cells extravasate by a 
process of selectin-mediated rolling adhesion, integrin-mediated firm adhesion, and 
migration across the endothelium. (B) Experimentally, two types of adhesion are 
observed: rolling adhesion (top row) and firm adhesion (bottom row). Colored labels 
indicate position of an example rolling or firmly adhered cell at successive points in 
time, where red represents the 0 second time point and blue represents the 4 second 
time point.33 
2.1.2 The Role of Selectins and Selectin-Ligands in the Adhesion Cascade 
Selectins are a family of three related calcium dependent, transmembrane adhesion 
molecules – P-selectin, E-selectin, and L-selectin – composed of a carbohydrate binding 
amino-terminal, an epidermal growth factor-like domain, and a series of two to nine short, 
consecutive repeats between the two domains, which differentiates the selectin based on 
the number of repeats (Figure 2.3).53,54 P-selectin is found on platelets and (lymphatic) 
endothelial cells and since it is stored in the α-granules of platelets and Weibel-Palade 
bodies of endothelial cells, it can be quickly expressed on the surface of cells in response 
to cytokines or activating agents, such as interleukin 4 or 13.55 (Lymphatic) endothelial 
cells also express E-selectin, which is transcriptionally regulated by cytokines, such a 
P 
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tumor necrosis factor α and interleukin-1. Unlike P-selectin, E-selectin is not stored in the 
cell, and therefore, must be transcribed, translated, and transported to the cell surface de 
novo.56 Finally, L-selectin is found on leukocytes, acting as a homing receptor for entry 
into secondary lymphoid tissue through the high endothelial venules of the vasculature.57–
61 
 
Figure 2.3. The structure of selectin molecules. Selectins are composed of a C-type 
lectin domain, an EGF-like domain, and consecutive repeats of complement-binding 
protein-like domains that vary in number and differentiate the selectins.62 
The propensity for cells, such as circulating cancer cells or leukocytes, to initiate 
interactions with selectin molecules and thereby engage in the first step of the adhesion 
cascade, is controlled by their expression of specific cell surface presented glycoproteins 
and glycolipids that act as selectin ligands.33,52,57,59,63 Tetrasaccharide sialyl lewis x (sLex), 
a terminal carbohydrate epitope of glycans attached to glycoproteins and glycolipids, is the 
most basic binding motif to all three selectins, and therefore must be expressed by a 
circulating cell for it to engage with selectin molecules presented by endothelial cells, 
platelets, and leukocytes.64,65 All selectins also bind PSGL-1 and it serves as the main 
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leukocyte ligand for adhesion to P-selectin.32,33 Two additional selectin ligands of 
particular interest in cancer biology are (1) CD44, which is a functional P- and E-selectin 
ligand that can be differentially spliced by metastatic cells to increase its binding avidity 
to P-selectin, and (2) carcinoembryonic antigen (CEA), which possesses E- and L-, but not 
P-selectin, ligand activity (Figure 2.4).57,66 Although selectins and some of their ligands 
are well studied, the understanding of the correlation between selectin-mediated adhesion 
in flow and the corresponding (co)expression of selectin ligands, and the molecular 
mechanisms that underlie this behavior, is currently deficient, particularly as it relates to 
extravasation of circulating tumor cells. 
 
Figure 2.4. Cancer Cell Expressed Selectin Ligands. Circulating cancer cells can 
escape from the vasculature amidst hydrodynamic forces to establish secondary 
tumors through cell-cell interactions mediated by selectins presented on the vascular 
endothelium or circulating host cells and the selectin ligands on the circulating tumor 
cell.12 
2.2 Contributions of Selectins and Their Ligands in Cancer Metastasis 
Numerous studies have implicated selectin-mediated adhesion in facilitating 
hematogenous dissemination of tumor cells in a process that mirrors leukocyte 
extravasation.9,11–13,40 E- and P-selectin has been shown involved directly in the adhesion 
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of circulating tumor cells to the vascular endothelium. Conversely, L-selectin, and in some 
cases P-selectin, has been shown to have an indirect role in metastatic extravasation.62,67 
Together, E-, P-, and L-selectin, in combination with additional cell adhesion molecules 
expressed by cells in vessels forming bonds with adhesion ligands present on the surface 
of cancer cells are hypothesized to allow a circulating tumor cell that has escaped into the 
blood or lymphatic system to slow down against fluid flow, adhere to the vessel wall, and 
extravasate.39,62,68 
2.2.1 Selectins in Cancer Metastasis 
E-selectin, which is expressed by both endothelial cells and lymphatic endothelial 
cells, mediates slow, persistent rolling adhesion, and has been found to be upregulated in 
metastatic cancer.11,13,57 Therefore, interactions between circulating tumor cells and E-
selectin are of particular interest when elucidating extravasation. Expectedly, the 
involvement of E-selectin in the formation of metastases in vivo has been interrogated by 
multiple groups. One study found that E-selectin knock-out mice have a drastically reduced 
capacity to form metastatic tumors compared to wild-type controls. In colon carcinoma, 
there is a direct association between the expression levels of numerous E-selectin ligands 
and metastatic phenotype characteristics, including enhanced adhesion to the endothelium 
of the blood vasculature.69 Further substantiating these observations is a study that showed 
transgenic mice overexpressing E-selectin in the liver are able to form liver metastases 
when injected with E-selectin expressing melanoma cells, whereas wild-type mice did not 
form any metastatic tumors.70 Despite this evidence that E-selectin is implicated in cancer 
metastasis, the mechanism underlying interactions between E-selectin and metastatic 
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cancer cells under flow, both in hematogenous and lymphatic microenvironments, has yet 
to be fully explored and explained in vitro.  
Endothelial cells and inflamed lymphatic endothelial cells also express P-selectin, 
and therefore, P-selectin is also conjectured to have a direct role in permitting circulating 
tumor cells adhesion to the endothelial cell-lined blood vessel walls or inflamed lymphatic 
vessel and lymph node walls.71,72 However, unlike E-selectin, P-selectin mediates 
nonpersistent adhesion of metastatic cancer cells with intermediate rolling velocities.11,13 
Finally, L-selectin is expressed by leukocytes, and mediates fast, nonpersistent tethering of 
metastatic cancer cells indirectly through secondary capture to form clusters of cells that 
are able to evade immune detection and overcome the dispersive forces created by 
hydrodynamic flow in vessels.11,13,64,73 Notably, P-selectin, which is expressed not only by 
(lymphatic) endothelial cells but also platelets, can also contribute indirectly to 
dissemination of circulating tumor cells in a manner similar to L-selectin through 
secondary tethering of circulating tumor cells to endothelial walls with platelets acting as 
an intermediary. 58 Although the characteristics of P- and L-selectin mediated adhesion of 
cancer cells is different than that of E-selectin, expression of P- and L-selectin is also 
correlated with increased metastases in vivo. For example, P-selectin deficient mice and L-
selectin deficient mice, as well as P-/L-selectin double deficient mice, exhibit decreased 
metastatic potential compared to untreated mice.74 Moreover, silencing of L-selectin on 
macrophages attenuates the occurrence of lymphatic metastases when mice are injected 
with lymphoma cells.75 Collectively, there is sufficient evidence to implicate E-, P-, and L-
selectin in directly and/or indirectly facilitating metastasis, and thus, after expounding the 
mechanisms by which selectin-mediated recruitment of disseminated tumor cells occurs, 
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drugs targeting specific molecules or mechanisms of this process may serve as promising 
anti-cancer metastasis therapeutics.25,28 
2.2.2 The Role of Selectin Ligand Expression in Cancer Cell Adhesion 
Since selectins have been shown to play an important role in cancer metastasis, the 
selectin ligands expressed by circulating cancer cells are also implicated as key regulators 
of the metastatic cascade.11–13,69,70,74 One hallmark of cancer cells is aberrant glycosylation, 
which is marked not only by changes in cell surface glycosylation between healthy and 
cancerous cells, but also continuation of alterations in cell surface glycosylation as the 
cancer progresses.13 Notably, one observed change in glycosylation is hypersialylation – 
the overexpression of sialic acid residues on the surface of cancer cells – which may 
enhance the metastatic potential of cancer cells by increasing the ability of circulating 
tumor cells being able to interact with, adhere to, and transmigrate across endothelial cells 
lining the blood or lymphatic vessel.76,77 Most of the cancer cells that interact with selectins 
express several selectin ligands, some of which are canonical ligands that are also 
expressed by leukocytes, such as CD44, while others are non-canonical ligands unique to 
cancer cells, such as CEA.78–80 Functionally, increased expression of selectin-ligands has 
been found to be directly and proportionally correlated with increased adhesion.11–13,78,81,82 
Notably, a series of in vitro studies interrogating extent of rolling adhesion of metastatic 
colon carcinoma cells on P-, E-, and L-selectin found that increased expression of sLex, the 
most basic binding motif for all selectins, conferred slower short time- and length-scale 
rolling velocities on all selectins. Furthermore, this same study noted that enhanced 
expression of CD44 was correlated with slower short time- and length-scale rolling 
velocities on E- and L-selectin, and enhanced expression of CEA conferred slower short 
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time- and length-scale rolling velocities on E-selectin.12 Clinically, expression levels of 
selectin ligand PSGL-1 is correlated with increased disease progression in myeloma, and 
E-selectin ligands expressions are increased in the tumor cells of acute myeloid leukemia 
patients with metastatic disease compared to patients with only primary tumors.83,84 
Taken together, selectin ligands may individually or synergistically contribute to 
circulating tumor cell adhesion in the microvasculature. However, there remains a 
deficiency of understanding of the direct relationship between endogenous expression of 
selectin ligands on metastatic cells and adhesivity, especially at long time- and length-
scales. 
2.2.3 Selectin Mediated Adhesion and Cancer Stem Cells 
Cancer stem cells (CSCs) represent a unique subset of cells that are characterized by 
their stem cell-like ability to self-renew, proliferate unlimitedly, and differentiate into 
multiple lineages, which grants them an enhanced capacity to form metastatic tumors.85,86 
There is accumulating evidence that the capacity of CSCs to self-renew indefinitely and 
differentiate into a heterogeneous population of cells is responsible for the resistance of 
many cancers to chemotherapeutics and cytotoxic agents.87–89 Notably, some markers of 
CSCs, such as CD44 and CD24, are also functional selectin ligands on metastatic cancer 
cells, suggesting that CSCs may also exhibit an enhanced ability to engage in selectin-
selectin ligand interactions under hydrodynamic flow that are necessary to initiate adhesion 
and extravasation through the vasculature for the eventual formation of metastatic 
tumors.80,90–92 However, there is some ambiguity in CSC markers among different cancers, 
as some ligands, such as CD24, are observed to be CSC markers in only a subset of cancers, 
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and even within particular cancers, there is a heterogeneous expression level of CSC 
ligands.91,93–95 Furthermore, the exact correlation between expression levels of CSC 
markers and a metastatic cancer cell’s adhesive propensity is unclear, as there is conflicting 
literature regarding the expression of selectin ligand markers and metastatic potential as it 
relates to CSC subsets.96–98 Relevant to studies in this thesis, one group found that 
knockdown of CD44 on metastatic colon cancer cells resulted in decreased metastases in 
vivo, despite CD44’s known role as both a CSC marker in colorectal cancer as well as a 
mediator of slow rolling behavior of metastatic colorectal cancer cells to P- and E-selectin 
in vitro.99 Further compounding these contradictory roles of CD44 is a study that colabeled 
metastatic cancer cells for two CSC markers – CD44 and CD24 – and analyzed the short 
time- and length-scale adhesion of these cells in vitro, and found that CD44hi/CD24hi, but 
not CD44low/CD24hi subsets of cells, had significantly greater proportion of slow rolling 
cells compared to fast rolling cells, suggesting that knocking-out CD44 .12  
Taken together, due to the potentially enhanced capability of CSCs to evade 
destruction by current cancer therapeutics, there is a clear need to engineer systems that 
can permit further interrogation of the existence of a relationship between expression levels 
of CSC markers and increased metastatic potential, as it can serve to reconcile conflicting 
reports regarding the adhesive propensity of cancer stem cells, provide more clarity to 
molecular underpinnings of cancer metastasis, and improve current cancer treatments or 
identify new drug targets. 
2.3 The Lymphatic System 
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The lymphatic system, like the circulatory system, is responsible for the movement 
of fluid throughout the body. There are two main components of the lymphatic system – 
(1) the lymphatic vessels, which are responsible for transporting interstitial fluid, soluble 
proteins, and immune cells; and (2) the lymph nodes (LNs), which are responsible for 
filtering the components of lymphatic fluid before returning it to the blood.100–103 Together, 
there are over 500 LNs in the human body, which are all interconnected by a vast network 
of lymphatic vessels.104 These lymphatic vessels are made up of highly permeable initial 
lymphatic capillaries that combine to form larger collecting lymphatic vessels. These 
collecting lymphatic vessels drain directly into the LNs via afferent vessels, permitting the 
contents contained within the lymphatic fluid to gain access into the lymph node.105–107 The 
first point of entry from the afferent vessel into the LN is the subcapsular sinus (SCS), 
which is lined by a layer of lymphatic endothelial cells (LECs) on top of a layer of SCS 
macrophages.108–111 After entering the SCS, lymphatic fluid drains through the trabecular 
sinus, into the medullary sinus, and finally out of the LN through the efferent lymphatic 
vessel (Figure 2.5A).103,104,112 Notably, the endothelial lining of the SCS basement acts as 
a crucial gatekeeper into the deeper regions of the LN, as penetration through the SCS 
permits access to the deeper LN cortex (Figure 2.5B).112–114 
Collectively, the lymphatic system is a series of interconnected lymphatic vessels 
and lymph nodes that provide cells with a route of transport throughout the body, and also 
play a crucial role in protecting host immunity by transporting antigen and antigen 




Figure 2.5. Anatomy of the Lymph Nodes. (A) Lymphatic fluid enters the lymph node 
from the afferent vessel, travels through the subcapsular sinus, trabecular sinus, 
medullary sinus, and leaves the lymph node by the efferent vessel. (B) Penetration 
through the subcapsular sinus allows access to the deeper cortex of the lymph node.112  
2.4 Lymphatic Metastasis 
Although direct hematogenous metastasis can occur, the lymphatics have also been 
found to play a central role in cancer metastasis, as the LNs provide efficient access to 
distant organs and an expanded network of local lymphatics by draining directly into the 
circulatory system or through the thoracic duct. Consequently, through a sequential 
sequence of events, a cancer cell that leaves the site of a primary tumor by intravasation 
can be rapidly carried to the LN afferent vessel and into the SCS of the sentinel LN via the 
natural route of lymphatic fluid flow.116–121 Once the disseminated tumor cell has entered 
the lymph node, it can: (1) Actively migrate through the endothelial lining of the sinus, 
multiply, and form a metastatic tumor within the LN; (2) Continue moving through the 
lymphatic network via the thoracic duct and take up residence in more distant lymph nodes; 
or (3) Drain into the circulatory system and begin the process of hematogenous metastasis. 
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There is direct evidence of the spread of metastatic tumor cells from the sentinel LNs to 
distant organs through lymphatic vessels, and, due to the multifaceted pathway of 
dissemination, the involvement of the LNs in the metastatic cascade is thought to allow the 
formation of numerous, simultaneously occurring secondary tumors originating from a 
single primary tumor, in addition to the formation of tumors within the lymph nodes 
themselves (Figure 2.6).122–125  
 
Figure 2.6. Disseminated Tumor Cell Invasion of the Lymphatic System. Tumor cells 
can intravasate into the lymphatic system and gain access to the subcapsular sinus 
through the afferent vessel. Once a circulating tumor cell has entered the lymph node, 
it can form a metastatic tumor within the lymph node or use the lymphatics to travel 
to other sites in the body to form distant organ metastases.125 
Substantiating the involvement of the LNs in cancer metastasis are numerous 
reports that have interrelated the existence of circulating tumor cells in the LNs to a poorer 
disease prognosis, with a negative correlation between a positive LN status and patient 
survival.17,126–132 For example, the five year survival rate for colorectal cancer patients 
diagnosed with LN positive cancer is over 30% less than patients with LN negative cancer, 
and the five year survival rate for LN positive pancreatic cancer patients is a mere 
12%.17,126,130 Furthermore, there are numerous in vivo reports of lymphatic metastases 
among cell lines from various cancers, including 4T1 breast cancer cell line, B16F10 
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melanoma cell line, LS174T colon adenocarcinoma cell line, and PANC-1 pancreatic 
cancer cell line.133–136 Despite the clinical and experimental evidence of lymphatic 
involvement in cancer metastasis, the mechanisms of lymphatic metastasis and the roles 
circulating tumor cell adhesion ligand – lymphatic endothelial cell adhesion molecule 
interactions remain widely unknown.   
2.4.1 Lymphatic Vessel Remodelling in Cancer 
 The presence of a primary tumor can lead to dynamic remodeling of the LNs, 
including lymphangiogenesis, lymphatic vessel diameter dilation, SCS dilation, and an 
upregulation of cellular adhesion molecules.137–142 Lymphangiogenesis involves the 
proliferation, sprouting, migration, and tube formation of new lymphatic vessels from 
existing lymphatics, and is driven by lymphatic endothelial cells migrating and 
proliferating at the site of the primary tumor to form sprouting lymphatic vessels that 
connect the tumor to the lymphatic system. Therefore, lymphangiogenesis can provide 
cancer cells increased access to the LNs, facilitating the infiltration of the lymphatic system 
with disseminated tumor cells.137,142,143 Also promoting the entry of cancer cells into the 
LNs is the enlargement of collecting lymphatics that is commonly observed in cancer 
patients. Although lymphatic vessel enlargement does not result in the formation of 
additional vessels, it can facilitate invasion simply by increasing the amount of drainage 
from the primary tumor to the sentinel LN, which leads to more efficient delivery of cancer 
cells to distant sites in the body through the LN.133,140,144  
2.4.2 Subcapsular Sinus Remodelling in Cancer 
 26 
 In addition to dilation of the collecting lymphatics, remodeled LNs in the presence 
of a tumor also exhibit dilation of the SCS, which results in an increase in the size of the 
LNs, including the height of the SCS. 14,139,145–147 This remodeling may create an 
transformed microenvironment that supports cancer metastasis by altering the fluid flow 
through the SCS and increasing the number of disseminated tumor cells that can be 
contained within the SCS.138,139,141 Additionally, the lymphatic endothelial cells lining the 
walls of the subcapsular sinus exhibit an increase in adhesion molecule presentation, 
including the upregulation of two molecules implicated in the metastatic extravasation 
adhesion cascade, ICAM-1 and VCAM-1, in response to inflammation, including 
inflammation created by the tumor microenvironment.148–152 Importantly, this enhanced 
ICAM-1 and VCAM-1 expression is directly correlated with increased LN metastases and 
poorer patient survival in clinical oral tongue squamous cell carcinoma patients.150 In vivo, 
one study found that less than one-third of mice injected with B16F1 cells with low affinity 
for VCAM-1 developed LN metastases. Conversely, over two-thirds of mice injected with 
B16F1 cells with high affinity for VCAM-1 developed LN metastases.153 Given the role of 
VCAM-1 in the process of tumor cell dissemination, these studies suggest that increased 
expression of VCAM-1 on lymphatic endothelial cells may have the functional 
consequence of increasing the ability of circulating tumors cells contained within the SCS 
to adhere and transmigrate across the basement of the SCS, however, this has yet to be 
shown experimentally. 
 Bridging the effects of shear stress and the enhanced expression of cellular adhesion 
molecules on lymphatic endothelial cells of remodeled LNs is a hypothesis that ICAM-1 
upregulation on lymphatic endothelial cells is due, at least in part, to increased shear force 
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from lymphatic fluid flow in the SCS of LNs that have altered in response to the tumor 
microenvironment.149,152 Kawai et al. isolated lymphatic endothelial cells from sentential 
LNs of breast cancer patients and stimulated them with high levels of shear stress. 
Quantification of ICAM-1 expression showed that both mRNA and protein levels increased 
upon stimulation, and this stimulation induced ICAM-1 upregulation was sufficient to 
increase the adhesion of breast cancer cells to lymphatic endothelial cells in vitro.149 These 
observations were substantiated by Miteva et al., who also found that fluid flow induces 
an upregulation of ICAM-1 expression on lymphatic endothelial cells in both in vitro and 
in vivo models.152 
 Together, lymphatic structure changes that occur in response to a tumor may further 
facilitate metastases by altering the fluid flow into the LNs and altering the wall shear stress 
profile within the SCS. The effect of lymphatic remodeling, however, remains widely 
unexplored as it relates to mechanisms of cancer extravasation, particularly the biophysics 
of cell adhesion in the context of lymphatic fluid flow. 
2.5 Current Technologies to Study Cell Adhesion 
To enable both the interrogation of biomechanical effects on metastasis and to better 
comprehend the mechanisms of adhesion, engineered microfluidic systems are frequently 
implemented to model metastasis in vitro.11,13 Despite being highly simplified systems 
relative to in vivo models, they have the advantage of enabling experimentation under 
defined cellular, molecular, and/or biophysical conditions.154 Using videomicroscopy-
based imaging integrated with microfluidics to monitor the extent of adhesion in simulated 
flow fields that exhibit forces similar to those experienced in the microvasculature, many 
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thousands of cells can be analyzed in a single experiment, enabling high sampling volumes 
in individual or parallelized experiments. Biochemical, biomolecular, and transcriptomic 
manipulations of analyzed cells can also be performed to interrogate biomolecular 
mechanisms contributing to metastatic adhesive phenotypes.11,12,44,154–156 The capacity to 
probe the attributes intrinsic to cancer cells that confer adhesion in an unperturbed manner, 
however, is not feasible using these interventional type approaches without a priori 
knowledge. Imaging based analyses alone provide limited insight into biomolecular 
mechanisms and also does not allow subsets of cells to be collected and assayed in an 
unbiased manner based on their phenotypes of adhesion.157  
Further, most flow-based microfluidic platforms that are currently used for cell 
adhesion assays do not have the capacity to interrogate long time- and length-scale 
adhesive behavior of cells, and instead analyze short time- and length-scale adhesion.11–
13,156 The ability to interrogate long time-and length-scale adhesion of cells or juxtapose 
short and long time- and length-scale adhesion of cells and analyze biological difference 
that underlie subsets of cells with different adhesion propensities is currently deficient. 
There is a need to elucidate different time- and length-scale adhesive propensity of 
metastatic cancer cells, as it has been previously noted that short time- and length-scale 
rolling behavior of cells over selectins does not predict average rolling behavior of cells. 
This phenomena, termed reduced “adhesion persistence”, may implicate specific subsets 
of cells in enhanced metastatic potential, and therefore a better understanding of 
observation can serve to improve anti-cancer metastasis therapeutics.11,13 
Outstandingly, sufficient in vitro models to study the mechanisms of lymphatic 
metastasis are even more lacking than microfluidic platforms to study hematogenous 
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metastasis, and the wall shear stress conditions under which tumor cells in the LNs are 
exposed to is rarely incorporated into such in vitro LN models. Previously, hydrodynamic 
flow in the LNs has been simulated through computer programming, but the results have 
not been incorporated into the design of a microfluidic system to model extravasation, since 
most LN metastasis models focus on exploring the role of cell proliferation and 
chemoattractant agents in promoting metastasis as opposed to the effects of altered fluid 
flow.44,158–160 
To this end, the development of new microfluidic platforms to interrogate adhesion 
of dissemination tumor cells in varied context is needed to facilitate a greater breadth of 
understanding of the mechanisms of metastatic extravasation, and give key insights into 




CHAPTER 3. ANALYZING MECHANISMS OF METASTATIC 
CANCER CELL ADHESIVE PROPENSITY LEVERAGING A 
PREPARATIVE ADHESION CHROMATOGRAPHY 
MICROFLUIDIC 
3.1 Introduction 
Over 90% of all cancer-related deaths result from metastasis, a multistep process in 
which cancer cells leave the primary tumor, intravasate into the blood stream, circulate in 
the vasculature until they are able to extravasate, and eventually take up residence in a 
secondary location in the body to form a metastatic tumor.1,40 Extravasation occurs in the 
presence of hemodynamic force, necessitating processes to overcome its dispersive effects. 
Amongst multiple implicated mechanisms, adhesive interactions with endothelial 
presented receptors such as E-selectin amongst others, act to slow down circulating cancer 
cells, leading to eventual cell arrest and extravasation.1,32,38,39,161 Despite the correlation 
between a cell’s propensity to exhibit selectin-mediated adhesion and metastatic potential, 
the cancer cell-intrinsic mediators facilitating the process are poorly understood.68,162–165 
Given that cancer is one of the largest public health burdens facing the U.S. today, afflicting 
over 14.5 million with nearly 1.7 million new diagnoses each year, a better understanding 
of the mechanisms underlying cancer metastasis and identification of relevant biomarkers 
or therapeutic targets is crucial for developing anti-metastatic cancer therapies and to 
monitor patient responses to therapy.29,81,82,166,167 
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To enable both the interrogation of biomechanical effects on metastasis as well as 
the elucidation of mechanisms of adhesion, engineered microfluidic systems are frequently 
implemented to model metastasis in vitro.12,164 Despite being highly simplified systems 
relative to in vivo mouse models, they have the advantage of enabling experimentation 
under defined cellular, molecular, and/or biophysical conditions. Using video microscopy-
based imaging to monitor the extent of adhesion in simulated flow fields that exhibit forces 
on par with those experienced in the microvasculature, many thousands of cells can be 
analyzed in a single experiment, enabling high sampling volumes in individual or 
parallelized experiments. Biochemical, biomolecular, and transcriptomic manipulations of 
analyzed cells can also be performed to interrogate biomolecular mechanisms contributing 
to metastatic adhesive phenotypes.81,82,161,165,168,169 The capacity to probe the attributes 
intrinsic to cancer cells that confer adhesion in an unperturbed manner, however, is not 
feasible using these interventional type approaches without a priori knowledge. Imaging 
based analyses alone also provide limited insight into biomolecular mechanisms and also 
do not allow for subsets of cells to be collected and assayed in an unbiased manner based 
on their phenotypes of adhesion.  
 To overcome the existing limitations but leverage the advantages of such in vitro 
microfluidic systems in the investigation of metastasis, we engineered a flow-based device 
that functions as an adhesive chromatography platform. This system, based on a widely 
used parallel-plate flow chamber, leverages the time-averaged velocities of cells perfused 
as a pulse and dispersed in perfusion media in a controlled flow field as a proxy for overall 
adhesion propensity to a substrate with or without surface functionalization with adhesive 
ligands (Figure 3.1a). The high-throughput nature of the cell adhesion chromatography 
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system permits the analysis of a large number of cells simultaneously in an environment 
that, used herein, recapitulates the physiological flow of the circulatory system. Using 
residence time theory, cells with lowly versus highly adhesive phenotypes can be 
separately enriched and collected at sufficient yields amenable to off-chip analyses, 
allowing further investigation of cell subsets expression profiles, metastatic potential, and 
molecular characteristics. Using this methodology, cell subsets exhibiting distinct adhesive 
behaviors within a population of genomically identical metastatic human colon carcinoma 
cells that nevertheless exhibit heterogeneous profiles of adhesion to E-selectin in flow were 
interrogated to reveal how expression and transcriptomic mechanisms associated with this 
transient metastatic phenotype are regulated by flow. 
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3.2 Materials and Methods 
3.2.1 Cell Culture 
Human colorectal adenocarcinoma LS174T cells and mouse melanoma B16F10 
cells were cultured in Dulbecco’s Modified Eagle Medium supplemented with 10% heat 
inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin-amphotericin (Life 
Technologies). The cells were harvested via mild trypsinization with 0.25% trypsin EDTA 
and 0.05% trypsin EDTA respectively, centrifuged at 400 X G for 5 min, and resuspended 
in culture medium. Cells were either used for perfusion experiments or diluted into tissue 
culture treated cell flasks for subculture. Prior to use in perfusion experiments, the LS174T 
cells were incubated in suspension for 2 hr at 37°C to allow cell surface glycoprotein 
regeneration. Quantification of cell confluency was performed by analyzing the area of 
adherent cell cultures compared to the total surface area of the well surface bottom using 
ImageJ (National Institutes of Health). The confluency at various time points was 
normalized to that at the time of seeding the cells. 
3.2.2 Channel Fabrication 
Microfluidic channels were fabricated as detailed previously.170 Concisely, the 
microfluidic channels were made using 100 um thick double-sided adhesive tape (3M) 
backed with a release liner into which a U-shaped channel of two parallel 2 cm wide by 14 
cm long sections connected by a 2 cm wide by 1.5 cm long section was cut using a craft 
cutter (Silhouette America). The adhesive channels were then affixed to 
Polydimethylsiloxane (PDMS) (Ellsworth Adhesives), which was previously cured by 
mixing PDMS base with curing agent at a ratio of 9:1 and curing for 3 hr at 90˚C in a Pyrex 
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dish. To finish fabrication, an inlet hole was punched into channel using a biopsy punch, 
and assembly was attached to a non-tissue culture treated polystyrene plates where an outlet 
hole was drilled.  
3.2.3 Channel Functionalization 
The channel was functionalized by incubating with 2.5 µg mL-1 Fc specific goat 
anti-human IgG (R&D Systems) in Dulbecco’s Phosphate Buffered Saline (D-PBS) 
without calcium and magnesium at 4˚C overnight, blocking with 1% BSA in D-PBS at 
room temperature for 1 hr, incubating with 2.5 µg mL-1 of recombinant human E-Selectin 
Fc chimera protein (R&D Systems) in D-PBS with calcium and magnesium at room 
temperature for 2 hr, and finally, blocking the entire device with 1% BSA in D-PBS at 
room temperature for 1 hr In between each step, the channel was washed three times with 
1 mL of D-PBS with calcium and magnesium. For Static flow experiments, the channel 
was functionalized from the outlet up to 1 cm from the inlet. For Continuous flow 
experiments, only the straight portion nearest the outlet was functionalized. 
3.2.4 Perfusion Experiments 
An inlet syringe coupled to tubing, which was filled with perfusion media (0.1 % 
BSA in D-PBS), were connected to a syringe pump (PhD Ultra Harvard Apparatus). The 
syringe pump was used to withdraw a cell pulse of 250,000 cells diluted in 200 µL of 
perfusion media into the inlet tubing at a rate of 0.5 mL min-1. The tubing-syringe pump 
was inserted into the inlet hole of the channel and a 5 mL test tube was connected to the 
bottom of the outlet hole as the cell collection reservoir. The entire apparatus was placed 
on an Eclipse TI optical microscope (Nikon) with an objective magnification of 10X and 
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linked to NIS-Elements software (Nikon) to acquire videos at 0.281 µs and a frame rate of 
25 frames per sec. To begin perfusion, the syringe pump was set to a flow rate to achieve 
the desired wall shear stress to initiate inflow from the syringe-tubing assembly. In Static 
flow experiments, perfusion was paused after two min of inflow to allow the cells to settle 
to the bottom of the channel and interact with the functionalized surface. After five min of 
stopped flow had transpired, flow was restarted for the predetermined free flow elution 
time of the cells (the time it takes for 95% of the cell pulse to elute out of an 
unfunctionalized channel), after which perfusion was stopped and the test tube containing 
the cell solution collected during perfusion was removed and a new test tube was attached. 
Finally, the syringe with inlet tubing was replaced with a new syringe-inlet tubing 
apparatus filled with only perfusion media and used to eject the cell solution out of the 
channel and into the second collection tube. In Continuous flow experiments, perfusion 
was stopped after the free flow elution time had been reached. At the end of the experiment, 
the number of cells and nonviable cells were counted, then analyzed using a BD LSRII 
flow cytometer (BD Biosciences) for expression of various ligands or put back into cell 
culture.    
3.2.5 Cell Fraction Quantification and Cell Viability Analysis 
The collected cell fractions were centrifuged at 400 X G for 5 min, the supernatant 
was decanted, and the cell pellet resuspended in 200 µL of perfusion media. Trypan Blue 
0.4% (Life Technologies) was diluted 1:1 with D-PBS. The 0.2% solution was mixed with 
collected cells in a 1:1 ratio and incubated at room temperature for 2 min. A sample of the 
cell-trypan solution was then loaded onto a hemocytometer and viewed under a microscope 
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to count the total number of cells collected in each fraction as well as the fraction of non-
viable cells and the viable cells. 
3.2.6 Flow Cytometric Analysis 
The cell solution was centrifuged at 400 X G for 5 min and resuspended in diluted 
antibody solutions on ice for 45 min, washed with D-PBS two times, and resuspended in 
perfusion media for analysis on the flow cytometer. The antibodies (BD Biosciences) were 
diluted in D-PBS in the following ratios – 1:20 for PE CD44 and PE CEA, 1:40 for APC 
or PE HECA452, and 1:10 for APC CD24. Obtained flow cytometric data was analyzed 
using FlowJo software (Treestar Inc.).  
3.2.7 Video Analysis 
The mean distance of the cells from the channel bottom at any given time was 
experimentally determined and calculated as previously described.13 Briefly, a cell pulse 
followed by perfusion media was perfused into an unfunctionalized channel and five min 
videos were taken with the focal place set to the channel bottom at nine evenly spaced 
positions across the channel length. The videos were subsequently analyzed using an 
OpenCV-based Traffic Flow Analyzer cell tracking software that is able to detect cell edges 
and their x and y position, and consequently determine the cell velocity according to 
Equation 1. The metric yvel/0.5(rx+ry) was used to represent the distance of a cell from the 
channel bottom based on its horizontal velocity. 
 






−  𝑦𝑦𝑣𝑣𝑚𝑚𝑤𝑤2 ) (1) 
 37 
3.2.8 Cell Pulse Location Quantification 
To determine the location of the cell pulse when perfusion is paused during static 
flow experiments, inflow of a 200 µL cell pulse at 1.25x106 cells mL-1 followed by 
perfusion media into an unfunctionalized channel was started for two min, stopped, then 
images were taken at evenly spaced positions along the length of the channel and the 
number of cells at each position were counted. Alike, the number of interacting cells in 
functionalized channels was quantified by taking 30 sec videos across nine evenly spaced 
length positions in the channel and three evenly spaced width positions at each length 
position after steady flow had been reached, and previously described metrics were used 
to distinguish interacting from non-interacting cells.171 Briefly, in perfusion experiments, 
a cell that paused within imaging field of view or translated substantially slower than the 
free flow velocity was defined as an “interacting” cell, whereas a “non-interacting” cell 
was defined as one that which did not mediate contact with the channel bottom during 
observation.13 
3.2.9 Free Flow Elution Time Quantification 
The free flow elution time of the cells was determined by modifying a procedure 
previously used to find the residence time of cells in a microfluidic channel.13  30 min 
videos of 250,000 cells perfused as a 200 µL cell pulse at a flow rate corresponding to the 
desired wall shear stress were taking 0.5 cm from the channel outlet. The aforementioned 
cell tracker code set to threshold of 4 and a blurring factor of 7 was used to identify objects 
that had a diameter between 12-18 µm that had traveled more than 400 μm during the 
course of the video and record the time it took the object to leave the field of view after 
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perfusion had begun. The values were put into Prism (GraphPad Software Inc) to create 
cumulative frequency plots. The elution time of free flow cells was defined as the time at 
which 95% of the tracked cells had left the field of view.  
3.2.10 In Vivo Metastasis Model 
104 LS174T cells, either from the unsorted parental population or fractionated using 
the adhesion chromatography system, were suspended in 100 µL of sterile saline and each 
fraction was injected intravenously via the tail vein into six week old female NSG mice 
under isoflurane anesthesia (Jackson Labs). After 7 or 14 d, mice were sacrificed by CO2 
asphyxiation, lungs dissected, and metastatic foci counted. Afterwards, the lungs were flash 
frozen in optimal cutting temperature (OCT) gel in a bath of 2’methylbutane cooled in a 
bath of liquid nitrogen then maintained in a freezer at -80◦C until cryosectioning into 10µm 
slices, staining with hematoxylin and eosin (H&E), and imaging with a Nanozoomer 
microscope (Hamamatsu Photonics). Cell densities were quanitified as previously 
described.170 Briefly, H&E stained histology images were imported into ImageJ using the 
NDPI tools plugin172 and thresholded using identical parameters across all images to 
quantify the percent area above the threshholded background to quantify the cell density 
of each cryosection.  All protocols for animal procedures were approved by the Institutional 
Animal Care and Use Committee at Georgia Institute of Technology. 
3.2.11 mRNA Extraction and Sequencing 
The cell samples used to for mRNA extraction were flash frozen using liquid nitrogen 
either immediately after perfusion or after 48 hr of culture. Total RNA was isolated by the 
RNeasy Micro Kit (Qiagen) according to the manufacturer’s instructions. Briefly, frozen 
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cell pellets (35 cells per pellet) were immediately suspended in RLT Plus lysis buffer in the 
presence of beta-mercaptoethanol. Lysates were homogenized via centrifugation (at 
maximum speed for 2 min) using Qiashredder columns. One volume of 70% ethanol was 
added to the lysate, and mixed via pipetting. The samples were transferred to RNeasy 
MinElute spin columns and centrifuged for 15 sec at 8000 X G. After washing column with 
RW1 buffer, on column DNase digestion was performed. After on-column washing steps, 
columns were dried via centrifugation at full speed for 5 min. RNA was eluted in 50 µL of 
RNase-free water. RNA concentration and purity were determined via a NanoDrop 
spectrophotometer. Once the mRNA was extracted, The New England Biolabs (NEB) 
mRNA isolation kit was used to pull down mRNA using poly T beads. Next, the NEB Ultra 
II RNA directional kit was used to convert the mRNA to double stranded cDNA, utilizing 
illumine adapters, which were added to each fragment in order to sequence the mRNA. 
3.2.12 mRNA Sequencing Analysis 
In preparing the RNA-Seq data from 6 LS174T samples for the differential gene 
expression analysis, quality control was performed on 12 raw FASTQ files using FastQC 
(Babraham Informatics) and Trimmomatic (Usadel Lab) to ensure the quality of the data. 
The quantification of the gene expression levels for the 6 LS174T samples was performed 
using Salmon.173 The gene counts were imported using a R package to prepare a count 
matrix for the downstream exploratory and gene-level analysis.173 For the analysis 
involving the single replicates, GFOLD was used to observe changes in gene expression. 
3.3 Results 
3.3.1 Microfluidic-based Adhesion Chromatography 
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We constructed from polydimethylsiloxane (PDMS), a polystyrene tissue culture 
plate, and an adhesive gasket a parallel plate flow chamber device whose inlet is connected 
to a syringe pump to vary the wall shear stress to mimic a range of physiologically relevant 
shear stresses (Figure 3.1b,c). Easy to rapidly construct and assemble, and amenable to 
high speed video microscopy imaging of perfusion experimentation throughout the flow 
channel (Figure 3.1b), cells perfused as a suspension into this device in perfusion media 
are subjected to a roughly uniform wall shear stress level across >90% of the channel width 
and can be collected into an interchangeable cell reservoir at the outlet (Figure 3.1c). 
Experimentation performed under “Continuous” flow conditions (no cessation of flow 
during experimentation, Figure 3.1d, 3.2a) necessitated a so-called settling region within 
the flow channel to ensure all perfused cells were in contact with an adhesive substrate for 
uniform distances, given the time, which in the context of flow translates to distance, 
necessary for all perfused cells to settle to the inferior channel substrate (Figure 3.1e).[11,19] 
Channels were thus functionalized only within the last third of the total channel length 
(channel positions 7-9, Figure 3.1d), where cells were uniformly in contact with the 
substrate as defined by being within one cell radii from the interior channel wall as 
experimentally validated by measurement of cell velocity and size (Figure 3.1e). In 
unfunctionalized channels passivated by blocking with bovine serum albumin (BSA), the 
time at which 95% of the infused cell pulse had eluted through the channel was defined as 
commencing the sorting phase of the experiment (Figure 3.1f). In the presence of E-
selectin, this resulted in extensive adhesion by selectin-binding LS174T cells as quantified 
by video image analysis that was restricted to and homogenously distributed along only 
the functionalized straight portion of the channel nearest the outlet (channel positions 7-9 
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but not 1-6, Figure 3.1g), extents unaffected by channel width position (Figure 3.1h). 
Adhesive LS174T cells also translated in rolling adhesion at similar velocities at various 
distances from the outside edge of the channel (Figure 3.1h), thus indicating good spatial 
control and uniformity of functionalization. Overall, given the exact size of this channel, 
the surface area of functionalization, wall shear stress level, and a minimum surface area 
density to prevent cell-cell interactions, adhesion chromatography experiments could be 
performed to a maximal loading capacity of approximately 106 cells, a number that can be 
tuned by parameters of channel configuration and flow. 
As a point of comparison given the capacity of force to regulate the initiation of 
rolling adhesion, we also established a workflow for evaluating cell adhesion initiated in 
the absence of force but presence of flow during de-adhesion, so called “Static” 
experimentation. During these experiments, after loading of the cell pulse into the channel, 
cells were allowed to settle and interact with the substrate for 5 min (Figure 3.2b), a time 
experimentally determined as sufficient for cells to settle in static conditions, after which 
time fluid flow was reinitiated to start the sorting phase of experimentation (Figure 3.1i, 
3.2c).13,174 Perfused again as a pulse, cells could be loaded into the device and distribute 
amongst the channel length (Figure 3.1j). When assessed by video microscopy, at times 
soon after 95% of cells had eluted from an unfunctionalized channel after reinitiation of 
flow (Figure 3.1k), the extent of adhesion by LS174T cells to E-selectin was substantial 
throughout the channel length (Figure 3.1l). Notably, the highest number of interacting 
cells were located at the middle length of the channel (Figure 3.1l), implying that 
interacting cells roll slowly and do not have time to reach the end of the channel by the end 
of perfusion The extent and velocity of rolling adhesion did not vary significantly with 
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channel width position (Figure 3.1m). Approximately 5E105 cells could be loaded into the 





Figure 3.1 Engineered cell sorting adhesion chromatography microfluidic to 
investigate cancer metastasis in vitro. (A) Elution profiles of LS174T metastatic colon 
carcinoma cell populations when perfused over E-selectin, demonstrating the early 
elution of free flow cells followed by subsequent elution of adherent cells. (B) 
Hemodynamic microenvironment-mimicking, parallel-plate microfluidic fabrication, 
into which (C, bottom) metastatic cancer cells are infused into the E-selectin 
functionalized channel, visualized via an integrated high speed videomicroscopy, and 
collected into collection tubes based on channel residence time. (D-H) Continuous 
perfusion experiments, (I-M) Static perfusion experiments. (D,I) Channel 
functionalization schematic and perfusion workflow diagram. (E) Distance of 
individual perfused cells from the channel bottom calculated based on measured 
individual cell velocity and size decreases from the inlet (channel position 1) until 
reaching channel position 3 after which it is uniform throughout the remaining 
channel length. Data represent mean ± s.e.m. (F,K) Representative relative frequency 
distribution of elution time of the infused cell pulse with the inset showing the mean 
time at which 95% of the cell pulse has eluted ± s.e.m. (G,L) Number of interacting 
cells along the length of the channel during the sorting phase. Data represent mean ± 
s.e.m. (H,M) Number of interacting cells along the width of the channel (black) and 
average velocity of rolling cells along the width of the channel (gray). Data represent 
mean ± s.e.m. (J) Location of cell pulse during static phase of Static perfusion 
experiments (E-H,J-M) Each point represents the mean ± s.e.m. of n≥5 independently 
run experiments. Cell pulse of LS174T colon carcinoma cells perfused at 1 dyn cm-2 
over (E,G,I,K) 2.5 ug mL-1 E-selectin or (F,J) unfunctionalized channels. * p < 0.05 ** 





Figure 3.2. Snapshots of Static and Continuous flow experiment videos at various 
timepoints. (A) Frames from a Continuous perfusion video showing the time-lapse of 
a free flow and adherent cell during the cell sorting phase. (B) Frames from a Static 
perfusion video showing the lack of movement of cells during the static flow cell 
settling phase when flow is stopped. (C) Frames from a Static perfusion video showing 
the time-lapse of a free flow and adherent cell after flow is restarted in the cell sorting 
phase following the 5 minute static flow cell settling period. (A-C) Perfusion of an 
LS174T cell pulse of 250,000 cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-2. Scale bar 




3.3.2 Adhesion Chromatography Microfluidic Enrichment of Distinct and Viable Cell 
Subsets of Varying In Vitro Adhesivities 
Experiments were performed under both Continuous and Static conditions to 
interrogate the effect of force on initiation of E-selectin-mediated adhesion and whether 
the extent and quality of experimentally observed adhesion to E-selectin differed between 
experimental flow types. A cell pulse of E-selectin-binding LS174T cancer cells and 
perfusion media was perfused through the channel surface functionalized with 2.5 µg mL-
1 E-selectin at a predetermined flow rates corresponding to physiological levels of wall 
shear stress where selectin-mediated adhesion occurs, ranging from 0.5 to 5 dyn cm-2.174 
Unsurprisingly, the extent of LS174T cell adhesion to E-selectin decreased with increasing 
wall shear stress level (Figure 3.3a). The velocity with which cells mediated adhesion also 
increased as the wall shear stress increased (Figure 3.3b).82,82,171 Strikingly, the velocity of 
rolling adhesion by LS174T cells on E-selectin did not differ between Continuous and 
Static experimentation at all wall shear stress levels tested, with the exception of the highest 
of 5 dyn cm-2, where the rolling velocity of cells of adherent cells in Continuous 
experiments was significantly greater than that in Static experiments (Figure 3.3a-b). Non-
E-selectin ligand expressing B16F10 melanoma cells were also separately perfused 
through the channel in a cell pulse under both Static and Continuous conditions.175 
Expectedly, there were minimal interacting B16F10 cells at all tested wall shear stresses 
levels (Figure 3.3a).  
The difference in elution times from an flow channel that result from differential 
ability of cells to mediate adhesion was leveraged to quantify the fraction of total cells 
capable of mediating adhesion to E-selectin in flow – with non-interacting, free flow cells 
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exiting the channel before interacting, adherent cells (Figure 3.1a).13,171 Cells that eluted 
prior to the predetermined “non-interacting cell elution time” were collected as the “Free 
flow” fraction. Subsequently, the cell collection reservoir was changed and the cell subset 
remaining within the microfluidic device removed by escalating the flow to 5 dyn cm-2 for 
5 min was collected labeled as the “Adherent” fraction (Figure 3.3c).  
Using this workflow and using a wall shear stress of at 1 dyn cm-2 and 2.5 µg mL-
1 E-selectin, >70% of cells (either LS174T or B16F10) were recovered during 
experimentation, levels unchanged by channel functionalization (Figure 3.3d). Of the cells 
recovered, ~60% of LS174T cells eluted in the adherent population (Figure 3.3e), extents 
at levels nearing those seen for Static experimentation (Figure 3.3a). Conversely, nearly all 
of B16F10 cells eluted into the non-interacting, Free flow fraction when perfused in either 
Static or Continuous flow set-ups, consistent with B16F10 cells, which lack E-selectin 
ligands failing to mediate adhesion to E-selectin in flow (Figure 3.3a).175 However, ~10% 
of perfused B16F10 cells were recovered in the Adherent fraction, a proportion similar in 
magnitude to the amount of LS174T cells recovered from unfunctionalized channels 
(Figure 3.3e) indicating a small extent of contamination within the enriched adherent cell 
subset. Nevertheless, the fraction of LS174T cells comprising the adherent fraction was 
substantially larger than for B16F10 cells. Of the collected cells of each clone type, over 
95% were viable in collected cell fractions, and viability was not affected by perfusion, 
channel functionalization, nor the adhesion propensity of the cell (Figure 3.3f). 
Furthermore, fractionated LS174T cell subsets cultured for 72 hr showed no differences in 
the ability to proliferate (Figure 3.3g) or grow (Figure 3.3h) in culture, indicating that the 
system is able to collect viable cells for further expansion and post-perfusion analysis.  
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When varying wall shear stress level to emulate the range of physiologically 
relevant flow conditions of the microenvironment a circulating metastatic cell may be 
exposed to, perfusion of selectin-ligand expressing LS174T cancer cells over E-selectin 
functionalized surfaces resulted in collection of a decreasing fraction of total perfused cells 
(Figure 3.3i). At 0.5 and 1.0 dyn cm-2, experiments performed under Continuous flow 
conditions resulted in slightly but significantly lower levels of cell recovery compared to 
Static experiments (Figure 3.3i). Taken together, these results indicate that this adhesion 
chromatography device is capable of not only separating cells based on adhesion 
propensity to the functionalized substrates in a manner regulated by hemodynamic force, 
but also that sorted cells can be retained and/or expanded for further phenotypic, genotypic, 
and molecular analysis post perfusion.  
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Figure 3.3 Collected cell fraction analysis. (A) Number of interacting cells during the 
sorting phase of perfusion. (B) Rolling velocity of interacting cells during the sorting 
phase of perfusion. n≥20. (A-B) Either static or continuous flow at 0.5, 1, 2, or 5 dyn 
cm-2. Each point represents the mean ± s.e.m. of n≥3 independently run experiments. 
(C) Experiment workflow diagram of static and continuous flow experiments. (D) 
Percent of total cells recovered from infused pulse of 250,000 cells after perfusion on 
either a functionalized or unfunctionalized channel. (E) Percent of cells collected in 
either the free flow or adherent cell fraction after either Static or Continuous flow on 
an unfunctionalized channel or a functionalized channel. (F) Percent of cells that are 
viable prior to perfusion or in each fraction after perfusion on either a functionalized 
or unfunctionalized channel. (G) Increase in cell number of cultured unsorted cells or 
collected cell fractions after 72 hr normalized to initial cell culture seeding number. 
FF: free flow, AD: adherent. (H) Representative brightfield images of cultured cells 
in a well of a 96 well plate at time of initial seeding (0 hr.) or after 72 hr. Scale bar 
represents 400 um. (I) Percent of LS17T or B16F10 cells collected in each fraction 
after perfusion under either Static or Continuous flow (D-G, I) Perfusion experiments 
were at 1 dyn cm-2. Functionalized experiments were over 2.5 µg mL-1 E-selectin. Each 
bar represents the mean ± s.e.m. of n≥3 independently run experiments. (E, I) * p < 
0.05, ** p< 0.01, **** p < 0.0001 by t-test comparing sizes of adherent cell fractions.  
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3.3.3 Sorted Cell Fractions Exhibit Different Metastatic Potential In Vivo 
We sought to explore the relationship between propensity to mediate adhesion to 
E-selectin, using channel residence time as a proxy, and metastatic potential in vivo. As 
such, using an E-selectin functionalized channel, a cell pulse of LS174T cells were 
perfused through the channel at 1.0 dyn cm-2 and sorted based on elution time into free 
flow and adherent populations, and 105 cells from sorted fractions were subsequently 
injected intravenously via the tail vail into NSG mice.  Markedly, the cells from the 
adherent subset, enriched in the adhesion chromatography device based on their enhanced 
ability to interact with E-selectin in vitro, exhibited greater lung metastatic tumor bearing 
potential than the cells from the free flow subset in vivo 7 and 14 d post injection as 
quantified by counting the total number of lung metastases in each mouse (Figure 3.4a-b).  
Further, when normalizing the number of metastasis in each lung 7 d post injection to the 
unsorted, parental population, the injected free flow cell group exhibited a decreased 
number of metastases, further elucidating the less metastatic nature of the free flow fraction 
(Figure 3.4c). Quantification of hematoxylin and eosin histology sections confirmed these 
results, as injection of cells from the free flow fraction resulted in a lower cell density 
within lung cryosections than injection of cells from either the adherent fraction or 
unsorted, parental population (Figure 3.4d). These results demonstrate the utility of this 
adhesion chromatography device in enriching cells with differential metastatic potentials 
based on their E-selectin binding capabilities.  
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Figure 3.4 LS174T cells collected using adhesion chromatography in the Free flow 
fraction metastasize in vivo less than Adherent fraction. (A) Representative bright 
field and chromogenic images of NSG mouse whole lobes and lung sections and 7 d 
post intravenous (i.v.) infusion of parent (unsorted) or sorted free flow or adherent 
LS174T cells. Arrows indicate metastatic tumors. Scale bars, 100 µm or 1 mm in 
regions of interest and whole lobe images, respectively. (B) Count of lung metastases 
in either the free flow group or the adherent group normalized to the mean number 
of lung metastases per NSG mouse in the parent (unsorted) group 7 d post i.v. 
infusion. (C) Quantification of hematoxylin and eosin staining for each group. (A-C) 
Perfusion and separation of an LS174T cell pulse of 250,000 cells was over 2.5 µg mL-
1 E-selectin at 1 dyn cm-2. NSG mice were injected i.v. with 105 LS174T cells. (B) Each 
point represents an individual mouse lung. (C) Bars represent mean ± s.e.m. of n≥5 
individual mice. Statistical test by (B) t-test Ho: µ= 1 * p < 0.05 or (C) one-way 
ANOVA with post hoc t-test with Bonferonni corrections for multiple comparisons * 
p < 0.05 ** p < 0.01 
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3.3.4 Differential Selectin Ligand Expression by LS174T Cells Separated Using 
Adhesion Chromatography by E-selectin Adhesivity 
Selectin ligand glycan epitope and glycoprotein expression levels in LS174T cell 
populations sorted for their enriched adhesive potential on E-selectin were measured. 
Sialofucosylated tetrasaccharides sialyl Lewis x (sLex) ligand expression, as measured by 
anti-sLex/a binding antibody HECA-452, on sLea-negative LS174T cells collected in the 
adherent versus free flow fractions, was assessed flow cytometrically. In both Static and 
Continuous flow experiments, the Free flow LS174T subset (the cells that did not interact 
with the E-selectin during perfusion through the microfluidic device) had significantly less 
HECA452 immunoreactivity relative to the cells that exhibited adhesion to E-selectin 
(Figure 3.5a,b). Furthermore, when binned into high and low HECA452 stained 
populations based on the highest 10% and lowest 10% of the unsorted parent populations 
(HECAhi and HECAlo, respectively), the adherent fraction had significantly more cells 
HECAhi (sLex hi expressing) cells whereas the free flow cell population had significantly 
more HECAlo (sLex lo expressing) cells (Figure 3.5c). Jointly, these results substantiate the 
finding that increasing sLex expression is associated with enhanced LS174T cell adhesivity 
to E-selectin in flow.13,171 
Relationships between LS174T cells’ capacity to mediate adhesion to E-selectin in 
flow and expression of CD44 and carcinoembryonic antigen (CEA), two previously 
identified selectin ligand glycoproteins, was also determined. Experiments performed 
under both Static flow and Continuous flow conditions revealed increased levels of CD44 
expression on cells collected in the interacting, adherent cell fractions (Figure 3.5d-
e).13,29,161 Despite differences in CD44 expression levels among collected fractions in both 
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perfusion methods, only an increase in CD44lo cells in the free flow subset and an increase 
in CD44hi cells in the adherent subset collected after continuous flow (Figure 3.5f) with 
high and low CD44 stained populations defined on the highest 10% and lowest 10% of the 
unsorted parent populations (CD44hi and CD44lo, respectively). Contrastingly, CEA 
expression levels among the two fractions did not differ (Figure 3.5g-h), and this lack of 
difference was also reflected in no change in the frequencies of the sorted populations 
within the high and low CEA stained populations defined on the highest 10% and lowest 
10% of the unsorted parent populations (CEAhi and CEAlo, respectively) (Figure 3.5i). 
Together, these results implicate a flow-regulated role for CD44 in E-selectin mediated 
adhesion and suggest a redundant role of E-selectin ligand CEA, as has been previously 
suggested.82 
Sorted cells were next costained to interrogate any relative co-enrichment of 
CD44/HECA(sLex) or CEA/HECA(sLex) expression by flow cytometry. Using mean 
fluorescence intensity of HECA452 as a proxy, sLex expression in CD44hi and CD44lo 
LS174T subset (Figure 3.5j) was found to be enhanced in the CD44hi subset in both Static 
and Continuous experimentation (Figure 3.5k). Dissimilarly, when employing the same 
gating strategy to analyze CEA and HECA coexpression, there was no difference found in 
sLex expression between the cell subset with either high or low CEA expression (Figure 
3.5l). Collectively, these findings elucidate the interrelation between the adhesion 
propensity of LS174T cells and their ligand expression, further demonstrating the 
importance of concurrent high expression of sLex and CD44 in enhancing LS174T cell 
interaction with E-selectin in flow. Moreover, they illustrate the utility of this platform in 
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Figure 3.5 LS174T cells collected using adhesion chromatography into Adherent 
subset after perfusion over E-selectin exhibits enhanced HECA and CD44, but not 
CEA, expression levels. (A,D,G) Representative flow cytometric histograms of sLex 
(HECA452), CD44, or CEA expression. (B,E,H) sLex (HECA452), CD44, or CEA 
expression normalized to the parent population between cells in the collected free flow 
fraction and adherent fraction. Each point represents the mean fluorescent intensity 
of analyzed cells ± s.e.m. (C,F,I) Percent of cells in each fraction that are in the top 
10% or bottom 10% of sLex (HECA), CD44, or CEA expressing cells. Each bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. (J) Representative 
flow cytometry gating and analysis strategy for (K,L) sLex (HECA452) expression 
levels normalized to the unsorted parent LS174T cell population in either high (top 
10%) or low (bottom 10%) expressing subset of (K) CD44 or (L) CEA. Each bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. Perfusion and 
separation of an LS174T cell pulse of 250,000 cells was over 2.5 µg mL-1 E-selectin at 
1 dyn cm-2.  * p < 0.05 ** p < 0.01 *** p , 0.001 by paired t-test. 
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3.3.5 Adhesion to E-selectin In Flow by LS174T Cells is a Transient Phenotypic 
Characteristic Not Associated with Significant mRNA Profile Expression Changes 
in Adhesive Ligand Genes 
In order to elucidate the drivers of invasive cancer metastasis, metastatic potential 
is often studied by probing genotypic differences among the various subsets of metastatic 
cancer cell populations.11,12 To interrogate the ability of LS174T cells to retain their 
metastatic selectin adhesion characteristics for subsequent study, LS174T cells were 
perfused in Continuous flow experiments and collected into Adherent or Free flow 
fractions. The subsets were either reperfused immediately to confirm enrichment based on 
adhesivity or placed in culture for 72 hr before analysis in subsequent perfusion 
experiments. Expectedly, immediate reperfusion resulted in the reperfused Free flow cells 
showing a decreased adhesion, as indicated by significantly more cells eluting into the Free 
flow fraction than the other two subsets. Correspondingly, the reperfused Adherent cells 
showed a greater adhesive propensity, and the cells also had a greater expression of sLex 
than the reperfused free flow cells (Figure 3.6a-b). When the cultured subsets were 
reperfused under Continuous conditions, however, there was no difference in the relative 
size of the collected interacting and non-interacting fractions between subsets, and 
HECA452 staining revealed no difference in expression levels (Figure 3.6a-b). These 
results reveal E-selectin adhesivity to be a phenotypic characteristic of LS174T that is not 
sustained.12 
To investigate the mechanisms underlying this transient metastatic phenotype of 
LS174T cells, mRNA sequencing was performed and gene expression profiles among 
various cell subset were quantified and compared. Specifically, parental populations of 
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LS174T colon carcinoma cells were perfused in Continuous flow at 1 dyn cm-2 over 2.5 µg 
mL-1 and sorted into Free flow and Adherent fractions based on elution time. A subset of 
each fraction was immediately processed for mRNA extraction and analysis, and the 
remaining cells from each fraction were cultured separately for 48 hr prior to transcriptome 
analysis. Additionally, a time-matched, perfused but unsorted population of parental 
LS174T cells were either immediately or cultured for 48 hr before processing for 
transcriptome analysis to serve as a control. Subsequently, the LS174T cells sorted in the 
adhesion chromatography system using E-selectin under Continuous flow conditions were 
analyzed and the sorted fractions were compared to each other as well as to that of the 
untreated parental cells.  
We hypothesized that since adhesivity is not a retained characteristic of LS174T 
cells but rather a transient phenotype, the sorted subsets of cells analyzed immediately after 
perfusion would exhibit different expression levels of genes, particularly those related to 
adhesion, the actin/cytoskeleton structure, and/or cell growth phase, compared to each 
other, as well as compared to that of the unsorted populations and sorted populations that 
were analyzed after 48 hr in culture – all of which we expected to all exhibit similar 
expression levels. Surprisingly, mRNA expression data for all samples showed minimal 
differences between subsets, and hierarchical clustering grouped the samples not by their 
respective fraction, but rather by the time at which they were analyzed after perfusion (0 
versus 48 hr), which is likely a growth phase related artifact (Figure 3.6c). Given these 
unexpected results, we analyzed changes in genes regulating sLex, CD44, and CEA 
expression but again found no significant differences between any group, and the 
hierarchical grouping still clustering samples by time rather than sorting (Figure 3.6d). 
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Further, interrogation of fold change of the genes of interest revealed only minor fold 
changes between all combinations, with a majority of the differences clustering at a fold 
change of nearly zero (Figure 3.6e-g). Finally, because changes in the actin cytoskeleton 
structure and cell cycle stage have been implicated in cancer metastasis, we probed the 
mRNA profile of those pathways, which again informed similar mRNA expression among 
all six samples and consistent clustering as to what was seen previously (Figure 3.6h-i). 
Taken together, these results indicate that the transient adhesive phenotypes of metastatic 
LS174T subsets is not reflected in changes mRNA profile of genes controlling adhesive 
ligand presentation, despite measured differences of both functional adhesive propensity 
on E-selectin and surface presented sLex and CD44 ligand expression. Notably, due to the 
lack of measurable changes in expression of pathways we hypothesized would control cell 
adhesivity to E-selectin, biological replicates were not conducted, and transcriptome 




Figure 3.6 Adhesivity to E-selectin is a transient phenotype by LS174T cells not 
caused by mRNA expression changes. (A) Percent of LS174T cells collected in either 
the free flow or adherent fraction of the parent (unsorted) population or reperfused 
cell subsets either immediately after perfusion or after 2 passages. Each bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. (B) Quantification 
of sLex expression of cells in each collected cell fraction. (C,D,H,I) mRNA expression 
heatmaps of (C) all analyzed mRNA, (D) genes regulating CEA, CD44, and sLex 
presentation, (H) actin-cytoskeleton structure, and (I) cell cycle stage. US0/FF0/AD0: 
unsorted/free flow/adherent, flash frozen at 0 hr; US48/FF84/AD48: unsorted/free 
flow/adherent, flash frozen at 48 hr. (E-G) Histograms of log2 fold change at 0 hr of 
genes regulating CEA, CD44, and sLex presentation of (E) free flow compared to 
adherent, (F) free flow compared to unsorted, and (G) adherent compared to 
unsorted. (A-C) Perfusion and separation of an LS174T cell pulse of 250,000 cells was 
over 2.5 µg mL-1 E-selectin at 1 dyn cm-2.  * p < 0.05 *** p < 0.001 **** p< 0.0001 by 
(A) One way ANOVA with post-hoc t-test or (B) t-test. 
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3.3.6 LS174T Cell E-selectin Adhesive Phenotype Association with Cancer Stem Cell 
Features 
The relationship between a molecular marker of cancer stem cells and adhesive 
phenotype on E-selectin in flow for LS174T cells were investigated through costaining 
sorted populations with CD24 and either HECA452, CD44, or CEA (Figure 3.7a-c). Upon 
evaluation of the expression of E-selectin ligands and cancer stem cell marker CD24, the 
highest 10% of HECA (sLex) and CEA expressing cells were found to exhibit higher levels 
of CD24 expression (Figure 3.7c,e).176 Contrastingly, the lowest 10% of CD44 expressing 
cells correlated with higher levels of CD24 expression (Figure 3.7b). Using the adhesion 
chromatography system to enrich cells on 2.5 µg mL-1 E-selectin at 1.0 dyn cm-2, the effect 
of E-selectin adhesivity on the frequencies of CD24 expressing cells within adhesive versus 
non-adhesive (free flow) subsets was measured. Irrespective of perfusion type (Continuous 
or Static), CD24 expression levels did not differ with adhesive phenotype (Figure 3.7d, 
Figure 3.8a), nor was there a difference in the frequency of CD24hi and CD24lo cells in 
either fraction (Figure 3.7e, Figure 3.8). When assessed as coexpression relationships via 
quadrant analysis, no differences in HECA452, CD44, or CEA with CD24 were observed 
for Static experiments (Figure 3.8c-e). However, under Continuous flow conditions, 
frequencies of HECAlo/CD24lo were increased for cells exhibiting a lowly adhesive 
phenotype (Figure 3.7f). Adherent LS174T cell subsets also exhibited decreased 
frequencies of CD44lo/CD24hi cells (Figure 3.7g) and increased levels of both 




Figure 3.7 CD24 expression does not differ between LS174T cells that do or do not 
exhibit E-selectin adhesivity. (A-C) Representative flow cytometric histograms of sLex 
(HECA452), CD44, or CEA expression indicating gating for the top and bottom 10% 
percent of cells expressing the respective ligand and the CD24 MFI in the highest 
versus lowest 10% of HECA, CD44, or CEA expressing cells. (D) Average mean 
fluorescent intensity of cells obtained from the free flow and adherent fractions in 
continuous flow. (E) Percentage of cells in the top or bottom 10% of CD24 expressing 
cells after continuous flow. (D,E) Each bar represents the mean ± s.e.m. of n≥3 
individually run experiments. (F-H) Comparisons between frequencies of cells in low 
versus high selectin ligand expression derived from costaining. (A-C, F-H) Each bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. Perfusion and 
separation of an LS174T cell pulse of 250,000 cells was over 2.5 µg mL-1 E-selectin at 




Figure 3.8 Static perfusion reveals no difference between collected fractions in 
coexpression of CD24 and selectin-ligands. (A) Average mean fluorescent intensity of 
cells obtained from the free flow and adherent fractions in static flow. (B) Percentage 
of cells in the top or bottom 10% of CD24 expressing cells after static flow. (D,E) Each 
bar represents the mean ± s.e.m. of n≥3 individually run experiments. (F-H) 
Comparisons between frequencies of cells in low versus high selectin ligand 
expression derived from costaining. (C-E) Comparisons between frequencies of cells 
in low versus high selectin ligand expression derived from costaining in static 
perfusion. (A-E) Each bar represents the mean ± s.e.m. of n≥3 individually run 
experiments. Perfusion and separation of an LS174T cell pulse of 250,000 cells. * p < 
0.05 ** p < 0.01 by paired t-test. 
3.4 Discussion 
We demonstrate the ability to rapidly sort in an unbiased, label free manner large 
populations of cells based on their adhesion propensity in flow through the use of an 
engineered, microfluidic based adhesion chromatography platform. Using residence time 
as a proxy for time-averaged cell adhesive behavior to collect two distinct fractions of cells 
– adhesive (interacting) and free flow (non-interacting), this platform - enables not only 
real-time visualization of cellular adhesion under hemodynamic force, but also allows post 
perfusion phenotypic analysis and in vivo modeling of the fractionated cell subsets under 
defined flow conditions. Noting that increased adhesion in vitro correlated with enhanced 
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metastatic potential in vivo by LS174T colon carcinoma cells, we demonstrate this sorting 
platform can be implemented to better understand the complex process of cancer metastasis 
by probing interactions between selectins and glycosylated ligands expressed by metastatic 
cells. We furthermore demonstrate the utility of this system in the interrogation of 
phenotypic attributes associated with E-selectin adhesion transiently exhibited by 
metastatic LS174T cells, noting that the observed phenotypic differences are likely not due 
to mRNA expression profile changes.  
This cell adhesion chromatography system permitted the interrogation of attributes 
shared within populations of cells that exhibit similar adhesion phenotypes. Notably, sLex 
and CD44, but not CEA, were found to have enhanced expression on LS174T cells that 
were able to mediate adhesive interactions with E-selectin in flow. With respect to 
endogenous sLex expression, this finding is consistent with the existing literature.12 CEA 
was also not found to be enriched in either collected subset of cells, which is supported by 
knockdown of CEA expression in LS174T cells failing to alter adhesive behavior on E-
selectin in flow.99 Previous reports, on the other hand, have demonstrated a correlation 
between CD44 expression and selectin-mediated adhesion over P- and L-, but not E-
selectin, which is in contrast with our findings of CD44 expression being enhanced with 
increased E-selectin adhesivity.11 However, this noted positive correlation between 
adhesion propensity on E-selectin in flow and CD44 expression is in direct agreement with 
previous reports that also found higher levels of rolling behavior over E-selectin in cells 
with enhanced CD44 as well as sLex expression.12,81 Our findings highlight the advantages 
of our cell-sorting microfluidic platform over systems used in previous reports for our 
integrated system permits the analysis of the relationship between multiple cell parameters 
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(adhesive phenotype and ligand expression levels) of unperturbed, distinct metastatic 
subsets based on population averages without the need for cumbersome cell knockdown 
studies, limitations of single level cell measurements, or repeated sorting of cells as a result 
of the ability to permit rapid interrogation of a large number of cells in a relatively short 
period of time. 
The apparent discrepancy between the lack of differential mRNA profiles and 
observed functional changes in adhesive propensity and E-selectin ligand presentation 
among sorted cell populations suggest that the protein expression changes result from post-
transcriptional and/or post-translational regulatory processes.177  One hypothesis is that the 
functional changes are a result of post-transcriptional alterations in microRNA (miRNA), 
which were not measured in this work. These results are consistent with previous reports 
that have noted only half of all protein expression changes are correlation with mRNA 
expression changes and post-translational repression of E-selectin ligand presentation on 
metastatic colon cancer cells via miRNA being implicated in regulating E-selectin 
mediated adhesion.178–180 Therefore, further analysis of the genomic profile of the sorted 
and unsorted cell fractions transcriptomally analyzed either immediately or cultured for 48 
hr by analyzing and comparing miRNA expression levels, and subsequently knocking-out 
any identified miRNA and quantifying adhesivity alterations using our microfluidic 
platform, may provide further insight into the phenotypic changes causing functional 
adhesive differences between subsets and corroborate our proposed explanation for the 
reported discrepancies in mRNA expression and adhesive ligand protein expression. In 
addition to unexplored potential post-translational differences, additional potential post-
 64 
transcriptional changes include alterations in the length of proteins or untranslated regions 
of mRNA.177  
Correlations between adhesive phenotype and cancer stem cell markers were 
assessed in LS174T cells by analyzing the cell subsets fractionated for adhesion to E-
selectin under flow for CD24 expression, a cancer stem cell marker whose expression is 
implicated in increased tumor progression, motility, and metastatic potential.81,170,172,176 We 
found that CD44 expression was inversely proportional to CD24 expression, noting the 
enrichment of CD24hi cells in a CD44lo subset, generally. This observation may give further 
insight into reports that demonstrate in vivo CD44-knockdown experiments lead to 
increased lung metastasis, despite our finding that high CD44 expression is linked with 
increased levels of adhesion on E-selectin, as the CD44 knockdown cells are subsequently 
augmenting a cancer stem cell subset.12,93,99  
Together, the noted increase in a CD44hi/CD24hi subset among adherent cells and 
increase in a CD44lo/CD24hi subset among free flow cells suggest that CD44 alone is 
predictive of adhesive phenotype, suggesting that there is no direct correlation between 
CD24 expression and adhesion on E-selectin under flow. Notably, these results conflict 
with what we recently measured for these cells when analyzed for E-selectin adhesion 
potential, however, those results were at a single cell, rather than population, level and 
obtained at 0.5 dyn cm-1, under which conditions a significantly higher fractions of cells 
mediate adhesion in flow (by ~50%, Figure 3.3i), which may explain the discrepancy. 
Furthermore, despite a lack of expression level differences between CEA in sorted 
populations, we found an increased CEAlo/CD24lo subset in the Adherent subset.12 
Interestingly, although CEA expression may not be correlated with adhesive differences 
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on E-selectin, CEAlo cells have been found to have increased cancer stem cell like 
properties, enhanced levels of sphere formation in vitro, and enhanced metastatic potential 
in vivo.181 Therefore, using our cell sorting platform, we are inadvertently able to enrich 
for this population. Low adhesive potential has previously been correlated with increased 
cancer stem properties in melanoma and breast cancer.182 Together our results indicate a 
lack of correlation between cancer stem cell marker CD24 and adhesion propensity on E-
selectin in LS174T colon carcinoma cells.  
Our results suggest a unique capacity for physiological force from fluid flow in 
influencing mechanisms of metastatic dissemination. Specifically, cell fractions collected 
via the Continuous perfusion method exhibited significant differences in ligand expression 
and coexpression between subsets that were not found in cell fractions collected via the 
Static perfusion method (Figure 3.5 and 3.7). We hypothesize that this is a result of forced 
contact between cell-expressed selectin ligands and the functionalized substrate in static 
flow experiments allowing a greater number of low affinity receptor-ligand interactions to 
occur in the free flow fraction that are not able to form in continuous flow experiments 
with a constantly applied shear stress. Thus, despite not changing the approximate 
frequency of adhesive cells of the total population, subtle differences in the collected cell 
subfractions were diluted in the absence of the dispersive effects of flow. Due to the 
continuous nature of fluid flow through the vasculature microenvironment in which cancer 
extravasation occurs, Continuous perfusion could be considered a more psychologically 
relevant experimental method for future investigations elaborating the mechanisms and 




In conclusion, we have engineered an integrated, parallel-plate microfluidic device 
to fractionate cells based on their elution time from a flow channel as a proxy for cell 
adhesivity to a substrate surface functionalized with adhesive ligand to investigate the 
pathway of cancer extravasation. Used here, wall shear stress-levels were modeled after 
hemodynamic flow of the vasculature microenvironment in order to simulate conditions 
under which in vivo metastasis occurs in vitro. By separately collecting two fractions of 
cancer cells - non-interacting and interacting – the cellular populations can be subsequently 
analyzed, reperfused, or modeled in vivo after perfusion, allowing interrogation of a large 
number of cells in a tightly controlled flow environment. This platform enabled the 
interrogation of cell molecular profiles, such as (co)expression levels of natively expressed 
selectin ligands (sLex, CD44, and CEA) and cancer stem cell marker CD24 on circulating 
cancer cells, as it relates to adhesive phenotype on a subset level based on adhesive 
propensity, thereby probing differences that may underlie varying adhesive phenotypes of 
a heterogeneous metastatic cancer cell population. Using the microfluidic analysis platform 
to study the behavior of cancer cells in the vascular microenvironment, and therefore 
relating the phenotypic characteristics of a cancer cell with their adhesive potential, will 
inform novel biomarkers that can be used to identify cancer cells and identify molecular 
pathways that can be targeted with therapeutics to prevent cancer metastasis. 
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CHAPTER 4. PHOTOCONVERSION AND 
CHROMATOGRAPHIC MICROFLUIDIC SYSTEM REVEALS 
DIFFERENTIAL CELLULAR PHENOTYPES OF ADHESION 
VELOCITY VERSUS PERSISTENCE IN SHEAR FLOW  
4.1 Introduction 
Systemic metastasis—a multistep progression in which cancerous cells disassociate 
from the primary tumor, infiltrate the circulatory system, leave the vasculature, and 
establish metastatic tumors in secondary tissues—is the cause of over 90% of all cancer-
related deaths.10,32,183 In order to travel to distant sites in the body during the process of 
metastatic cancer extravasation, circulating tumor cells utilize a highly orchestrated 
adhesion cascade that, like leukocytes, can involve slow rolling interactions with 
endothelial cells under hemodynamic forces.6–9,162 This process is mediated by interactions 
between endothelial-presented selectins and selectin ligands [such as sialofucosylated 
CD44 variants and carcinoembryonic antigen (CEA)] present on the tumor cell’s 
surface.68,163,164 The interaction of selectins with their ligands slows the cells to allow cell-
cell signaling or firm adhesion to occur within in the dynamic fluid flow environment of 
the circulatory system, and thus represents a critical regulatory step leading to subsequent 
cell transmigration and eventual formation of distant metastatic tumors.9,12,26,68,81,82 
Identification of cellular attributes and/or pathways contributing to metastatic 
dissemination in the context of selectin-mediated adhesion are therefore of high interest for 
its potential to identify cancer cell-selective drug targets inhibiting cancer’s spread.28,184,185  
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Although they are highly simplified compared to in vivo mouse models, engineered 
in vitro systems that mimic the in vivo microenvironment offer numerous advantages for 
the investigation of mechanisms underlying malignant progression in a highly controlled 
manner.12,186 The application of microfluidics to such problems allows the interrogation of 
biomechanical effects on metastatic cell transport under defined cellular, molecular, and 
biophysical conditions.24,81,187,188 For example, in vitro systems have been used to sense 
morphological cell changes in a hypoxic tumor microenvironment, to probe force 
interactions between cells and the extracellular matrix, and to elucidate the impact of 
hemodynamic flow induced shear stress on regulating mechanotransduction mechanisms 
of circulating cancer cells.189,190 Further, and relevant to this work, they can be designed to 
recapitulate selectin-mediated cell adhesion in flow, permitting the examination of 
adhesion mechanisms, and when coupled with high speed video microscopy, can be used 
to visualize the adhesive behavior of cells in flow fields that simulate the microenvironment 
of the vasculature.11–13,26 Despite their numerous advantages, approaches to date have been 
limited to indirect analysis of perturbation of associated pathways or drugs on measured 
adhesion quantity and quality. Few approaches have been described that allow cells to be 
recovered and analyzed, fewer still that enable high content analysis of metastatic cancer 
cell adhesion and expression phenotypes to enable mechanistic disease and drug response 
modeling. 
To fill this technical gap, a cell sorting microfluidic was previously engineered by 
our group to fractionate cells based on their residence time in a selectin functionalized 
channel as a proxy for average velocity. This platform permits the separation and 
enrichment of subsets of cells exhibiting little to no adhesion versus those that are highly 
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adhesive based on their elution time through the functionalized microfluidic for 
interrogation of their metastatic potential in vivo and profiling of cellular molecular 
profiles.26 This approach solely separated cells into fractions of cells exhibiting any 
adhesion versus that did not. A natural extension of this proof-of-principle would be to 
perform such analyses with finer resolution in elution times (e.g. fast versus slow rolling 
adhesion). The persistence of adhesion by metastatic colon cancer cells to selectins in shear 
flow is highly variable, however, complicating interpretation of elution time alone as a 
readout of cell adhesion phenotype11,13 and the application of the cell adhesion 
chromatography system to analyze complex or even subtle adhesive mechanisms.  
To establish a methodology to analyze cellular phenotypes associated with different 
quantities and qualities of adhesion in flow, we sought to reconcile and address the 
potential confounding effects of sustained versus diminished adhesion persistence on 
fractionating and profiling cell subsets with differing adhesive phenotypes among a 
heterogeneous population of metastatic cancer cells. To do so, a fluorescence-based 
velocity probe recently reported by our group as enabling the off-chip analysis of velocities 
with which cells move through spatially defined shedding areas of photoconverting light 
was incorporated into the cell adhesion chromatography microfluidic system.12 
Individually, the cell sorting microfluidic quantifies adhesion in flow over long time- and 
length-scales on a large, subset basis. Conversely, the photoconversion technique 
quantifies velocities of rolling adhesion in flow over short time- and length-scales on a 
single cell basis. The integration of the cell sorting and photoconversion systems thus 
permits the simultaneous evaluation of cellular properties associated with long versus short 
time- and length-scale adhesion behaviors of metastatic tumor cells. Using this 
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methodology, analysis of persistent adhesion via photoconversion and adhesion 
chromatography converged to yield the same analyzed cellular velocities and phenotypes 
associated with rolling adhesion by human LS174T metastatic colon carcinoma cells that 
are frequently used to model selectin-mediated tumor dissemination.82,191–193 This 
analytical method also revealed rolling adhesion on E-selectin to be strongly associated 
with expression of E-selectin ligands, correlations that vary with ligand type and rolling 
velocity magnitude. Further, discrete selectin ligand expression profiles were found to 
underlie persistent versus non-persistent adhesion by LS174T cells to E-, P-, versus L-
selectin in flow, suggestive of divergent regulatory mechanisms. This integrated cell 
sorting and photoconversion microfluidic platform thus enables in vitro analysis and 
comparisons of adhesive phenotypes as they relate to mechanisms of cancer cell metastasis 
in the context of selectin mediated adhesion to reveal new insights into potential cancer 
dissemination pathways.  
4.2 Materials and Methods 
4.2.1 Cell Culture 
Human colorectal adenocarcinoma LS174T cells (both parental and those 
transfected to stably express Phamret14) were cultured in Dulbecco’s Modified Eagle 
Medium supplemented with 10% heat inactivated fetal bovine serum (FBS) and 1% 
penicillin-streptomycin-amphotericin (Life Technologies). Cells were harvested via mild 
trypsinization with 0.25% trypsin EDTA, centrifuged at 400 X G for 5 min, and 
resuspended in culture medium. Prior to use in perfusion experiments, the cells were 
 71 
incubated in suspension for 2 h at 37°C to allow regeneration of adhesive cell surface 
ligands. All cells were obtained from American Type Culture Collection. 
4.2.2 Channel Fabrication 
Microfluidic channels were fabricated as detailed previously.26 Briefly, the 
microfluidic channels were made using 100 µm thick double-sided adhesive tape (3M) 
backed with a release liner into which a U-shaped channel was cut, using a craft cutter 
(Silhouette America), consisting of two parallel 14 cm long by 2 cm wide sections 
connected by a 1.5 cm long by 2 cm wide straight portion of adhesive tape. The channel 
was designed as a U-shape to optimize the size of the platform for ease of use with the 
spatial constraints of the high speed videomicroscopy, while permitting settling of the cell 
pulse before reaching the functionalized portion of the channel, as experimentally and 
quantitatively validated previously.26 The adhesive channels were then affixed to PDMS 
(Ellsworth Adhesives), which was previously cured by mixing PDMS base with curing 
agent at a ratio of 9:1 and curing at 90˚C for 3 h in a Pyrex dish. To complete fabrication, 
an inlet hole was punched into the end of one of the long, straight portions of the channel 
using a 3 mm biopsy punch. The platform was attached to a non-tissue culture treated 
polystyrene plate into which an outlet hole was drilled prior to assembly to permit the 
collection of the cell fractions into easily interchangeable reservoirs without disturbing 
flow, as described previously.26 
4.2.3 Channel Functionalization 
The long, straight portion of the channel nearest the outlet was functionalized 
through the following steps: incubating at 4°C overnight with Fc specific goat anti-human 
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IgG (R&D Systems) diluted in Dulbecco’s Phosphate Buffered Saline (D-PBS) without 
calcium and magnesium to a concentration of 2.5 µg mL-1 for E-selectin experiments or 25 
µg mL-1 for P- and L-selectin experiments, which is non-specifically adsorbed onto the 
surface of the polystyrene plate; blocking for 1 h at room temperature with 1% BSA in D-
PBS; incubating for 2 h at room temperature with either 2.5 µg mL-1 of recombinant human 
E-Selectin Fc chimera protein (R&D Systems), 25 µg mL-1 of recombinant human P-
Selectin Fc chimera protein (R&D Systems), or 25 µg mL-1 of recombinant human L-
Selectin Fc chimera protein (R&D Systems), all of which were diluted in D-PBS with 
calcium and magnesium; and finally, blocking the entire device for 1 h at room temperature 
with 1% BSA in D-PBS at room temperature. In between each step, the channel was 
washed three times with 1 mL of D-PBS with calcium and magnesium. Only the straight 
portion nearest the outlet was functionalized by pipetting 200 µL of goat anti-human IgG 
Fc specific, 1% BSA and selectin solutions into the drilled outlet hole which, by virtue of 
this volume covering only the terminal straight channel portion, prevented 
functionalization of the rest of the channel. In so doing, cells that had all settled to the 
bottom of the channel prior to reaching the functionalized portion of the channel were 
ensured to experience a uniform channel length with which to mediate adhesive 
interactions.26  
4.2.4 Perfusion Experiment Workflow 
Perfusion experiments were performed in a similar manner to that formerly 
described.26 An inlet syringe connected to tubing filled with perfusion media (0.1 % BSA 
in D-PBS), was connected to a syringe pump (PhD Ultra Harvard Apparatus) and used to 
withdraw a cell pulse of 250,000 cells diluted in 200 µL of perfusion media into the inlet 
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tubing at a rate of 0.5 mL min-1. The tubing connected to the syringe was inserted into the 
inlet hole of the channel. An outlet reservoir was made by connecting a 5 mL test tube to 
the bottom of the drilled outlet hole on the polystyrene plate. The assembled platform was 
placed on an Eclipse TI optical microscope (Nikon) with an objective magnification of 10X 
and linked to NIS-Elements software (Nikon) to acquire videos at a frame rate of 25 frames 
per second at an exposure time of 0.281 µs and 2x2 binning of a 500 by 376 pixels. To 
complete the set-up, the system was integrated with a 405 nm light source was placed under 
the channel, directly upstream of the microscope objective, at the beginning of the 
functionalized portion of the channel. To ensure a short time- and length-scale velocity was 
ascribed to the cells, a mask that is placed atop the laser and has a rectangular cutout 1.2 
cm wide by 1 cm long to permit light exposure across the entire width of the channel but 
only 1 cm down the length of the channel in the direction of flow to occlude light exposure 
outside the defined window. 
To begin perfusion, the 405 nm was turned on at maximum power and the syringe 
pump was set to a flow rate of 1 dyn cm-2 for E-selectin experiments or 0.5 dyn cm-2 for P-
selectin and L-selectin experiments to initiate inflow from the syringe-tubing assembly. 
The flow rate to achieve desired wall shear stresses was determined from Equation 2, with 
the assumption that the apparent viscosity of the perfusion media was 0.009 P.  
 
𝑄𝑄 =  
𝜏𝜏𝑤𝑤 ∗  ℎ2 ∗ 𝑤𝑤
6 ∗  𝜇𝜇
 (2) 
Perfusion was continued for 10 min for experiments conducted at 1 dyn cm-2 or 20 
min for experiments conducted at 0.5 dyn cm-2, as these were the predetermined elution 
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times for the free flow cells to elute through the channel (as measured previously)13,26, after 
which perfusion was stopped and the test tube containing the cell solution collected during 
perfusion was removed and a new test tube was attached. Finally, the syringe with inlet 
tubing was replaced with a new syringe-inlet tubing apparatus filled with only perfusion 
media and used to eject the cell solution out of the channel and into the second collection 
tube for experiments in which only one adherent (AD) fraction was collected. For 
experiments in which two AD fractions were collected, after the predetermined free flow 
cell elution time, the cell collection reservoir was changed, perfusion was continued for an 
additional 10 min (the time required for 50% of the adherent cells to elute). For experiments 
in which three adherent fractions were collected, after the predetermined free flow cell 
elution time, another fraction was collected after 28 min, the time for 66% of adherent cells 
to elute, to collect Adherent 2/3.  
In experiments where cells were statically pre-photoconverted and photoconverted 
with perfusion, the cell pulse of 250,000 Phamret LS174T cells diluted in 200 µL of 0.1% 
BSA perfusion media were first statically photoconverted for 4 or 8 min in 96 well plate 
prior to perfusion through an E-selectin functionalized channel as described above.  
4.2.5 Confirmation of Retention of Fc Specific Goat Anti-human IgG Surface 
Functionalization after Perfusion 
Retention of Fc specific goat anti-human IgG adsorption was verified by 
functionalizing dishes with either 2.5 µg mL-1 or 25 µg mL-1 of FITC labelled Fc specific 
goat anti-human IgG. The channels were then blocked with 1% BSA for 1 h, and 
subsequently, perfusion experiments were conducted at either 1 dyn cm-2 for 28 min (the 
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longest time experiments are performed at 1 dyn cm-2) or 0.5 dyn cm-2 for 20 min (the 
longest time experiments are performed at 0.5 dyn cm-2). During the experiments, the 
perfusion media was collected, and the mean fluorescent intensity (MFI) of the perfusion 
media was measured using a plate reader. The MFI of the collected perfusion media was 
correlated to an Fc specific goat anti-human IgG concentration using a standard curve. The 
perfusion media was found to contain a negligible amount of Fc specific goat anti-human 
IgG (anti-IgG) (Figure 4.1). 
 
Figure 4.1 Verification of Fc specific goat anti-human IgG functionalization after 
perfusion. (A) Standard curve of mean fluorescence intensity (MFI) of FITC labeled 
Fc specific goat anti-human IgG (anti-IgG) at different concentrations with MFI of 
perfusion media collected after either functionalization and perfusion with 2.5 µg/mL 
Fc specific goat anti-human IgG (anti-IgG) at 1 dyn cm-2 for 28 minutes (purple circle) 
or 25 µg/mL Fc specific goat anti-human IgG (anti-IgG) at 0.5 dyn cm-2 for 20 minutes 
(orange square). 
4.2.6 Elution Time Quantification 
Similar to previous work26, 2 hour videos of 250,000 cells perfused as a 200 µL 
cell pulse at a flow rate corresponding to a wall shear stress of 1 dyn cm-2 were taken 0.5 
cm from the channel outlet. Our custom written cell tracker code was used to analyze 
collected videos, setting to threshold of 4 and a blurring factor of 7 to identify objects that 
had a diameter between 12-18 µm that had traveled more than 400 μm during the course 
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of the video and record the time it took the object to leave the field of view after perfusion 
had begun. Cummulative frequency plots generated in Prism (GraphPad Software Inc) 
based on the elution time of each cell quantified using cell tracking software. For 
experiments where 2 AD fractions were collected, the elution time of the adherent 1/2 
(AD1/2) fraction was 10 min after the free flow cells had eluted. For experiments where 3 
adherent fractions were collected, the elution time of the adherent 1/3 (AD1/3) fraction was 
8 min after the free flow cells had eluted and the elution time of the adherent 2/3 (AD2/3) 
fraction was 10 min after the AD1/3 cells had eluted. 
4.2.7 Flow Cytometric Analysis 
Collected cell solution fractions were centrifuged at 400 X G for 5 min and 
resuspended in diluted antibody solutions on ice for 45 min, washed with D-PBS with 
calcium and magnesium two times, and resuspended in 0.1% BSA perfusion media for 
analysis on the flow cytometer. The antibodies (BD Biosciences) were diluted in D-PBS 
with calcium and magnesium in the following ratios – 1:20 for PE CD44 and PE CEA, 
1:40 for APC HECA452, and 1:10 for APC CD24. Obtained flow cytometry data was 
analyzed using FlowJo software (Treestar Inc.).  
4.2.8 Quantification of Adhesive Cell Behavior 
Cell adhesive phenotypes were characterized based on both their long and short 
time- and length-scale velocities of rolling adhesion in flow when perfused over a selectin 
functionalized substrate. The short time- and length-scale velocity of perfused cells was 
quantified by their green fluorescent protein to cyan fluorescent protein (GFP/CFP) ratio 
compared to an unphotoconverted control and converted to velocity using a 
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photoconversion standard curve. Average cell velocities were quantified based on their 
population average residence times in the functionalized channels.26  
4.2.9 Development of Standard Curve 
Channels were blocked with 1% BSA (diluted with D-PBS with calcium and 
magnesium) to inhibit any non-specific cell interaction with the polystyrene dish during 
perfusion. The light source was set to maximum power and masked, as described above, to 
allow light only on 1 cm of the channel in the direction of flow. By varying the flow rate 
within the channel and, therefore, the velocity of cells, the residence time of cells exposed 
to the 10 mm window of light from the light source can be controlled. Using this setup, 
cells were perfused in the channels at differing flow rates which corresponded to desired 
velocities of cells, as derived previously13, and desired residence times of cells exposed to 
light source according to Equations 3 and 4, where the cell radius is assumed to be 8 µm 
and medium viscosity 0.009 P. 
 
𝑣𝑣𝑚𝑚𝑖𝑖𝑖𝑖𝑖𝑖𝑤𝑤𝑖𝑖𝑖𝑖𝑤𝑤𝑖𝑖𝑚𝑚𝑖𝑖𝑚𝑚𝑖𝑖 =  
𝑚𝑚𝑚𝑚𝑚𝑚𝑚𝑚 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙ℎ
𝑟𝑟𝑙𝑙𝑚𝑚𝑟𝑟𝑟𝑟𝑙𝑙𝑙𝑙𝑟𝑟𝑙𝑙 𝑙𝑙𝑟𝑟𝑚𝑚𝑙𝑙 𝑟𝑟𝑙𝑙 𝑟𝑟ℎ𝑚𝑚𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙
 (3) 
 
𝑣𝑣𝑚𝑚𝑖𝑖𝑖𝑖𝑖𝑖𝑤𝑤𝑖𝑖𝑖𝑖𝑤𝑤𝑖𝑖𝑚𝑚𝑖𝑖𝑚𝑚𝑖𝑖 =  
𝜏𝜏𝑤𝑤




− 𝑟𝑟2] (4) 
Each perfusion was allowed to run for the duration of the time experimentally 
determined necessary for the cell pulse to traverse the light source window. After which, 
the cells and perfusion media was expelled from the channel at high flow rates into the 
reservoir. The cells and perfusion media in the reservoir were collected, centrifuged at 400 
X G, and resuspended in FACS buffer (0.1% BSA diluted in D-PBS with calcium and 
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magnesium) for flow cytometry analysis of extent of photoconversion. Data from flow 
cytometry was collected and analyzed using FlowJo (Treestar Inc). Graphing the 
relationship between the extent of photoconversion—as given by ratio of GFP to CFP, 
normalized to a control sample perfused with the light source off—and velocity of cells at 
different flow rates using Prism (GraphPad Software Inc), a nonlinear regression was fit to 
the data. This was done for Phamret LS174T cells of different passage age and different 
cell thaws to ensure the standard curve was broadly applicable (Figure 4.2). 
 
Figure 4.2 Comparison of interpolated standard curves. (A) Overlay of 
photoconversion standard curves created either by statically photoconverting 250,000 
Phamret-expressing LS174T cells for various amounts of time (gray line) or perfusing 
a cell pulse of 250,000 Phamret-expressing LS174T cells in an unfunctionalized 
channel at various flow rates (black line). (B) Static standard curve (orange) and 
perfusion standard curve (black) from (A) overlaid with a perfusion standard curve 
from a population of Phamret-expressing LS174T cells (teal) thawed at a different 
time than the cells used to create the standard curves from (A). 
4.2.10 Ligand Expression and Extent of Photoconversion 
FlowJo (Treestar Inc) and Prism (GraphPad Software Inc) were used for gating and 
subsequent analysis of flow cytometry data. For all experiments, collected events from the 
BD LSR II Flow Cytometer were gated for live cells. The live cell population was then 
gated into photoconverted and unphotoconverted populations, and coefficients of 
correlation in linear models were quantified as previously described.12 Briefly, after an 
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unphotoconverted sample of LS174T Phamret cells were analyzed on the flow cytometer 
and gated to include only live cells, logarithmic plots of GFP versus CFP signal were made 
using FlowJo, and the resultant population was used gate the photoconverted negative 
population, likewise, any cells with a greater GFP/CFP ratio as compared to the 
unphotoconverted cells were gated as photoconverted positive. In order to determine 
correlation coefficients of the linear, the photoconverted negative or photoconverted 
positive cells, which were labeled with a PE- or APC-conjugated antibody for the ligand 
of interest, from each collected fraction were subsequently analyzed on the flow cytometer 
at the single cell level for fluorescent intensity of PE or APC, GFP, and CFP. The resulting 
data points were then pooled and divided into four equal subgates based on their extent of 
photoconversion, as quantified by the GFP/CFP ratio such that the center of each subgate 
was the mode of the cell population. The range for each quartile was determined by a 
perfused, photoconverted, but unsorted control that was conducted on each day for each 
experimental condition. This was done each time an experiment was performed to account 
for inherent variability between cells. For each subgate, the mean PE or APC fluorescent 
intensity and GFP/CFP ratio was calculated. Finally, Prism was used to fit a linear 
regression model to the data, as well as perform post-hoc tests for non-zero slopes and 
differences between slopes.  
4.2.11 Outlier Detection and Elimination 
ROUT outlier tests with criteria Q = 1 were conducted on all data sets used for 
linear regression models. Recognized outliers were removed from the data sets prior to 
model fitting. 
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4.2.12 Enzymatic Treatment 
Prior to perfusion in functional adhesion experiments with enzymatic treatment, 
Phamret LS174T cell suspensions at 1X107 cells mL-1 were incubated with or without 0.1 
U mL-1 Vibrio Cholerae Neuraminidase (Roche Applied Science) at 37°C for 1 hr, as 
described previously.81,194 After treatment, cells were washed to remove the enzyme and 
resuspended in 0.1% BSA diluted in D-PBS with calcium and magnesium for perfusion. 
To confirm complete digestion, cells were stained with a fluorescent mAb HECA452 
(which recognizes LS174T expressed sialic-acid–bearing epitope sialyl Lewis x) and 
analyzed on a flow cytometer. 
4.3 Results 
4.3.1 Adherent Relative to Free Flow Cell Fractions Exhibit Greater Photoconversion 
Proportion and Extent 
A previously engineered cell sorting microfluidic platform based on a parallel plate 
flow chamber configuration was modified by adding a 405 nm laser to the beginning of the 
selectin functionalized portion of the channel (Figure 4.3A,B).26 The start of the 
functionalized channel portion was intentionally chosen as the light exposure location in 
order to standardize when cells would be exposed to light during experimentation, thus 
minimizing potential variance in when cells were light exposed (e.g. after different times 
of adhesion) that may confound interpretation of experimental results. Note that by virtue 
of the upstream settling feature, all cells perfused through the device were within ~10% of 
a cell radius from the inferior substrate, ensuring all cells had the opportunity to mediate 
adhesive contacts.13,26 Metastatic human colon carcinoma LS174T cells of epithelial origin 
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and approximately 14 cell µm diameter were used as the model cell line, as they have been 
extensively studied in adhesion assays and for interrogation of mechanisms underlying 
colon cancer metastasis.9,11–13,26,81,195,196 LS174T cells that stably expressed Phamret, a 
photoconvertible fluorescent protein formed from fusion of photoactivatable green 
fluorescent protein (GFP) with cyan fluorescent protein (CFP), exhibited no difference in 
adhesion behavior compared to untransfected parental cells (Figure 4.4A,B). Use of this 
engineered cell line thus enabled a readout of short time- and length-scale velocity to be 
ascribed individually to each cell in proportion to their transit time through the illuminated 
region during perfusion, as previously described and quantified by an increase in GFP 
signal relative to an unchanged CFP signal resulting in an increased GFP/CFP ratio (Figure 
4.3A, 4.5A).12,197,198  
 
Figure 4.3 Integrated photoconversion, cell sorting adhesion chromatography 
microfluidic for in vitro interrogation of metastatic cancer cell adhesive phenotypes. 
(A) The short and long time- and length-scale velocity of an infused cell pulse can be 
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simultaneously quantified by utilizing a 405 nm laser to photoconvert Phamret-
expressing cells to ascribe an short time- and length-scale velocity and 
interchangeable cell fraction tubes to ascribe an average velocity in a (B) 
hemodynamic microenvironment-mimicking, parallel-plate microfluidic device, into 
which metastatic cancer cells are infused into the selectin functionalized channel and 
visualized via integrated high speed videomicroscopy. (C) LS174T cells perfused over 
a functionalized channel were sorted into a free flow (FF) and adherent (AD) fraction 
based on their elution time from the cell sorting system. 
 
As selectins mediate cell adhesion over a wide range of rolling velocities (order of 
1-100 µm/sec) and efficiencies,11 parameters under which this device was implemented to 
interrogate mechanisms underlying of long- versus short- scale adhesive interactions by 
LS174T cells to E-, P-, and L-selectin were adjusted in order for the collected cell 
population sizes to be roughly similar amongst selectins and sufficiently large to enable 
subfractionation and fluorescent labeling analyses described below. Specifically, all 
experiments were performed at concentrations of 2.5 versus 25 μg mL-1 and 1.0 dyn cm-2 
versus 0.5 dyn cm-2 for E- versus P- and L-selectin, respectively, and cells sorted over 20 
min into Free flow (FF) versus Adherent (AD) fractions (Figure 4.3A) for analysis (Figure 
4.4C-E). The chosen wall shear stresses of 0.5 and 1 dyn cm-2 recapitulate the low venular 
shear stresses under which metastatic circulating tumor cell recruitment occurs. 11,199,200 
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Figure 4.4 Photoconvertible LS174T cell line and adhesive chromatography 
microfluidic characterization. (A,B) Comparison of (A) average rolling velocity and 
(B) percent of cells collected in each fraction from a cell pulse of either 250,000 control 
LS174T cells or Phamret-expressing LS174T cells over 2.5 µg mL-1 E-selectin at 1 dyn 
cm-2. (C) Number of interacting cells along the length of the channel during the 
sorting phase in an E-, P-, or L-selectin functionalized channel. (D) Representative 
relative frequency distribution of elution time of a cell pulse infused at 0.5 dyn cm-2. 
Inset depicts the mean time at which 95% of the cell pulse has eluted ± s.e.m. (E) 
Percent of cells collected in each fraction after perfusion in an E-, P-, or L-selectin 
functionalized channel. (F) Viability of cells in each collected Free flow or Adherent 
fraction. (C-F) Perfusion and separation of a Phamret-expressing LS174T cell pulse 
of 250,000 cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-2 or 25 µg mL-1 L- or P-selectin 
at 0.5 dyn cm-2. (A-E) Each dot or bar represents the mean ± s.e.m. of n≥3 
individually run experiments. Statistical analysis (A,B,F) by paired t-test or (E) one-





Within each collected subfraction, the extent and proportion of total cells that were 
photoconverted was measured based on unphotoconverted control cells (Figure 4.5B,C). 
Expectedly, the extent of photoconversion (GFP/CFP ratio) was significantly greater for 
the AD relative to FF subset, though not to a statistically significant extent on P-selectin 
(Figure 4.5D), potentially due to the wider range of velocities typically observed for cells 
mediating adhesion to P-selectin11,13 and diminished adhesion persistence11 resulting in 
cells not mediating adhesion within the photoconversion window eluting into the AD 
fraction or vice versa. Additionally, measured ratios in the FF fraction were not statistically 
different from unphotoconverted cells when perfused over E- and P-selectin (Figure 4.5E). 
However, a small increase was measured over L-selectin (Figure 4.5D), in line with the 
tethering type interaction mediated by L-selectin and very low adhesion persistence 
mediated by LS174T cells on L-selectin.11 The frequency of photoconversion positive 
(PC+) cells (Figure 4.5E) was also increased in AD relative to FF fractions after perfusion, 
though again not to a statistically significant extent on P-selectin (Figure 4.5E), changes 
not associated with differences in cell viability (Figure 4.4F). Notably, the frequencies of 
PC+ cells were significantly non-zero in the FF fraction (Figure 4.5E). Thus, despite high 
(>220 µm/sec) average velocities indicated by their elution into the FF fraction, a low but 
substantial fraction of cells within the FF fraction did exhibit some level of 
photoconversion above background. Consistent with previous reports,11 a subfraction of 
cells thus exhibit non-persistent adhesion which in this case is captured by a subfraction of 
cells that elute into the FF fraction but have been photoconverted as a result of adhesion 
within the light exposure window that slows them down to some level below minimum 
detectable short time- and length-scale velocity (Figure 4.5F). In its capacity to identify 
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and measure different adhesion qualities (persistent versus non-persistent adhesion), this 
system also substantiates previous results that a higher proportion of LS174T cells exhibit 
diminished adhesion persistence on P- and L- relative to E-selectin (Figure 4.5E). 
In an effort to further quantify differences short time- and length-scale velocity 
magnitudes exhibited by FF versus AD cells, the extent of photoconversion was assessed 
by subdividing the PC+ cells into GFP/CFP ratio quantile bins based on perfused and 
photoconverted but unsorted cells (Figure 4.5G). The proportion of cells exhibiting high 
extents of photoconversion (bin 4) corresponding to low short time- and length-scale cell 
velocities was substantially higher in AD but not FF cells collected on all three selectin 
types (Figure 4.5H-J). This integrated system can thus assess both the quantity (frequency 
of AD versus FF and PC+ cells of total) as well as quality [persistent (PC+ in AD) versus 
non-persistent (PC+ in FF)] of rolling adhesion by cells in shear flow. 
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Figure 4.5 Adherent relative to free flow cell fractions exhibit increased extents of 
photoconversion and proportions of photoconverted cells. (A) Photoconversion 
standard curve relating cell velocity and GFP/CFP ratio normalized to an 
unphotoconverted control. (B) Flow cytometry scatter plot gating of photoconverted 
(PC+) and unphotoconverted (PC-) Phamret-expressing LS174T cells based on 
unphotoconverted control population. (C) Representative flow cytometry plots of the 
extent of photoconversion from cells collected in the FF (left) or AD fractions (right). 
(D) GFP/CFP ratio measured by flow cytometry and (E) percent of PC+ cells from 
collected fractions after perfusion, photoconversion, and separation over E-, P-, or L-
selectin. Intercept of d dashed line: E, 1; F, 2.5%. (F) Schematic depicting persistent 
versus non-persistent adhesion along adhesive ligand-functionalized substrate. Cell A 
represents a free flow cell, while cell B represents a lowly persistent, photoconverted 
cell that would elute into the FF fraction. Cell C and cell E are also lowly persistent 
cells. Cell D is a fast rolling highly persistent cell, whereas cell F is a slow rolling highly 
persistent cell. (G) PC+ cells from a perfused and photoconverted, but unsorted, cell 
pulse used to create four extents of photoconversion quantile bins. (H-J) Percent of 
PC+ cells from collected fractions contained within each bin after perfusion, 
photoconversion, and separation over (H) E-, (I) P-, or (J) L-selectin. (D,E,H-J) 
Each dot or bar represents the mean ± s.e.m. of n≥3 individually run experiments. * 
p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 by (D,E) one sample t-test (*) with 
(D) h0 = 1 or (E) h0 = 2.25% or paired t-test (#). (I-K) One-way ANOVA with post hoc 
t-test with Bonferroni corrections for multiple comparisons.  
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4.3.2 Velocity of Rolling Adhesion Magnitude on E-Selectin Correlates Differentially 
with Ligand Type 
The expression of selectin ligands within subfractions/subsets of perfused cells was 
assessed in the context of E-selectin adhesion, which is highly persistent (Figure 4.5D-F).13 
Thus, enrichment of specific selectin ligands over differing rolling velocity magnitudes 
was measured and results between chromatography versus photoconversion methodologies 
was compared.  
First, the fractionation resolution was increased to further elucidate phenotypic 
differences amongst late and early eluting cells within the AD fraction. Specifically, 
collection of either two fractions of interacting cells (Figure 4.6A, 4.7A,B) – the first and 
later 50% of interacting cells to elute (AD 1/2 and 2/2, corresponding to average velocities 
of 83 – 220 and <83 µm/s, respectively) – or three fractions of interacting cells (Figure 
4.6B, 4.7A,C) – the first, middle, and last third of interacting cells to elute (AD 1/3, 2/3, 
and 3/3, corresponding to average velocities of 90 – 220, 60 – 90, and <60 µm/s, 
respectively) was performed (Table 4.1).  




Figure 4.6 Long and short time- and length-scale cell velocities converge when 
measured using photoconversion and chromatographic methodologies in 
combination. Phamret-expressing LS174T cells perfused over 2.5 µg mL-1 E-selectin 
at 1 dyn cm-2 were sorted into (A) two or (B) three AD fractions based on their elution 
time from the selectin functionalized integrated photoconversion and cell sorting 
system. (C-H) Extent of photoconversion measured by flow cytometry (C,F) and 
percent of PC+ cells (D,G) within each fraction normalized to the unphotoconverted 
control population when either (C,D) two or (F,G) three AD fractions were collected. 
FF denotes free flow, AD denotes adherent. (E,H) Binning and analysis of PC+ cells 
from each fraction based on extent of photoconversion measured by flow cytometry 
normalized to the unphotoconverted control after collection of (E) two or (I) three AD 
fractions. (I-K) Short time- and length-scale velocity ± s.e.m and average velocity 
± s.e.m among cells in each fraction when (I) one, (J) two, or (K) three AD fractions 
were collected. (C-K) Each dot or bar represents the mean ± s.e.m. of n≥3 individually 
run experiments. Perfusion, photoconversion, and separation of a Phamret-
expressing LS174T cell pulse of 250,000 cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-
2. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 by one-way ANOVA with post 




Figure 4.7 Elution time determination for collection of multiple AD fractions. (A) 
Relative cumulative frequency of elution time of the interacting cells in a perfused cell 
pulse. Orange, blue, and green lines represent elution of 33%, 50%, and 66% of the 
interacting cells, respectively. (B,C) Percent of cells in each fraction when either (B) 
2 or (C) 3 Adherent fractions are collected. (A-C) Perfusion of 250,000 Phamret-
expressing LS174T cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-2. (B,C) Each bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. 
In so doing, the extent of photoconversion for cells in AD 2/2 but not AD 1/2 was 
found to be greater than that of FF (Figure 4.6C) with a greater percentage of AD 2/2 cells 
being photoconverted, specifically to high extents (Figure 4.6D,E fourth quartile) as would 
be expected given the upper limit of photoconversion measurable velocities (Figure 4.5A). 
Similarly, when the perfused cells were fractionated into three adherent subsets, again, only 
the latest eluting fraction (AD 3/3) had significantly greater extents of photoconversion 
(Figure 4.6F) and greater percent of cell photoconverted (Figure 4.6G,H fourth quartile) 
compared to the FF cells and earlier eluting adherent cells (AD 1/3 and AD 2/3). In 
converting these photoconversion extents to velocities, analysis of all collected cells in 
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PC+ fractions demonstrated rolling behavior over E-selectin that was in alignment at both 
long and short time and length scales (e.g. long and short time- and length-scale rolling 
velocity, respectively), in contrast to all cells (PC+ and PC-) that exhibited short time- and 
length-scale velocities higher than those predicted by their elution time (Figure 4.6I-K).  
Expression levels of selectin ligands among the AD fractions were next assessed 
by flow cytometric analysis post sorting (Figure 4.8A). PC+ cell populations eluting in the 
latest fractions demonstrated the most pronounced enhancements in sLex and CD44 
expression compared to the non-interacting (PC- and FF) and early eluting AD cells (Figure 
4.8B,C,E,F). CEA ligand expression was also enriched in the latest fraction of eluting AD 
cells compared to levels measured for FF cells (Figure 4.8D,G), a trend not seen when only 
one AD fraction was collected.26 Notably, no differences were observed between adhesive 
ligand expression on E-selectin among PC- cells (Figure 4.8B-G).  
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Figure 4.8 Selectin ligand expression increased in cells mediating persistently slow 
rolling on E-selectin. (A) Phamret-expressing LS174T colon carcinoma cells perfused 
over selectin-functionalized channels, photoconverted in a manner proportional to 
short time- and length-scale velocity, sorted into fractions based on average velocity, 
and gated using flow cytometry into photoconverted (PC+) and unphotoconverted 
(PC-) populations. Cells collected in each fraction are stained with fluorescently 
tagged antibodies, allowing correlations between ligand expression, elution time, and 
photoconversion to be elucidated. (B-G) Perfused, photoconverted, and sorted 
Phamret-expressing LS174T cells were collected into (B-D) two or (E-G) three AD 
fractions fluorescently labeled for (B,E) sLex, (C,F) CD44, or (D,G) CEA to measure 
ligand expression levels among PC+ or PC- cells between the collected fractions. MFI 
denotes mean fluorescent intensity. (B-G) Each bar represents the mean ± s.e.m. of 
n≥3 individually run experiments. Perfusion, photoconversion, and separation of a 
Phamret-expressing LS174T cell pulse of 250,000 cells over 2.5 µg mL-1 E-selectin at 
1 dyn cm-2. * p < 0.05, ** p < 0.01, *** p < 0.001 by one-way ANOVA with post hoc t-




Relationships between adhesive ligand expression with short time- and length-scale 
velocity magnitude, as measured by a cell’s mean GFP/CFP ratio, in various fractions were 
next assessed. After further dividing the PC+ and PC- subsets of cells separately based on 
GFP versus CFP expression into four evenly distributed bins (quantiles with respect to the 
frequency of an unphotoconverted parent population of Phamret LS174T cells, Figure 
4.9A) to quantify the GFP/CFP ratio spread among the cells, mean ligand expression levels 
were quantified for each bin in the FF and AD fraction of PC+ or PC- cell populations. In 
so doing, the relative correlations (when statistically non-zero) between adhesion molecule 
expression and cellular velocity was quantified, with greater slope differences between 
subfractions indicating different relative roles for each ligand in mediating selectin 
adhesion within each fraction, e.g. slow (PC+ in AD 2/2 and AD 3/3) versus fast (PC+ in 
AD 1/2, AD 1/3, and AD 2/3) rolling adhesion. 
Regression analyses comparing ligand expression levels amongst PC+ cells within 
various AD fractions revealed sLex and CD44 expression being proportional to the 
GFP/CFP ratio of PC+ cells perfused, photoconverted, and sorted into either two (Figure 
4.9B,C) or three (Figure 4.9E,F) adherent fractions on E-selectin in flow. These 
relationships were more pronounced with increasing the number of collected AD fractions. 
Notably, significant correlations with CEA expression were also found, a relationship not 
observed when only one AD fraction was analyzed26 but consistent with results using 
photoconversion methodology alone (Figure 4.9D,G).12 No correlations were seen between 
ligand expression and velocity among PC- cells (Figure 4.10). Overall, these data 
demonstrate that increased expression of adhesive ligands sLex and CD44 to be inversely 
correlated with slower rolling on E-selectin over a broad range of velocity magnitudes, 
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Figure 4.9 Magnitude of persistent, slow cell rolling mediated by E-selectin adhesive 
interactions inversely correlates with selectin ligand expression. (A) PC+ and PC- 
cells from the photoconverted but unsorted cell fraction (A, middle) binned into four 
equal gates (left/right) based on their extent of photoconversion after perfusion over 
2.5 µg mL-1 E-selectin at 1 dyn cm-2 or 25 µg mL-1 L- or P-selectin at 0.5 dyn cm-2. The 
extent of photoconversion (GFP/CFP ratio) of FF PC- cells and (B-D) two or (E-G) 
three fractions of AD PC+ cells  related to the expression of (B,E) sLex reactive 
HECA452, (C,F) CD44, and (D,G) CEA. (B-G) Binned, flow cytometry data of PC+ 
cells was pooled from independent experiments and plotted with corresponding linear 
fits; CAD and CF represent the regression slope of the PC+ cells in the AD and FF 
fractions, respectively, * denotes non-zero slopes of the linear fit, † denotes 
significance of comparison between the CAD values and CF. * p < 0.05, ** p < 0.01. 
Outlier tests with criteria Q = 1 were conducted on all data sets, and outliers were 
removed prior to regression and statistical analysis. Perfusion, photoconversion, and 
separation of a Phamret-expressing LS174T cell pulse of 250,000 cell over 2.5 µg mL-




Figure 4.10 No correlations between ligand expression and GFP/CFP ratios among 
PC- cells within any collected cell fraction. (A-E) The extent of photoconversion 
(GFP/CFP ratio) of FF PC- cells and (A-C) 2 or (D-E) 3 AD fractions related to the 
expression of (A,D) sLex reactive HECA452, (B,E) CD44, and (C,F) CEA. (A-
F) Binned, flow cytometry data of PC- cells was pooled from independent 
experiments and plotted with corresponding linear fits; CF and CAD represent the 
regression slope of the PC- cells in the Adherent and Free flow fractions, respectively. 
Outlier tests with criteria Q = 1 were conducted on all data sets, and outliers were 
removed prior to regression and statistical analysis. Perfusion, photoconversion, and 
separation of a Phamret-expressing LS174T cell pulse of 250,000 cell over 2.5 µg mL-
1 E-selectin at 1 dyn cm-2. 
4.3.3 Slow and Fast Rolling Adhesion on E-selectin is Associated with Sialyl Lewis X 
Expression 
Within the experimental configuration described so far, only fractions that exhibit 
velocities within the dynamic range of the photoconversion system are measurable via 
photoconversion (Figure 4.11A). Under all fractionation conditions, the latest eluting cells, 
and therefore the cells with the slowest average rolling velocities, exhibited the most 
significant correlations between increasing extent of photoconversion and adhesive 
molecule presentation (Figure 4.9B-G). However, with the photoconversion methodology, 
velocities above ~200 µm/s are poorly discernible (Figure 4.5A). As such, although the 
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photoconversion methodology reduces noise within subfractionated populations to reveal 
subtle trends, it is limited to the direct analysis of cells interacting with slow short time- 
and length-scale velocities only (Figure 4.11A).  
To expand the working parameters and versatility of the system to elucidate 
expression relationships for cells exhibiting higher velocities of rolling adhesion, 
photoconversion of cells prior to perfusion was performed (Figure 4.11B). In so doing, 
GFP/CFP ratios were increased for all cells depending on the time of light pre-exposure 
(Figure 4.12A). As a result, different fractions of cells are adjusted to GFP/CFP levels 
within the working dynamic range of the fluorometric velocity measurement technique 
based on pre-exposure time length (Figure 4.11A), broadening the range of adhesive 
phenotypes (in this case to include on average fast rolling cells) over which expression 
correlations can be quantified using this photoconversion method. For example, with pre-
exposure for 4 min, nearly all cells were PC+ when fractionated on E-selectin into two AD 
fractions (Figure 4.11C), with minimal differences in viability amongst collected fractions 
(Figure 4.12B). However, photoconversion extent varied widely with GFP/CFP ratio of 
AD 1/2 within the photoconversion dynamic range (Figure 4.11A). Regression analysis 
revealed sLex expression positively correlated with photoconversion extent for not only 
AD 1/2 but also the AD 2/2 fraction with 4 min pre-photoconversion (Figure 4.11D,E), in 




Figure 4.11 Cellular sLex expression inversely correlated with magnitude of fast 
rolling adhesion on E-selectin revealed by pre-photoconversion. (A) Measured 
GFP/CFP ratios and average velocities (calculated by elution time) of collected cell 
fractions. Circles, measured average velocities; Squares, average velocities adjusted 
based on pre-photoconversion time and measured average velocities. (B) Experiment 
workflow depicting static photoconversion of cells pre-perfusion to increases the 
baseline photoconversion of the cell pulse, followed by perfusion and photoconversion 
over an E-selectin functionalized channel in order to maximally photoconvert late 
eluting adherent cells. (C) Percent of Phamret-expressing LS174T cells 
photoconverted after exposure to the 405 nm laser for 4 min of pre-photoconversion. 
FF denotes free flow, AD denotes adherent. PC denotes photoconversion. (D) 
Quantification of mean fluorescent intensity of sLex reactive HECA452 in each 
collected fraction of either PC+ or PC- subsets. (E) The extent of photoconversion 
(GFP/CFP ratio) of PC+ cells within the FF and 2 AD fractions related to the 
expression of sLex (HECA452). Binned, flow cytometry data of PC+ cells was pooled 
from independent experiments and plotted with corresponding linear fits; CAD1/2, 
CAD2/2, and CF represent the regression slope of the PC+ cells in the AD 1/2, AD 2/2, 
and FF fractions, respectively, * denotes non-zero slopes of the linear fit, † denotes 
significance of comparison between CAD1/2, CAD2/2, and CF. Outlier tests with criteria 
Q = 1 were conducted on all data sets, and outliers were removed prior to regression 
and statistical analysis. (F) Quantification of mean fluorescent intensity of sLex 
expression normalized to a perfused, but not pre-photoconverted control after 4 or 8 
min of pre-photoconversion. (C-F) 4 min of pre-photoconversion followed by 
perfusion, photoconversion, and (C-E) fractionation of a Phamret-expressing 
LS174T cell pulse of 250,000 cell over 2.5 µg mL-1 E-selectin at 1 dyn cm-2. (A,C-F) 
Each dot or bar represents the mean ± s.e.m. of n≥3 individually run experiments. * 
p < 0.05, ** p < 0.01, *** p< 0.001 **** p < 0.0001 by (C-E) one-way ANOVA 
with post hoc t-test with Bonferroni corrections for multiple comparisons or (F) one 
sample t-test with h0 = 1. Dashed line at 1. 
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Of note, overexposure to photoconverting light results in loss of cell viability 
(Figure 4.12A). When using a light pre-exposure time that results maximal 
photoconversion but 50% cell loss (8 min, Figure 4.11A, 4.12A), perfusion over E-selectin 
resulted in loss of cell viability. In the context of collection into multiple fractions, nearly 
half of the free flow cells (FF) and 40% of early eluting, adhesive cells (AD 1/2) remained 
viable, whereas only about 20% of the late eluting adhesive cells (AD 2/2) were viable 
(Figure 4.12C). Notably, pre-photoconversion does not affect the adhesive behavior of 
cells in the channel, as the percent of pre-photoconverted cells that elute into the FF, 
AD1/2, and AD2/2 fractions after perfusion through the channel without photoconversion 
during perfusion is not statistically different than the percent of cells that elute into the 
aforementioned fractions without pre-photoconversion (Figure 4.12D,E). Without 
subfractionation, expression of sLex by viable cells post perfusion was lower in cells pre-
exposed to the photoconverting light for 8 min versus those without pre-photoconversion 
(Figure 4.11F). This supports sLex enabling adhesive interactions to E-selectin in flow as 
the viability of cells exhibiting the most extensive adhesive interactions would be 
compromised. Findings using this pre-photoconversion technique thus confirm inverse 
correlations between sLex expression and velocity of rolling adhesion across a broad range 
of velocity magnitudes. 
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Figure 4.12 Effects of pre-photoconversion on cells pre and post perfusion. (A) 
Percent of viable Phamret-expressing LS174T cells after exposure to the 405 nm laser 
for different lengths of static pre-photoconversion time. Gray line represents 75% cell 
viability, black line represents 50% cell viability. (B,C) Percent of cells viable (B) 4 or 
(C) 8 min of pre-photoconversion. FF denotes Free flow, AD denotes Adherent. PC 
denotes photoconversion. (D,E) Percent of cells collected in each fraction after either 
(D) 4 or (E) 8 minutes of static photoconversion, followed by perfusion without 
photoconversion and fractionation.  (A-E) Pre-photoconversion and perfusion of 
a Phamret-expressing LS174T cell pulse of 250,000 cell over 2.5 µg mL-1 E-selectin at 
1 dyn cm-2. (A-E) Each bar represents the mean ± s.e.m. of n≥3 individually run 
experiments. (B,C) ** p < 0.01, *** p< 0.001, **** p < 0.0001 by one-way ANOVA 
with post hoc t-test with Bonferroni corrections for multiple comparisons. (D,E) Two 
sample t-test comparing percent of cells in each fraction compared to percent of cells 




4.3.4 Selectin Ligands Enriched in Cells Mediating Persistent but Not Non-persistent 
Selectin Adhesion 
The capacity of this system to differentiate subsets of LS174T cells in persistent 
versus non-persistent adhesion with selectins was next leveraged in order to interrogate 
mechanisms underpinning these different qualities of selectin adhesion (Table 4.2). Ligand 
expression levels amongst subfractions were compared and relationships between 
measured short time- and length-scale velocities evaluated. Specifically, a subset of non-
persistent cells (e.g. those within the PC+ subset of the FF fraction) were compared to those 
of the PC+ cells within the AD fraction, which exhibit sustained rolling adhesion, the 
caveat being for reasons described above that the latter is limited to only slow rolling cells 
(<200 µm/s) for fractionation experiments performed without pre-photoconversion.  
Table 4.2 Correspondence of photoconversion integrating cell sorting microfluidic 
readout to adhesion persistence. 
 
Within fractions collected on selectin functionalized substrates of AD cells only, 
expression of sLex and CD44 was increased in PC+ subset (Figure 4.13A,B). Expression 
of sLex was also increased in PC- cells collected on P-, but not E- or L-, selectin (Figure 
4.13A). No other correlations were found between velocity and selectin ligand expression 
among cells that remain unphotoconverted (PC-, Figure 4.13A-C). Additionally, CEA 
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expression was found to be increased in PC+ AD but not FF subset on P- and L-, but not 
E-, selectin (Figure 4.13C), a surprising trend given CEA’s function as an E- but not P-
selectin ligand in these cells. These data demonstrate sLex but not CD44 to be enriched in 
LS174T cells mediating not only persistent but also non-persistent slow rolling adhesive 
interactions with P-selectin in shear flow and CEA is associated with persistent adhesive 




Figure 4.13 Selectin ligands sLex, CD44, and CEA are enriched in cells mediating 
persistent slow rolling selectin adhesion in flow. (A-C) Expression levels of selectin 
ligands (A) sLex, (B) CD44, and (C) CEA among PC+ and PC- cell subsets collected 
after exposure to a 405 nm light during perfusion of a cell pulse of 250,000 Phamret-
expressing LS174T cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-2 or 25 µg mL-1 L- or 
P-selectin at 0.5 dyn cm-2. Each bar represents the mean ± s.e.m. of n≥3 individually 
run experiments. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 by one-




Regression analyses revealed sLex and CD44 expression to vary directly versus 
inversely with cell velocity magnitude (measured by GFP/CFP ratio) on E-selectin in the 
context of persistent (PC+ cells in AD fraction) versus non-persistent (PC+ cells in FF 
fraction) adhesion, respectively (left panels, Figure 4.14A,B). No correlations direct or 
otherwise were seen for CEA expression (Figure 4.14C, left panel). In the context of P- 
and L-selectin adhesion, sLex and CEA but not CD44 expression correlated directly with 
GFP/CFP ratio for persistent adhesion (middle and right panels, Figure 4.14A-C). 
Contrastingly, inverse correlations in expression of all three ligands with GFP/CFP ratio 
were found in the context of non-persistent adhesion (PC-, Figure 4.14D). Consistent with 
results from the collection of multiple adherent fractions, no correlations are observed in 
PC- cells subsets (Figure 4.15). Together, these results demonstrate the differential overall 
expression levels of selectin ligands and associations with velocity magnitudes between 
cells mediating persistent versus non-persistent adhesion. For example, although CD44 
expression overall is enriched in cells in cells exhibiting persistent adhesion to P-selectin, 
its expression does not correlate with slower rolling velocities. Furthermore, although sLex 
expression is increased in cells mediating slow rolling P-selectin non-persistently, its 
expression is associated with increased, not decreased, velocity magnitudes. This 
integrated analysis platform can thus reveal complex interdependent relationships in 
cellular phenotypes associated with both rolling adhesion quantity (e.g. velocity) and 
quality (e.g. persistence). 
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Figure 4.14 Opposing ligand expression correlations with rolling velocity magnitudes 
between persistently versus non-persistently adhesive cells. Sorted cell fractions 
labeled with fluorescently tagged antibodies for (A) sLex, (B) CD44, and (C) CEA, 
then applying the photoconversion gates and binning allowed the extent of 
photoconversion and elution time to be correlated to the relative ligand expression. 
Binned, flow cytometry data of cells was pooled from independent experiments and 
plotted with corresponding linear fits; CAD and CF represent the regression slope of 
the PC+ cells in the Adherent and or PC- cells in the Free flow fractions, respectively, 
* denotes non-zero slopes of the linear fit, † denotes significance of comparison 
between CAD and CF. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Outlier 
tests with criteria Q = 1 were conducted on all data sets, and outliers were removed 
prior to regression and statistical analysis. Perfusion, photoconversion, and 
separation of a Phamret-expressing LS174T cell pulse of 250,000 cells over either 2.5 
µg mL-1 E-selectin at 1 dyn cm-2 or 25 µg mL-1 L- or P-selectin at 0.5 dyn cm-2. (D) 
Summary of P-values of comparisons between the slopes of the linear relationships 
for interrogated ligands cells in the Adherent (CAD) versus Free flow (CF) fractions; 




Figure 4.15 No correlation between selectin ligand expression and GFP/CFP ratios 
among cells that remain unphotoconverted. The extent of photoconversion (GFP/CFP 
ratio) of PC- cells within FF and AD fractions related to the expression of 
(A) sLex (HECA452), (B) CD44, and (C) CEA sorted over E-, P-, or L-selectin. (A-
C) Binned, flow cytometry data of PC- cells was pooled from independent 
experiments and plotted with corresponding linear fits; CAD and CF represent the 
regression slope of the PC- cells in the AD and FF fractions, respectively. Outlier tests 
with criteria Q = 1 were conducted on all data sets, and outliers were removed prior 
to regression and statistical analysis. Perfusion, photoconversion, and separation of 
a Phamret-expressing LS174T cell pulse of 250,000 cell over 2.5 µg mL-1 E-selectin at 
1 dyn cm-2 or 25 µg mL-1 P- or L-selectin at 0.5 dyn cm-2. 
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4.3.5 Screening Ligand Degrading Enzyme Effects on Adhesion Mechanisms 
To demonstrate the versatility of this microfluidic approach to assess  drug 
treatment effects on cell adhesion extent and mechanism, cells were treated with 
neuraminidase (NA), a sialidase that cleaves the terminal sialic acid residues on sLex 
epitopes,81,201,202 203–205 and cell adhesion to selectin-functionalized surfaces analyzed via 
the integrated microfluidic and photoconversion based approach (Figure 4.16A). With NA 
treatment, sLex expression was completely lost (Figure 4.16B), while surface expression 
levels of CD44 and CEA ligands remained unchanged compared to untreated cells (Figure 
4.16C,D) in all collected cell fractions. As previously reported,81,82,168 NA treated LS174T 
cells retained the ability to mediate adhesion to E-, but not P- or L-, selectin (Figure 4.16E-
F, 4.17). When fractionated on E-selectin, approximately 25% of perfused cells eluted into 
the AD fraction (Figure 4.16E). With respect to the extent of photoconversion, GFP/CFP 
ratios were diminished for AD but slightly increased for FF fractions as a result of NA 
(Figure 4.16F). Although the proportion of PC+ cells in AD fraction was also strikingly 
decreased as a result of NA, the proportion was strongly increased for FF (Figure 4.16G), 
suggestive of NA treatment diminishing LS174T adhesion persistence and velocity of 
rolling adhesion on E-selectin. The overall relative frequency of PC+ cells in the AD 
compared to FF fraction remained increased, however, though the relative difference much 
reduced (Figure 4.16H).  
As CD44 expression has a strong inverse correlation with E-selectin rolling 
velocities by LS174T cells that holds across velocity magnitudes (Figure 4.8,4.9,4.11), 
effects of NA treatment on regression trends with CD44 were assessed. As expected given 
the role of sialylfucosylated CD44 variants in mediating E-selectin adhesion by these 
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cells12,26, NA treatment eliminated correlations between CD44 and extent of 
photoconversion within PC+ subsets of cells collected into AD cell fractions on E-selectin 
(Figure 4.16I). The lack of correlation of CEA expression was also sustained (Figure 
4.16J). No changes were seen in correlations were seen in treated cells that eluted into the 
FF fraction, as they continued to show a lack of correlation between selectin-ligand 
expression and rolling velocity (Figure 4.16I,J). Together, these data suggest that sialylated 
CD44 mediates sustained adhesion to E-selectin and non-persistent adhesion that results 




Figure 4.16 Sialyl Lewis x and CD44 correlated in highly but not lowly persistent slow 
rolling selectin-mediated adhesion. (A) Experimental workflow for neuraminidase 
(NA) treatment perfusion experiments. (B-D) quantification of mean fluorescent 
intensity of (B) sLex, (C) CD44, or (D) CEA expression after treatment with/without 
NA and perfusion over E-selectin. FF denotes the Free flow, AD denotes Adherent, 
US denotes an unsorted group. (E) Percent of cells collected in the AD and FF 
fractions, (F) Mean GFP/CFP ratio after perfusion over E-selectin, (G) percent of 
cells photoconverted, and (H) percent of cells photoconverted in the AD fraction 
normalized to the FF fraction with/without NA treatment. (I,J) The extent of 
photoconversion (GFP/CFP ratio) of PC- cells within the Free flow fraction or PC+ 
cells within the AD fraction related to the expression of (I) CD44 or (J) CEA sorted 
over E-selectin. Binned flow cytometry data of cells was pooled from independent 
experiments and plotted with corresponding linear fits after perfusion over E-selectin 
with/without NA treatment. Outlier tests with criteria Q = 1 were conducted on all 
data sets, and outliers were removed prior to regression and statistical analysis. (B-J) 
Perfusion, photoconversion, and separation of a Phamret-expressing LS174T cell 
pulse of 250,000 cells over 2.5 µg mL-1 E-selectin at 1 dyn cm-2. (E-J) Each dot or bar 
represents the mean ± s.e.m. of n≥3 individually run experiments. (B-J) * p < 0.05, ** 
p < 0.01, **** p < 0.0001 by (B-K) paired t-test or (J) one sample t-test with h0 = 1; 
dashed line at y=1. (G) # denotes difference between -NA AD group and +NA AD 




Figure 4.17 Neuraminidase treatment effects on cell adhesion in flow to P- and L-
selectin. (A,C) Percent of cells collected in the FF and AD fractions. (B,D) Percent of 
cells photoconverted in the AD fraction normalized to the FF fraction after perfusion 
of a cell pulse of 250,000 Phamret-expressing LS174T cells over 25 µg mL-1 (A,B) P- 
or (C,D) L-selectin at 0.5 dyn cm-2. FF denotes Each dot or bar represents the mean 
± s.e.m. of n≥3 individually run experiments. **** p < 0.0001 by (A,C) one-
way ANOVA with post hoc t-test with Bonferroni corrections for multiple 




The ability to evaluate within a heterogeneous population the cellular features 
associated with different qualities of rolling adhesion using a novel, integrated cell sorting 
and photoconversion adhesive chromatography microfluidic platform was demonstrated 
here through the juxtaposition of measured long and short time- and length-scale adhesive 
rolling behaviors. Building off of a previously designed cell sorting system that fractionates 
subsets of cells based on their time-averaged cell adhesive behavior,26 a 405 nm laser was 
added to photoconvert cells in a manner directly proportional to their velocity under the 
small window of light exposure,12 thereby “labeling” the cells with their short time- and 
length-scale velocity. Cells with slow rolling velocities within the light exposure window 
could thus be compared across elution times, i.e. adhesive versus non-adhesive fractions. 
Furthermore, cellular features could be analyzed using this preparative technique to 
distinguish expression pattern differences between cells with different adhesion 
phenotypes, as was explored here using flow cytometry.  
First, the photoconversion readout allowed ligand expression signal in measured 
population subfractions to be filtered to exclude those that were exhibited non-persistent 
adhesion (and were thus PC-). In so doing, expression of CEA was found to be enriched in 
cell subfractions mediating adhesion to E-selectin, increases not seen without 
photoconversion.26 Even low levels of diminished persistence thus diluted signal and 
photoconversion could distinguish CEA expression by cells mediating slow, persistent 
rolling adhesion on E-selectin (Figure 4.8). Additionally, pre-photoconversion as well as 
increasing the number of collected adhesive subfractions allowed trends to be explored 
across rolling adhesion magnitudes (Figures 4.6,4.8,4.9,4.11). These techniques revealed 
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adhesive ligands sLex and CD44 to be inversely correlated with slower rolling on E-selectin 
over a broad range of velocity magnitudes, whereas CEA expression is associated with E-
selectin adhesion in the context of slow rolling only.  
Concurrent measurement of short and long time- and length-scale velocities also 
permitted the elucidation of cellular molecular phenotypes related to different adhesion 
persistence phenotypes. We previously reported colon carcinoma cells to exhibit in their 
interactions with P- and L- but not E-selectin diminished adhesion persistence,11,13 defined 
as the capacity for cells to sustain adhesion and this case rolling adhesion over time and 
distance. In the instance of highly persistent adhesion, cells would mediate the same 
adhesive behavior along the entire channel length. Thus, so long as rolling velocities are 
below the threshold detectable by photoconversion, AD fractions would contain PC+ cells. 
Cells exhibiting low adhesion persistence on the other hand would interact for only portions 
of their transit time through the channel. Cells eluting into the FF fraction that are PC+ 
would thus be considered very lowly persistent as they were mediating adhesion within the 
light exposure window but deadhered. It should be noted that PC- cells cannot be assigned 
as either persistent or non-persistent, as they may have not photoconverted as a result of 
lack of adhesion or their rolling adhesion velocity being higher than the maximum velocity 
detectable by photoconversion.  
This photoconversion and chromatographic method confirmed previous results using 
videomicroscopy only11,13 that LS174T cells exhibit a persistent phenotype over E-, but not 
P- or L-selectin (Figure 4.5). Concurrent cellular phenotyping also revealed that although 
CD44 expression overall is enriched in cells in persistent P-selectin adhesion, its expression 
does not correlate with slower rolling velocities. Furthermore, although sLex expression is 
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increased in cells mediating slow rolling P-selectin non-persistently, its expression is 
associated with increased, not decreased, velocity magnitudes. CEA expression was also 
associated with persistent adhesive phenotype on both P- and L-selectin (Figure 4.13), 
despite not serving as a ligand for the former.82 Correlations in selectin ligand expression 
with rolling velocity magnitude were also found to be inverted between persistently versus 
non-persistently adhesive cells on all selectins (Figure 4.14). Furthermore, enzymatic 
digestion of sialofucosylated epitopes also reduced persistent but not non-persistent 
adhesion by LS174T cells to E-selectin in flow (Figure 4.15), the latter presumably 
mediated by another selectin ligand unexplored herein. Molecular expression 
characteristics thus vary by adhesion quality amongst selectin types, which has 
ramifications for the potential contribution of adhesion types and molecular pathways in 
dissemination mechanisms. This integrated analysis platform can thus reveal complex 
interdependent relationships in cellular phenotypes associated with both rolling adhesion 
quantity (e.g. velocity) and quality (e.g. persistence) as well as drug effects on the 
molecular mechanisms underpinning such processes. 
4.5 Conclusion 
In closing, this integrated system is capable of isolating and identifying subsets of 
cells with different adhesive behaviors to enable associated cellular phenotypes to be 
discerned. Separating cells based on biophysical characteristics is a broadly used technique 
for probing mechanisms underlying multiple disease types, and this platform improves 
upon former methods by enabling both quantification of rolling adhesion velocities and 
assessment of their qualities, e.g. persistent versus non-persistent. Our results 
demonstrating divergent molecular profiles associated with various adhesive phenotypes 
 113 
suggests the potential for this system to be applied to identify druggable targets on distinct 
subsets of circulating cancer cells (tumor initiating, for example) or provide nuance to the 




CHAPTER 5. LYMPH NODE SUBCAPSULAR SINUS 
MICROENVIRONMENT-ON-A-CHIP TO MODEL LYMPHATIC 
METASTASIS AND IMMUNE CELL HOMING 
5.1 Introduction 
Lymph node status negatively correlates with patient survival in many cancers.206–
210 Though still debated,145,211–214 the general hypothesis underlying how lymph node 
metastasis occurs is that the lymphatic vasculature provides a conduit for invasive cancer 
cells to move towards lymph nodes driven by both chemotactic ques and fluid flows driven 
by lymph propulsion. Once in lymph nodes, metastatic cells have the opportunity to 
undergo extensive interactions with resident immune cells that can influence their 
metastatic behavior. In particular, it is known that immune tolerance is associated with 
metastatic spread as well as drug resistance.215,216 Understanding interactions of metastatic 
cells within this anatomical location, which has been widely implicated in influencing anti-
tumor immunity and response to therapy, is thus of high relevance in the current era of 
cancer immunotherapy. Additionally, a therapeutic window has been proposed wherein 
systemic dissemination of metastatic disease can be therapeutically ameliorated.217–219 In 
such a context, understanding the biology underlying lymphatic metastasis has the potential 
to identify unique druggable targets for lymph node positive, but not systemic, disease. 
Transit via the lymphatic system has the potential to provide access to lymph-borne 
cells to the systemic circulation in two manners, the first by virtue of lymphatic vessels 
returning lymph to blood at the thoracic duct.220 Numerous reports have demonstrated the 
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potential for a second, perhaps more likely, dissemination route via invasion within the 
local lymph node microenvironment and access to lymph node parenchyma-resident cancer 
cells to access the circulatory system through lymph node capillaries.23,212,213,221 Thus, the 
ability to arrest in lymph nodes despite lymph flow and then transmigrate into the lymph 
node parenchyma may be a contributing factor in metastatic dissemination through the 
lymphatic route. Notably, numerous reports have documented evidence of the 
accumulation of circulating tumor cells within the subcapsular sinus, whose invasion into 
the lymph node parenchyma can be blocked by inhibition of adhesion receptors222–225 or 
chemotactic ques.14,22,145,226–228 Together, the involvement of the lymph nodes in the 
multifaceted progression of the metastatic cascade is thought to allow the formation of 
numerous, simultaneously occurring secondary tumors originating from a single primary 
tumor, however, the mechanisms by which this occurs remain widely unknown. 
As in the hematogenous context, metastasis by lymph-borne cells occurs within 
luminal flow fields, which in the context of lymphatic vessels is driven by propulsive 
lymph flow.211,229 The resulting hydrodynamic forces are known to play essential roles in 
regulating adhesion relevant to metastatic extravasation.41,220,230 Specifically, the 
dispersive effects of hydrodynamic force must be overcome by adhesive interactions in 
order to enable receptor signaling and chemotaxis.41,231–233 Although volumetric flow rates 
of lymph are far lower than that in blood, the stress levels experienced within vessels are 
not dissimilar.234 Thus, it could be expected that adhesive processes involved in cell 
homing and metastasis through the blood vasculature may be involved in regulating 
lymphatic dissemination. Indeed, this is supported by observations of cell adhesion 
molecules E- and P-selectin as well as ICAM and VCAM by lymphatic endothelial cells 
 116 
that form the interior of the lymphatic vessel lumen and within the lymph node sinus, whose 
expression of which has been reported to change in states of inflammation.235–239 
Concurrent with stromal cell and lymphocyte responses disease and/or inflammation, 
lymph nodes are widely reported to structurally remodel. A hallmark of metastatic disease 
is lymphadenopathy, i.e. swollen lymph nodes.240 Concurrently, tissue stiffening has been 
reported,241,242 which is most often attributed to metastatic colonization but an effect that 
has also been reported in lymph nodes prior to metastasis.241,243,244 In addition to expansion 
of the lymph node parenchyma-localized fibroblastic reticulum245 and high endothelial 
venules,246 both afferent (lymph node-entering) lymphatic vessels and the subcapsular 
sinus are known to dilate in contexts of human disease,247–249  effects that are also 
recapitulated in mouse models.235–239 How these changes have the potential to 
synergistically influence cell dissemination to lymph nodes has not been systemically 
explored. This however is hampered in large part by the reliance on mouse models, which 
differ subtly in their structures250,251 as well as the inability in mouse systems to uncouple 
biomolecular versus biophysical changes that often occur concurrently in states of disease. 
To fill this critical gap, we sought to bring to bear in vitro tools long employed in the 
context of studying neutrophil adhesion and blood-borne metastasis to the problem of 
analyzing mechanisms of lymph node metastasis. Although in vivo mouse models are more 
complex, these microfluidic systems offer the advantage of enabling high-throughput 
experimentation under defined molecular, cellular, and/or biophysical 
conditions.11,13,165,252–254 Furthermore, coupling these microfluidic devices with high-speed 
videomicroscopy permits rapid and facile visualization and quantification of the adhesive 
behavior of thousands of cells in a single experiment largely infeasible even with the most 
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advanced intravital imaging systems.11,13,26,27,255 In particular, we applied a parallel plate 
flow chamber technology adapted to recapitulate the dissipating wall shear stress (WSS) 
experienced within the lymph node subcapsular sinus as a result of the radially dispersed 
flow after lymph entry into the lymph node via the afferent vessel. Using this lymph node 
“sinus-on-a-chip” adhesive microfluidic platform, we explored the effects of WSS 
magnitude and dissipation on adhesion by human monocytic and metastatic cancer cells 
lines, both of which are known to disseminate to lymph nodes via the lymphatic 
vasculature. Monocytes home to the lymph node via the afferent vessel into the subcapsular 
sinus and play a crucial role in mounting an immune response against disease.256–258 
Pertinently, previous research has found that monocytes can mediate and increase the adhesive 
behavior of cancer cells under flow, and it has been shown in vitro that monocytes can promote 
colon cancer extravasation and the formation of metastases in the lungs.259,260 We also chose 
to focus on metastatic pancreatic cancer and colon adenocarcinoma cells due to the high 
clinical relevance of lymphatic metastasis in these diseases, as 89% pancreatic cancer of patients 
have disseminated tumor cells within their lymph nodes and 45% of colon cancer patients have 
lymph node involvement.261,262 This analytical method revealed that cell adhesion within 
dissipating fields of WSS is regulated by both WSS magnitude and the time of cell in 
transit. As a result, structural changes within the sinus and afferent vessel alters the 
potential position at which cells can optimally interact and/or within the lymph node 
subcapsular sinus, effects also influenced by presented adhesion receptors. Metastatic cell 
co-perfusion with monocytes also increases the extent of cell adhesion, implicating 
inflammation and mobilization of lymph borne immune cells as regulating lymphatic 
metastasis.  Given the defined chemotactic programs that drive lymphocyte and myeloid 
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cell migration in lymph nodes from lymph, our results implicate the biophysical effects of 
lymph node remodeling and their influence on directing adhesion within the subcapsular 
sinus space as a potential axis that can regulate the mechanisms driving lymph node 
invasion. 
5.2 Materials and Methods 
5.2.1 Immunohistochemistry 
 Whole mouse lymph nodes were collected, embedded in optimum cutting 
temperature embedding medium, and stored at -80° C. Whole lymph nodes were sliced 
using a cryostat into 10 μm thick tissue sections, mounted onto histological slides, and 
stored at -20° C until slicing. Prior to staining, the slides were fixed in acetone for 20 min 
at -20° C, blocked with 10% goat serum diluted in Dulbecco’s Phosphate Buffered Saline 
(D-PBS) with calcium and magnesium for 1 h at room temperature, then incubated 
overnight at 4° C with the following primary antibodies: (1) rabbit anti-mouse LYVE-1 
(1:200, Invitrogen, PA1-16635), (2) chicken anti-mouse CD62E (1:100, Novus 
Biologicals, AF575), and (3) hamster anti-mouse CD54 (1:100, Novus Biologicals, NBP2-
22540) or rat anti-mouse CD106 (1:50, Novus Biologicals, NB100-77474). The following 
day, the slides were incubated for 1 h at room temperature with the following fluorophore 
conjugated secondary antibodies: (1) goat anti-rabbit Alexa Flour 633 (1:300, Invitrogen, 
A-21070), (2) goat anti-chicken Alexa Flour 488 (1:200, Invitrogen, A-11039), and (3) 
goat anti-hamster DyLight 550 (1:1000, Novus Biologicals, NBP1-71730R) or goat anti-
rat DyLight 550 (1:100, Invitrogen, SA5-10019). Finally, the slides were mounted using 
Vectashield mounting medium with DAPI and microscopic images were taken using a 
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Zeiss 710 confocal microscope. In between each step, the slides were washed three times 
with gentle agitation in 0.1% Tween 20 diluted in D-PBS with calcium and magnesium. 
5.2.2 COMSOL Wall Shear Stress Modeling 
 The wall shear stress profile along the floor of the subcapsular sinus was simulated 
using COMSOL Multiphysics Software version 5.4. An idealized lymph node sinus was 
designed in SolidWorks, modeling the afferent vessel as a cylinder leading into a thin disk, 
which was used to model the subcapsular sinus (Figure 5.2B). Different dimensions for 
quiescent or remodeled lymph node afferent lymphatic vessel diameter (LVD) and 
subcapsular sinus height (SCS h) were used to construct three variations of the lymph node 
geometry (Figure 5.2B,3D), while the upper limit of the subcapsular sinus radius was 
maintained at 5 m, which was chosen based on the average size of a human lymph node, 
yielding a physiologically relevant slope of wall shear stress decrease.15,263,264 The 
geometry was exported as a .STL file and imported into COMSOL. Within COMSOL, the 
fluid material was defined as a Newtonian, incompressible fluid with a dynamic viscosity 
of 1200 Pa s and a density of 1009 kg m-3, which were chosen on literature cited values.220 
The fluid flow was set to laminar flow with a constant volumetric flow rate of 1.45E-10 m3 
s-1, which is within the range of flow rates measured in humans.265 The boundary walls 
were chosen to be the outer surface of the liquid domain, the inlet was defined as the top 
of the afferent vessel cylinder, and the outlet was defined to be the circumferential side 
wall of the subcapsular sinus thin disc. Finally, the cut plane where the wall shear stress 
values were quantified was defined as the bottom of the thin disc, representing the floor of 
the lymph node subcapsular sinus.  
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 The Particle Tracing for Fluid Flow module of COMSOL Multiphysics Software 
version 5.4 was used to simulate the trajectory of a cell as it moved from the afferent vessel 
into the subcapsular sinus and determine the point at which the cell had settled to the floor 
of the subcapsular sinus. The particle properties were modeled after that of a cancer cell, 
with a diameter of 14 μm and a mass density of 1032 kg m-3.220 The same inlet, outlet, flow 
rate, fluid properties, and boundary walls as used in the wall shear stress modeling were 
used. For each simulation, a particle (modeling a cell) began its flow trajectory through the 
geometry at the top of the afferent vessel (height 2.5 mm) in a randomly selected radial 
position (less than or equal to one half the diameter of the afferent vessel), and the height 
and radial position of the particle was tracked until it reached the periphery of the 
subcapsular sinus. The particle was defined as settled on the subcapsular sinus floor when 
the center of the particle was at a height of 7 μm, the radius of the particle. For each lymph 
node condition (Figure 5.4D) five cell simulations were plotted.  
5.2.3 Cell Culture 
THP-1 monocytes were cultured every three days via 1:5 dilution in Roswell Park 
Memorial Institute 1650 supplemented with 10% FBS and 1% PSA. PANC-1 cells, 
graciously provided by Dr. Gregory Lesinski, were cultured in DMEM supplemented with 
10% FBS, 1% PSA, and 1% Glutamax. Human colorectal adenocarcinoma LS174T cells 
and Phamret-expressing LS174T cells, stably transfected as described previously12, were 
cultured in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% heat 
inactivated fetal bovine serum (FBS) and 1% penicillin-streptomycin-amphotericin. 
LS174T cells and PANC-1 cells were harvested via mild trypsinization with 0.25% trypsin 
EDTA, centrifuged at 400 X G for 5 min, resuspended in culture medium, and either diluted 
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into tissue culture flasks for subculture or incubated in suspension for 2 h at 37°C to allow 
regeneration of adhesive cell surface ligands.  
5.2.4 Channel Fabrication 
Microfluidic channels were fabricated in a manner similar to that as detailed 
previously.12,26,182 Briefly, using a craft cutter, the adhesive microfluidic channel, which 
consisted of a straight 10 cm long by 0.2 cm wide section connected to a 4 cm long 
divergent section that increased in width from 0.2 cm to 1.2 cm, was cut from sheet of 125 
µm thick double-sided adhesive tape backed with a release liner. The channel was then 
affixed to polydimethylsiloxane (PDMS), which was previously cured by mixing PDMS 
base with curing agent at a ratio of 9:1 and curing at 90˚C for 3 h in a Pyrex dish prior to 
being cut to the outer dimensions of the channel shape. To complete fabrication, an inlet 
hole was punched into the beginning of the long, straight portion of the channel using a 3 
mm biopsy punch, and platform was attached to a non-tissue culture treated polystyrene 
plates into which an outlet hole was drilled prior to assembly.  
5.2.5 Channel Functionalization 
The short, divergent portion of the channel nearest the outlet was functionalized 
through the following steps: incubating at 4°C overnight with Fc specific goat anti-human 
IgG in D-PBS without calcium and magnesium to a concentration of 2.5 µg mL-1 for E-
selectin experiments, 5 µg mL-1 for E-selectin + 2.5 µg mL-1 ICAM and E-selectin + 2.5 
µg mL-1 VCAM experiments, or 12.5 µg mL-1 for E-selectin + 10 µg mL-1 VCAM 
experiments; blocking for 1 h at room temperature with 1% Bovine serum albumin (BSA) 
in D-PBS with calcium and magnesium; incubating for 2 h at room temperature with 2.5 
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µg mL-1 of recombinant human E-Selectin Fc chimera protein, plus the addition of 2.5 µg 
mL-1 of recombinant human ICAM-1/CD54 Fc chimera protein, 2.5 µg mL-1 of 
recombinant human VCAM-1/CD106 Fc chimera protein or 10 µg mL-1 of recombinant 
human VCAM-1/CD106 Fc chimera protein for some experiments, all of which were 
diluted in D-PBS with calcium and magnesium. Finally, the entire channel was blocked for 
1 h at room temperature with 1% BSA in D-PBS with calcium and magnesium at room 
temperature. In between each step, the channel was washed three times with 1 mL of D-
PBS with calcium and magnesium. 
5.2.6 Perfusion Experiment Workflow 
Perfusion experiments were performed in a similar manner to that formerly 
described.26 Succinctly, an inlet syringe connected to tubing filled with perfusion media 
(0.1 % BSA in D-PBS with calcium and magnesium) was connected to a syringe pump and 
used to withdraw a cell pulse into the inlet tubing at a rate of 0.5 mL min-1. For single cell 
perfusion experiments, the cell pulse was 200,000 THP-1 monocytes, PANC-1 cells, or 
LS174T cells diluted in 125 μL of perfusion media. The tubing and syringe assembly was 
inserted into the inlet hole of the channel and an outlet reservoir was made by connecting 
a 5 mL test tube to the bottom of the drilled outlet hole on the polystyrene plate. The 
assembled platform was placed on an Eclipse TI optical microscope with an objective 
magnification of 10X and linked to NIS-Elements software to acquire videos at a frame 
rate of 25 frames per second at an exposure time of 0.281 µs and 2x2 binning of 500 by 
376 pixels.  
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To begin perfusion, the syringe pump was set to a constant flow rate, based on 
desired wall shear stress ranges of different lymph node models derived from COMSOL 
simulations, to initiate inflow into the channel from the syringe-tubing assembly. A flow 
rate of 34.7 µL min-1 was used to model a quiescent lymph node, a flow rate of 27.4 µL 
min-1 was used to model a lymph node with a dilated lymphatic vessel diameter, and a flow 
rate of 9.7 µL min-1 was used to model a lymph node with a dilated subcapsular sinus. 
Perfusion was continued until all cells, except those that firmly adhered to the 
functionalized portion of the channel, eluted from the device. Once the cells reached the 
divergent portion of the channel during perfusion, 30 sec videos were taken along the center 
of the channel at 0.5 cm increments to quantify the number of interacting cells and average 
rolling velocity of interacting cells at different wall shear stresses. 
5.2.7 LS174T Cell and THP-1 Cell Co-perfusion Workflow 
 For co-perfusion experiments, a mixed cell pulse of 125 μL was made by adding 
100,000 Phamret-expressing LS174T cells to either 33,333, 100,000, or 300,000 THP-1 
monocytes immediately before perfusion to establish ratios of LS174T to THP-1 cells: 
75:25; 50:50; 25:75, respectively. The Phamret LS174T only cell pulse contained 100,000 
cells diluted in 125 μL of perfusion media. The perfusion workflow and quantification of 
adhesive cell behavior was the same as described above, however, in order to distinguish 
the Phamret-expressing LS174T cells from the THP-1 monocytes, the Phamret-expressing 
LS174T cells in the channel were imaged using a fluorescein isothiocyanate filter 
(excitation bandpass 475-492 nm, emission bandpass 505-535 nm) with a Chroma 
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Technology 100W PhotoFluor mercury lamp with same microscope settings as described 
above, save for an exposure time of 200 ms. 
5.2.8 Quantification of Adhesive Cell Behavior 
Cell adhesive behavior was characterized based on the number of interacting cells 
and the velocities of rolling adhesion of interacting cells in flow when perfused over an E-
selectin +/- ICAM or VCAM functionalized substrate. An adhering cell was defined as one 
that was seen to exhibit horizontal translation at a velocity substantially slower than the 
non-interacting cells, which were cells that did not mediate specific adhesive contact with 
the substrate of the channel during observation and whose velocity magnitude is known 
based on calculated velocity profiles as well as cell velocities through unfunctionalized 
channels. The number of interacting cells at various wall shear stresses was quantified by 
counting the number of interacting cells in 30 sec videos taken at 0.5 cm increments along 
the divergent portion of the channel. Individual cell velocities were measured 
quantitatively using ImageJ with a manual particle tracking plugin. The location of 
maximum adhesion for each lymph node microfluidic model and functionalization scheme 
(Figure 5.8-5.10S) was defined as the distance in the divergent channel where the greatest 
number of interacting cells per 30 seconds was observed, calculated by finding the mean 
of five perfusion experiments for every mode at each channel location or wall shear stress.  
5.2.9 Quantification of Adhesive Cell Behavior 
For pairwise comparisons (Figures 5.5-5.12), every combination of two points at 
every wall shear stress or channel location where a measurement was taken was statistically 
analyzed using an unpaired t-tests, defining statistically significant differences as a p < 
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0.05, as noted by a *, #, or $. When analyzing statistical differences among different lymph 
node conditions as a function of wall shear stress (Figures 5.8G-R,5.9G-R,5.10G-R), the 
nonlinear regression best fit line was compared between the overlapping wall shear stress 
range of healthy LN versus dilated LVD (0.62 – 0.16 dyn/cm2), healthy LN versus dilated 
SCS (0.28 – 0.16 dyn/cm2), and dilated LVD versus dilated SCS (0.28 – 0.11 dyn/cm2). 
Statistical significance was determined by the extra sum-of-squares F-test to determine if 
one curve adequately both sets of data with a p < 0.05, noted by ꝉ. 
5.3 Results 
5.3.1 Lymphatic metastasis, lymph node invasion, and tissue remodelling 
Lymphatic metastasis is a multistep process (Figure 5.1A), which includes invasion 
of lymph-borne metastatic cells into lymph nodes through invasion through the subcapsular 
sinus, which results in formation of lymph node tumors seen in humans212,213,266 as well as 
metastatic mouse tumor models.267–270 Multiple structural features of lymph nodes 
influence flow paths and thus the movement of lymph-borne cells, including transition of 
fluid and cells from the lymphatic vessels into the lymph-filled sinus which in general 
moves flow orthogonally to lymph in flow (Figure 5.1B). This results in the radial 
distribution of lymph around the lymph node parenchyma.15,220 In the context of disease or 
inflammation, the structure of lymph nodes is altered,235–239 including dilation of both the 
lymphatic vessel23,271–273 as well as subcapsular sinus.14,274,275 There is less consensus on 
the effects of disease and inflammation on measured lymphatic flow rates and these effects 
are less widely reported, though both increases and decreases have been reported in the 
context of cancer, inflammation, and other diseases such as lymphedema or 
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obesity.133,220,276–278 Alterations in sinus-presented adhesion molecules have also been 
reported148–152 and expression of adhesion receptors by lymphatic endothelial cells, which 
line the subcapsular sinus, is known to be altered by shear stress and exposure to other 
inflammatory mediators. Indeed, in mouse lymph nodes, remodeling induced by tumor 
growth in the downstream results in altered adhesion receptor expression relative to naïve 
animals (Figure 5.1C-D). The concerted effects of these biophysical (structural, flow) and 
biochemical (adhesion molecule expression) changes on cell adhesion within the context 




Figure 5.1. Cancer cells from primary tumors can harness the lymphatics, which 
remodel in states of inflammation, to form metastases. (A) Cancer cells can leave the 
site of a primary tumor, enter the lymphatic system, and gain access to the lymph 
nodes to form metastatic tumors. (B) In the presence of a tumor or in states of 
inflammation, lymph nodes remodel through dilation of the subcapsular sinus height, 
dilation of the lymphatic vessel diameter, and increased expression of adhesion 
molecules, such as intracellular adhesion molecule-1 and vascular cellular adhesion 
molecule-1 on the surface of sinus lining lymphatic endothelial cells. (C,D) 
Immunohistochemistry images of quiescent (left panel, i) or B16F10 tumor draining 
(right panel, ii) lymph nodes stained for lymphatic endothelial cells (Lyve-1, red), E-
selectin (green), and either (C) ICAM-1 (blue) or (D) VCAM-1 (blue). (C,D) Scale bar 
is 400 μm. LVD denotes lymphatic vessel diameter, SCS denotes subcapsular sinus. 
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5.3.2 Altered shear stress profiles within remodeled lymph node sinuses 
In order to analyze the effects of lymph node biophysical remodeling (Figure 5.2A) 
on fluid flow profiles through the lymph node subcapsular sinus,14,257,279,280 lymphatic fluid 
flow that disperses radially after reaching a planar (e.g. Figure 5.2D, neglecting curvature) 
lymph node capsule was modeled (Figure 5.2B).14,257,279,280 First, the solution to this fluid 
velocity profile predicts a wall shear stress (WSS, τ in the equation below) profile that 
decays with radial position (Figure 5.2C, Equation 4).281  




The magnitude of shear stresses experienced by cells at the inferior sinus surface are thus 
highly sensitive to changes in sinus height (h) and volumetric flow rate (Q), though to a 
lesser extent. The magnitude of the peak WSS within the sinus region is also a function of 
lymphatic vessel diameter (LVD), with the peak value decreasing with increasing diameter. 
When considering these geometries of mouse and human lymph nodes (Table 5.1) but 
leaving Q fixed given its pulsatile nature as well as less well characterized magnitudes, a 
range of WSS values would be predicted to be experienced within the lymph node sinus 
region (Figure 5.2D-E).  
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Table 5.1. Human and lymph node parameter reference ranges. 
 
The effects of redistribution of fluid flow from the lymphatic vessel into the sinus 
on shear stress profiles were also modeled using COMSOL (Figure 5.2C, F-G). 
Importantly, the wall shear stress ranges calculated using the COMSOL simulations closely 
agreed with those derived from the analytical solution. In so doing, alterations in lymph 
node geometries were found to minimally influence the likelihood of cells being in contact 
with the inferior sinus floor upon entry into the lymph node sinus region (Figure 5.3). 
Supporting the suitability of our original assumptions, curvature of the lymph node sinus 
was also found to negligibly influence these WSS profiles at most geometric confirmations 




Figure 5.2. Modeling lymphatic fluid flow between quiescent and remodeled lymph 
nodes in COMSOL. To computationally model (A) the effect of lymphatic remodeling 
or inflammation on the ability of a circulating cell to adhere to the lymphatic 
endothelial cells lining the subcapsular sinus floor, we (B) made a simplified model of 
an afferent lymphatic vessel leading into the subcapsular sinus in SolidWorks and (C) 
imported it into COMSOL to perform fluid flow simulations to quantify the wall 
shear stress along the subcapsular sinus floor (solid line) and also calculated the 
analytical solution (dashed line). Given the variability in lymph node parameters in 
human and mice, (D,E) the range of resulting wall shear stresses was calculated using 
the analytical solution for (D) human or (E) mouse lymph nodes based on maximum 
and minimum literature cited parameters for subcapsular sinus height.  Lymph 
viscosity was assumed to be 1.2E-3 Pa*s, the volumetric flow rate was assumed to be 
(D) 1.45E-10 m3/s or (E) 8.33E-13 m3/s, and the subcapsular sinus radius was assumed 
to be (D) 5 mm or (E) 500 μm. WSS denotes wall shear stress. SCS denotes 
subcapsular sinus. LVD denotes lymphatic vessel diameter. LV denotes lymphatic 
vessel. H denotes height. (F,G) COMSOL shear stress simulation plots along the (F) 
floor of the subcapsular sinus and (G) center of the z-plane in the idealized lymph 





Figure 5.3. Cells entering the lymph node have settled to the floor of the subcapsular 
sinus by the time they leave the afferent vessel. (A-C) COMSOL cell trajectory 
simulations using human lymph node parameters showing the position of the center 
of a cell of diameter 14 μm as it moves from the afferent lymphatic vessel into the 
subcapsular sinus. Each colored line represents the trajectory of a single cell with a 
randomized radial starting location at the top of the afferent vessel. Dashed line on y-
axis at a height of 7 μm, indicating the cell has settled to the bottom of the subcapsular 
sinus floor. Dashed line on x-axis represent afferent vessel radius of (A,C) 0.6 mm 
(healthy afferent vessel diameter) or (B) 0.9 mm (dilated lymphatic vessel diameter). 
5.3.3 Engineered lymph node “sinus-on-a-chip” adhesion microfluidic 
We engineered a lymph node “sinus-on-a-chip” parallel plate adhesion flow 
chamber that can be configured to mimic the hydrodynamic microenvironment of a 
quiescent or remodeled lymph node, and specifically here the WSS experienced within the 
lymph node sinus (Figure 5.4A). The device, which is easy and rapid to fabricate, is 
constructed from a sheet of polydimethylsiloxane and a polystyrene tissue culture plate 
between which is a 125 μm adhesive gasket. The microfluidic is connected to high speed 
videomicroscopy to permit the visualization and quantification of cell adhesion of an 
infused cell pulse along the length of the divergent portion of the channel (Figure5.4A,E). 
The divergent portion of the microfluidic channel was also functionalized with adhesion 
receptors13,255,282,283 within the divergent channel portion to recapitulate their expression on 
the lymphatic endothelium-lined subcapsular sinus floor (Figure 5.4B). The channel was 
also designed with a 10 cm long unfunctionalized straight portion (Figure 5.4C) sufficient 
in length to allow perfused cells to be uniformly in contact with the substrate,283 as the cells 
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entering the lymph nodes would be expected to be immediately settled to the subcapsular 
sinus floor upon arrival from the afferent vessel in all lymph node conditions based on our 
analyses (Figure 5.3). The simulated magnitude and rate of WSS dissipation predicted for 
quiescent or diseased human lymph nodes (Figure 5.4D,F)14,15,133,144,237,267,271,284–286 could 
be recapitulated within this perfusion system wherein a 4 cm long functionalized divergent 
portion that increases linearly in width from 0.2 cm to 1.2 cm (Figure 5.4C) by simply 
varying the volumetric flow rate of fluid perfusion through the system using the inline 
pump system. Specific conditions tested in the microfluidic system herein (Figure 5.4G) 
were chosen to recapitulate consensus parameters from the literature on human lymph 
nodes (Table 5.2). 





Figure 5.4. Engineered divergent adhesion chromatography system to interrogate 
lymphatic metastatic extravasation mechanisms in vitro. Motivated by the wall shear 
stress profile of COMSOL human lymph node models, (A) we designed a subcapsular 
sinus microenvironment-mimicking, divergent parallel-plate microfluidic. (B) To 
recapitulate the microenvironment of the lymph node subcapsular sinus and adhesion 
cascade of immune or cancer cells, the divergent portion of the channel is 
functionalized with adhesion molecules. (C) The channel is designed with an 
unfunctionalized settling portion settling portion connected to a functionalized, 
divergent portion with an increasing width, which was modeled after fluid flow 
through (D) quiescent and healthy human lymph nodes. Cell adhesion in the channel 
can be (E) visualized via integrated high speed videomicroscopy .The divergent shape 
of the channel was designed (F) based on COMSOL simulations of the wall shear 
stress profile of healthy and dilated human lymph nodes which very closely (G) 
recapitulates the decreasing wall shear stress profiles of the idealized human lymph 
node models. (E) Scale bar is 200 μm.  
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5.3.4 Remodeling regulates cell adhesion in subcapsular sinus-mimicking flow fields 
 The adhesive behavior of monocytes, which migrate to the lymph nodes via the 
afferent vessel and into the subcapsular sinus during states of inflammation and disease,287–
289 as well as metastatic pancreatic and colon cancer cells in different lymph node sinus 
flow models was assessed in order to elucidate effects of lymph node remodeling on these 
behaviors.287,290–292 To this end, 200,000 THP-1 monocytic cells as well as PANC-1 and 
LS174T cells, which are commonly used cell lines used to investigate cell adhesive 
behavior255,282,283,293,294 with the latter two being commonly used metastatic cancer cell 
lines known to exhibit lymphatic metastasis in xenograft tumor models,295,296 were 
perfused at varying flow rates through the microfluidic system. These channels were 
functionalized within the divergent portion of the microfluidic device with various 
combinations of adhesion receptors. Specifically, four different functionalization schemes 
were used: 2.5 μg/mL E-selectin alone (1) or in combination with 2.5 μg/mL ICAM (2), 
2.5 μg/mL VCAM (3), or 10 μg/mL VCAM (4). These molecules were chosen given their 
widely appreciated roles in mediating cell adhesion in fluid flow,11,47,153,226,297,298 
expression by subcapsular sinus lining cells,299 and reported changes in expression in this 
anatomical location in response inflammation.226,300,301 Cell adhesion was then quantified 
within the perfusion system by counting the number of interacting cells and quantification 
of the average rolling velocity of the interacting cells at 0.5 cm increments along the center 
of the functionalized, divergent portion of the flow channel (left column, Figures S2-S4, 4-
6). As each measurement location corresponds to a different wall shear stress acting on the 
cells (Table 5.3), comparisons between extent of adhesion and rolling velocity at similar 
and WSS level were also be made (middle and right columns, Figures 5.5-5.10).  
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Overall, whereas neither THP-1, PANC-1, nor LS174T cells mediated adhesion to 
ICAM or VCAM under flow, co-presentation of adhesion receptors with E-selectin 
increased cell adhesion in all tested conditions, though effects were channel location and/or 
shear stress dependent (Figures 5.5-5.7). This is unsurprising given E-selectin’s well-
established role in mediating fast rolling adhesion13,283 to enable slower adhesive 
interactions, such as those mediated by integrins.153,302,303   
Table 5.3. Wall shear stress ranges along the length of the divergent channel at 






Figure 5.5. THP-1 adhesive behavior is altered with the addition of adhesion 
molecules. The (A,B,D,E,G,H) number of interacting cells and (C,F,I) average rolling 
velocity of interacting cells in a (A-C) healthy lymph node, (D-F) LN with a dilated 
lymphatic vessel diameter, or (G-I) lymph node with a dilated subcapsular sinus. (A-
I) Statistical analysis by unpaired t-tests between points at each wall shear stress. p < 
0.05 between: $ E-selectin vs. E-selectin + 2.5 μg/mL ICAM, * E-selectin vs. E-selectin 
+ 2.5 μg/mL VCAM, and # E-selectin vs. E-selectin + 2.5 μg/mL ICAM. LN denotes 




Figure 5.6. Copresentation of ICAM-1 and high VCAM-1 increase the adhesive 
behavior of pancreatic cancer cells. The (A,B,D,E,G,H) number of interacting cells 
and (C,F,I) average rolling velocity of interacting cells in a (A-C) healthy lymph node, 
(D-F) LN with a dilated lymphatic vessel diameter, or (G-I) lymph node with a dilated 
subcapsular sinus. (A-I) Statistical analysis by unpaired t-tests between points at each 
wall shear stress. p < 0.05 between: $ E-selectin vs. E-selectin + 2.5 μg/mL ICAM, * 
E-selectin vs. E-selectin + 2.5 μg/mL VCAM, and # E-selectin vs. E-selectin + 2.5 
μg/mL ICAM. LN denotes lymph node, LVD denotes lymphatic vessel diameter, SCS 




Figure 5.7. Enhanced expression of adhesion molecules increases the adhesivity of 
colon carcinoma cells. The (A,B,D,E,G,H) number of interacting cells and (C,F,I) 
average rolling velocity of interacting cells in a (A-C) healthy lymph node, (D-F) LN 
with a dilated lymphatic vessel diameter, or (G-I) lymph node with a dilated 
subcapsular sinus. (A-I) Statistical analysis by unpaired t-tests between points at each 
wall shear stress. p < 0.05 between: $ E-selectin vs. E-selectin + 2.5 μg/mL ICAM, * 
E-selectin vs. E-selectin + 2.5 μg/mL VCAM, and # E-selectin vs. E-selectin + 2.5 
μg/mL ICAM. LN denotes lymph node, LVD denotes lymphatic vessel diameter, SCS 
denotes subcapsular sinus. 
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When considering the influence of hydrodynamic flow environment, perfusion 
parameters recapitulating  lymph nodes with dilated afferent lymphatic vessels and 
subcapsular sinuses had the greatest effect on altering the adhesive behavior of perfused 
monocytes along the length of the divergent channel functionalized with E-selectin alone 
or in combination with ICAM or VCAM. Specifically, conditions mimicking a dilated 
lymph node sinus resulted in maximal THP-1 cell adhesion at lower WSS levels when co-
perfused on E-selectin co-functionalized with ICAM or 2.5 ug/ml of VCAM (Figure 
5.8G,I,K,L), corresponding to cells accumulating at locations earlier in the channel (Figure 
5.8A,C,E,F). This would suggest that these WSS regimes may result in THP-1 cell arrest 
at locations within the lymph node subcapsular sinus that are more proximal to the afferent 
vessel (Figure 5.8S), perhaps a result from the low cell rolling velocities of adhesion at 
these WSS levels, which notably did not vary appreciably between perfusion condition 
(Figure 5.8M,O,P,R). Seemingly similar effects were seen for THP-1 adhesion on E-
selectin alone or E-selectin co-functionalized with 10 ug/ml VCAM (Figure 5.8B,L). 
However, we note the nearly identical or highly similar profile of adhesion with respect to 
channel position (Figure 5.8A,F), implicating effects of time in flow/transit rather than 
WSS directly on THP-1 cells as influencing adhesion within these contexts. 
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Figure 5.8. Dilation of the lymphatic vessel or the subcapsular sinus decreases the 
distance, but not magnitude, of maximum adhesion of monocytes in the subcapsular 
sinus. (A-L) The number of interacting and (M-R) the average rolling velocity of 
interacting THP-1 monocytes in divergent channels functionalized with (A,G,M) 2.5 
µg/mL E-selectin, (B,H,N) 2.5 µg/mL ICAM,  (C,I,O) 2.5 µg/mL E-selectin + 2.5 
µg/mL ICAM, (D,J,P) 2.5 µg/mL VCAM, (E,K,Q) 2.5 µg/mL E-selectin + 2.5 µg/mL 
VCAM, or (F,L,R) 2.5 µg/mL E-selectin + 10 µg/mL VCAM. (A-F) Statistical 
significance by unpaired t-tests. p < 0.05 between: $ healthy LN and dilated LVD, * 
healthy LN and dilated SCS, and # dilated LVD and dilated SCS. (G-L) Statistical 
significance by comparison of nonlinear regression of overlapping wall shear stress 
range comparing fit of number of interacting cells. ꝉ indicates p < 0.05. (S) Location 
of maximum adhesion in channel. Dot size scaled to number of interacting cells. LN 
denotes lymph node, LVD denotes lymphatic vessel diameter, SCS denotes 
subcapsular sinus. E denotes 2.5 μg/mL E-selectin. 
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 Adhesion of PANC-1 pancreatic cancer cells, which have been shown in vivo to 
form metastatic tumors and also express numerous functional selectin, ICAM-1, and 
VCAM-1 ligands, including sLex, LFA-1, and VLA-4,304,305 was next explored. Like THP-
1 cells, perfusion over surfaces functionalized with ICAM or VCAM alone resulted in no 
adhesion (Figure 5.9B,D,H,J,N,P). Notably, however, unlike THP-1 cells, PANC-1 cells 
also minimally adhered to E-selectin alone (Figure 5.9A,G) or E-selectin functionalized 
with low levels (2.5 ug/ml) of VCAM-1 (Figure 5E,K). Accordingly, minimal to no 
differences in the number of interacting cells (Figure 5.9A,E,G,K) and their average rolling 
velocities (Figure 5.9M,Q) were observed between hydrodynamic perfusion conditions 
using each functionalization scheme. Contrastingly, co-presentation of E-selectin with 
ICAM or E-selectin and higher levels (10 ug/ml) of VCAM substantially increased the 
number of interacting cells compared to the other functionalization schemes (Figure 5.6, 
5.9C,F,I,L), while also decreasing the average rolling velocity (Figure 5.6, 5.9O,R). 
Furthermore, in channels co-functionalized with E-selectin and ICAM-1 or 10 ug/ml 
VCAM-1, the number of cells interacting in perfusion conditions modeling remodeled 
lymph nodes was significantly different than of quiescent lymph nodes, in both remodeled 
contexts as a function of channel position, though more significantly in channels co-
functionalized with E-selectin and ICAM-1 or 10 ug/ml VCAM-1 in the context of a dilated 
afferent vessel (Figure 5.9C,F). However, overall extents of adhesion remained relatively 
unchanged as a function of WSS (Figure 5.9I,L) and average rolling velocities of the 
interacting cells were also sustained between differing hydrodynamic perfusion conditions 
(Figure 5.9O,R), save for at very low WSS. This suggests that PANC-1 cell adhesion is 
regulated most substantially or directly by both adhesion molecules presented within the 
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subcapsular sinus microenvironment as well as local WSS level, which serves to decrease 
the distance traveled into the channel before maximum adhesion is reached in dilated 




Figure 5.9. Lymphatic vessel or subcapsular sinus dilation decreases the distance in 
the subcapsular sinus that maximum adhesion of pancreatic cancer cells occurs while 
minimally altering the average rolling velocity trends. (A-L) The number of 
interacting and (M-R) the average rolling velocity of interacting PANC-1 cells in 
divergent channels functionalized with (A,G,M) 2.5 µg/mL E-selectin, (B,H,N) 2.5 
µg/mL ICAM,  (C,I,O) 2.5 µg/mL E-selectin + 2.5 µg/mL ICAM, (D,J,P) 2.5 µg/mL 
VCAM, (E,K,Q) 2.5 µg/mL E-selectin + 2.5 µg/mL VCAM, or (F,L,R) 2.5 µg/mL E-
selectin + 10 µg/mL VCAM. (A-F) Statistical significance by unpaired t-tests. p < 0.05 
between: $ healthy LN and dilated LVD, * healthy LN and dilated SCS, and # dilated 
LVD and dilated SCS. (G-L) Statistical significance by comparison of nonlinear 
regression of overlapping wall shear stress range comparing fit of number of 
interacting cells. ꝉ indicates p < 0.05. (S) Location of maximum adhesion in channel. 
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 Adhesion by LS174T colon carcinoma cells, which are well studied for their 
adhesive properties within flow fields13,255,282,283 and express a variety of adhesion ligands 
for selectins80,252,306,307 and other CAMs 308, were next evaluated.171,252,255,282,283,306,307 
Though they adhered extensively to E-selectin (Figure 5.10A,G), LS174T cells exhibited 
no adhesion in flow to ICAM or VCAM alone (Figure 5.10B,D,H,J,N,P) like THP-1 and 
PANC-1 cells. As hypothesized, perfusion in flow experiment configurations simulating 
dilated lymphatic vessels and subcapsular sinuses appeared to substantially alter WSS-
dependent profiles of cell adhesion (Figure 5.10A,C,E,F,G,C,K,L). However, though the 
extent of LS174T cell adhesion when perfused under hydrodynamic conditions mimicking 
quiescent and dilated afferent vessels interacted with E-selectin alone or when co-presented 
with VCAM varied significantly by WSS, no differences in channel position-dependent 
adhesion were seen (Figure 5.10A,E,F). Adhesion under conditions mimicking dilated 
subcapsular sinus hydrodynamic environments on the other hand did not exhibit similar 
channel position dependencies (Figure 5.10A,E,F). When perfused over E-selectin co-
presented with ICAM, adhesion appeared highly WSS-dependent, with LS174T cell 
adhesion extents of dilated afferent vessel perfusion conditions closely matching trends 
seen in quiescent conditions. (Figure 5.10C). Perfusion under dilated sinus conditions 
however altered this WSS dependency (Figure 5.10I), though the channel position 
dependency closely matched that of dilated afferent vessel perfusion conditions (Figure 
5.10C). With each functionalization scheme, measured velocities of interacting cells did 
not differ with respect to WSS irrespective of hydrodynamic perfusion condition (Figure 
5.10M,O,Q,R). Overall, both time in flow and hydrodynamic condition, either due to the 
WSS level or the rate of WSS dissipation, appeared to interdependently regulate the extent 
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of LS174T cell adhesion whereas rolling velocity magnitude remained influenced by WSS 
only (Figure 5.10S).   
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Figure 5.10. The location of maximum adhesion of colon carcinoma cells occurs 
earliest in lymph nodes with dilated subcapsular sinus. (A-L) The number of 
interacting and (M-R) the average rolling velocity of interacting PANC-1 cells in 
divergent channels functionalized with (A,G,M) 2.5 µg/mL E-selectin, (B,H,N) 2.5 
µg/mL ICAM,  (C,I,O) 2.5 µg/mL E-selectin + 2.5 µg/mL ICAM, (D,J,P) 2.5 µg/mL 
VCAM, (E,K,Q) 2.5 µg/mL E-selectin + 2.5 µg/mL VCAM, or (F,L,R) 2.5 µg/mL E-
selectin + 10 µg/mL VCAM. (A-F) Statistical significance by unpaired t-tests. p < 0.05 
between: $ healthy LN and dilated LVD, * healthy LN and dilated SCS, and # dilated 
LVD and dilated SCS. (G-L) Statistical significance by comparison of nonlinear 
regression of overlapping wall shear stress range comparing fit of number of 
interacting cells. ꝉ indicates p < 0.05. (S) Location of maximum adhesion in channel. 
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5.3.5 Cell adhesivity increases when co-perfused with monocytes 
The effect of monocyte co-perfusion on LS174T cell adhesion to E-selectin in flow 
was assessed using a total of 100,000 LS174T cells diluted to different LS174T:THP-1 cell 
ratios: 3:1, 1:1, and 1:3. Co-perfusion increased both the number of interacting cells (Figure 
5.11A-C) and decreased the average rolling velocity of interacting cells (Figure 5.11D-F). 
Notably, the WSS level at which adhesion peaked also decreased in the case of flow 
configurations mimicking quiescent and dilated lymphatic vessels (Figure 5.11A-B) but 
not dilated sinuses (Figure 5.11C).   
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Figure 5.11. Adhesive propensity of metastatic colon carcinoma cells to E-selectin 
increases when co-perfused with monocytes in a manner proportional to the relative 
percent of monocytes. (A-C) The number of interacting LS174T cells and (E-G) the 
average rolling velocity of interacting LS174T cells perfused either alone or co-
perfused with THP-1 monocytes at 25% THP-1: 75% LS174T, 50% THP-1: 50% 
LS174T, or 75% THP-1: 25% LS174T with wall shear stresses modeling a (A,D) 
healthy lymph node, (B,E) a dilated subcapsular sinus, or (C,F) a dilated subcapsular 
sinus. Channels were functionalized with 2.5 μg/mL E-selectin. (G-L) Statistical 
analysis by unpaired t-tests between points at each wall shear stress. p < 0.05 between: 
$ LS174T cell pulse only vs. 25% LS174T cell pulse, * LS174T cell pulse only vs. 50% 
LS174T cell pulse, and # LS174T cell pulse only vs. 75% LS174T cell pulse.  
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When the effect of adhesive ligand co-presentation was next interrogated in the 
context of co-perfusion at LS174T to THP-1 ratios of 1:1, the overall extent of adhesion 
was uniformly equivalent, albeit extents peaked at different WSS levels in all cases, save 
few (Figure 5.12C, right column, 8D middle column). Specifically, changes in adhesion 
resulted from channel functionalization context, as monocytes increased the number if 
interacting cells in channels functionalized with E-selectin and ICAM-1 or moderate 
VCAM-1 (Figure 5.12A,C), but not high VCAM-1 (Figure 5.12E). Velocities of rolling 
adhesion were also on average lower for almost all tested conditions. Overall, our results 
revealed that co-perfusion with THP-1 cells generally enhances the adhesive propensity of 
LS174T cells, which substantiates previous research that has found monocytes to augment 
cancer cell adhesion and may provide a rationale for previous studies that have shown 





Figure 5.12. Colon carcinoma cells co-perfused with monocytes increases their 
adhesion behavior in lymph node models with enhanced adhesion molecule 
expression. The (A,C,E) number of interacting LS174T cells and (B,D,F) average 
rolling velocity of interacting LS174T cells perfused either alone or a cell pulse of 50% 
LS174T cells and 50% THP-1 monocytes with wall shear stresses modeling a healthy 
lymph node (orange), a dilated subcapsular sinus (blue), or a dilated subcapsular 
sinus (purple). Channels were functionalized with 2.5 μg/mL E-selectin + (A,B) 2.5 
μg/mL ICAM-1, (C,D) 2.5 μg/mL VCAM-1, or (E,F) 10 μg/mL VCAM-1. (A-F) 
Perfusion of cell pulse of either 100,000 LS174T cells only or 100,000 LS174T cells + 
100,000 THP-1 monocytes diluted in 125 uL of perfusion media. Statistical 




Microfluidic-based flow systems have long been employed as in vitro models of the 
blood vasculature microenvironment to investigate biomechanical effects on the 
mechanisms of adhesion.255,282,283,309,310 This lymph node sinus microenvironment 
mimicking microfluidic platform thus enables in vitro analysis and comparison of cell 
adhesivity as it relates to lymphatic remodeling during inflammation or in the presence of 
a tumor to provide novel insights into the poorly understood but clinically significant 
process of lymphatic metastasis. Through the use of a divergent channel design, easily 
changeable perfusion flow rates, and varying channel functionalization schemes, this 
device was capable of mimicking quiescent lymph nodes, as well as lymph nodes that have 
remodeled in the presence of a tumor or inflammation through dilation of the lymphatic 
vessel diameter or subcapsular sinus and/or enhanced adhesion molecule expression. In so 
doing, videomicroscopy was used to permit the evaluation of the effects of lymphatic 
remodeling on the WSS-dependency and accumulation of adherent cells in physiologically 
relevant fluid flow. WSS magnitudes predicted by analytical solutions and COMSOL 
models were highly similar in magnitude to those seen within the venous circulatory 
system.35,276,299 We recognize that a limitation of our simulations and microfluidic model 
is that it fails to incorporate the pulsatile nature of lymphatic flow. However, given the 
dramatic increase in cross sectional area upon lymph entry into the lymph node, we expect 
flow pulsations to be minimal within the subcapsular sinus. Also, lymphatic flow rates are 
hypothesized to be substantially changed in disease contexts. However, given that the 
dependencies of WSS on sinus height are second order, we focused instead how small 
changes with respect to absolute sinus size could influence cell interactions within the 
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subcapsular space. However, given the direct proportionality and thus less sensitive 
dependency of WSS on lymph volumetric flow rate, results of this work could be 
interpreted to encompass volumetric flow rate changes in the absence of or with very small 
changes to subcapsular sinus dimension. 
 ICAM and VCAM have been implicated in metastasis by pancreatic and colon 
cancer cells in mice and humans. First, increased ICAM or VCAM expression correlates 
with enhanced colon adenocarcinoma cell adhesion to lymphatic endothelial cells in 
vivo.149 Second, expression levels of ICAM and VCAM are correlated clinically with 
increased lymph node metastases in a variety cancers.206,208,311 However, adhesion in flow 
by all tested cell types to ICAM and VCAM necessitated co-presentation with E-selectin, 
as would be expected given previous results studying cell adhesion in flow.301,312  This 
helps contribute understanding to the previous observations of E-selectin involvement in 
lymphatic metastasis in mouse models313–315 as well as the interdependency of metastasis 
on E-selectin expression and integrins.316 The dependency on these adhesion molecules in 
the context of lymphatic metastasis has not been clearly delineated, but is supported by 
observations of direct correlation between the expression of these adhesion molecules and 
the incidence lymph node metastasis.150,153 Our findings do however implicate the changes 
in expression of these molecules by lymphatic endothelial cells in response to altered flow 
states or inflammatory mediators as playing a physiological role in mediating cell 
infiltration into lymph nodes. In addition to facilitating immune cell homing in the context 
of immune response or inflammation, biochemical changes within the lymph node sinus 
may therefore contribute to or influence the pathway of metastatic dissemination by 
pancreatic and colon cancer cells. In a similar vein, adhesion by metastatic cells was 
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increased in a seemingly proportional manner by co-perfusion with monocytes. This is 
suggestive of inflammation influencing metastatic dissemination in another context. 
Indeed, our results indicate that co-perfusion results in activation of monocytes and cancer 
cells, suggesting in flow cross-talk. During co-perfusion experiments of monocytes and 
cancer cells, we noted the formation of large cell aggregates engaging in selectin-mediated 
adhesion, an observation unique to co-perfusion experiments and not seen in single cell 
population perfusion experiments. As such, we hypothesize that the increase in adhesion 
of the cancer cells may be due, at least in part, to facilitation of selectin-mediated rolling 
of non-adherent cancer cells by interacting monocytes, which act as an intermediary to 
slow down the cancer cells and initiate their adhesion, a process that has been seen by other 
groups.260 These observations also provide context as to why many groups propose single 
cancer cells are less efficient or unable to form metastases, as cell-cell interactions can 
significantly increase the adhesive and extravasation potential of metastatic cancer cells in 
the context of lymphatic metastasis.  
 The effects of lymphatic remodeling in the presence of a tumor or during 
inflammation may also have indirect effects on lymphocyte or cancer cell homing and 
extravasation in the lymph nodes by altering the tightly controlled chemotactic axis within 
the lymph node microenvironment which drives the regulated timing and location of lymph 
node infiltration.227,317,318 For example, CCR7 is a key chemokine receptor that directs the 
trafficking of lymphocytes crucial to the adaptive immune response, such as B and T cells, 
from the blood vessels and into the lymph nodes.319 The ligands for CCR7 - CXCL19 and 
CXCL21 - are highly expressed in the inner cortex of the lymph nodes, thus promoting the 
migration of CCR7 expressing cells into deep portions of the lymph nodes.135 Another 
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chemokine receptor, CXCR4, acts in a similar way to promote lymphocyte homing to the 
lymph nodes.320–323 however, our findings that biophysical and biochemical remodeling 
that occurs in the presence of a tumor or during states of inflammation significantly alters 
cell adhesion suggest that this may also influence cell homing in the context of chemotactic 
cues, thereby hindering the adaptive immune response. Notably, pancreatic cancer cells 
and colon adenocarcinoma cells also express CCR7 and CXCR4, and this expression level 
is directly correlated with increased lymph node metastases in patients.135,136,324 We 
hypothesize that these cancer cells may be able to harness and the CXCL19/CXCL21 
gradient to continue migrating into the inner lymph node cortex after extravasating through 
the subcapsular sinus where they can for metastases. Furthermore, these CCR7 and/or 
CXCR4 expressing cancer cells may disrupt the sensitive chemokine gradient to impede 
chemotactic immune cell homing, prevent proper immune cell priming and maturation, 
and, thus, prevent an effective immune response. Concisely, given the defined chemotactic 
programs that drive lymphocyte and myeloid cell migration in lymph nodes from lymph, 
our results implicate the biophysical effects of lymph node remodeling and their influence 
on directing adhesion within the subcapsular sinus space as a potential axis that can 
regulate the mechanisms driving lymph node invasion. 
5.5 Conclusion 
In summary, we have developed a microfluidic system designed to recapitulate the 
dissipative WSS environment of the lymph node subcapsular sinus. Using this system and 
solutions to the WSS profile under different flow conditions, the effects of lymph node 
remodeling on cell adhesion were assessed. Our results indicate that biophysical changes 
including WSS magnitude, dissipation rate and cell transit time in flow as well as 
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biochemical changes such as adhesion receptor expression within the sinus lumen and the 
presence of lymph-borne cells synergistically contribute to the extent of adhesion that 
differs by cell type. Given the tight orchestration of chemotactic cues within lymph nodes 
to drive optimal adaptive immune responses, these findings implicate lymph node 
remodeling to regulate the location at which cells can optimally interact and/or within the 




CHAPTER 6. CONCLUDING REMARKS AND FUTURE 
DIRECTIONS 
6.1 Conclusions 
Cancer metastasis, both hematogenous and lymphatic, necessitates that circulating 
tumor cells extravasate through (lymphatic) endothelial cells lining the lumen of the blood 
vasculature or lymphatic system in a high shear microenvironment caused by dynamic fluid 
flow. This process is mediated, in part, by circulating tumor cells interacting with selectins 
presented by (lymphatic) endothelial cells in a highly orchestrated adhesion cascade, which 
acts to slow circulating tumor cells under hydrodynamic forces, permitting firm adhesion 
to the vessel wall or subcapsular sinus floor, extravasation, and the eventual formation of 
metastatic tumors in distant tissues or organs. Despite a basic biological understanding of 
selectin-mediated interactions, an outstanding problem in the field is defining and 
understanding the role of wall shear stress and cellular molecular profiles in initiating and 
sustaining selectin mediated adhesion, and the underlying causes of different abilities of 
disseminated tumor cells to engage in these interactions.325 Therefore, in this work, we 
sought to: (1) Develop an adhesion chromatography microfluidic that sorts cells based on 
their elution time from a selectin functionalized substrate of the flow channel to analyze 
attributes of cells with different adhesive phenotypes; (2) Uncouple short time- and length-
scale velocity from long time- and length-scale average velocity by integrating a 
photoconversion system with a cell sorting adhesion chromatography platform; (3) 
Engineer a “lymph node sinus on-a-chip” cell adhesion microfluidic device to elucidate the 
effect of altered wall shear stress profiles of remodeled lymph nodes in response to tumors 
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in promoting immune cells and circulating tumor cell recruitment and enhancing lymphatic 
metastasis.  
First, we engineered an integrated, parallel-plate microfluidic device to interrogate 
and fractionate cells based on their adhesivity to a substrate surface functionalized with 
adhesive ligands in a tightly controlled flow environment to elucidate associated cell-
intrinsic pathways implicated in cellular adhesion. We modeled wall shear stress levels and 
endothelial presentation of E-selectin after the inflamed vasculature microenvironment in 
order to simulate in vitro conditions under which in vivo hematogenous metastasis occurs. 
Based on elution time from the flow channel, we collected separate fractions of cells – non-
interacting and interacting – at high yields and viabilities, which enabled multiple post-
perfusion analyses, including flow cytometry, in vivo metastasis modeling, and 
transcriptomic analysis. Therefore, this platform enabled the interrogation of flow-
regulated cell molecular profiles, such as (co)expression levels of natively expressed 
selectin ligands sLex, CD44, and carcinoembryonic antigen, and cancer stem cell marker 
CD24. Additionally, this revealed that E-selectin adhesivity exhibited by metastatic human 
colon carcinoma cells is a transient phenotype. Facile and rapid, this methodology for 
unbiased, label free sorting of large populations of cells based on their adhesion in flow 
represents a method of studying flow-regulated adhesion in vitro for the identification of 
molecular drug targets to aid the development as anti-metastatic cancer therapeutics by 
enabling a system to elucidate cancer cell specific ligands that initiate slow rolling to 
selectins. 
Second, we integrated a photoconversion cell sorting parallel-plate chromatography 
channel engineered in the first portion of this thesis, which enabled the measurement of 
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long and short time- and length-scale velocities of cells mediating adhesion in flow fields 
to study the mechanisms underlying adhesion to selectins by metastatic cancer cells. 
Through the facile enrichment of cells into subfractions of differing adhesive behaviors 
and a fluorescent velocity probe amenable to off-chip analysis, underlying, causal 
molecular profiles implicated in differing adhesive phenotypes of metastatic cancer cells 
were interrogated. This analytical method revealed selectin-mediated rolling adhesion was 
strongly associated with expression of selectin ligands, correlations that vary with ligand 
type and rolling velocity magnitude. Discrete selectin ligand expression profiles were also 
found to underlie persistent versus non-persistent adhesion on selectins, suggestive of 
divergent regulatory mechanisms. This integrated cell sorting and photoconversion 
microfluidic platform thus enabled in vitro analysis and comparisons of adhesive 
phenotypes as they relate to mechanisms of cancer cell metastasis in the context of selectin 
mediated adhesion, which revealed new insights into potential cancer dissemination 
pathways. 
Finally, we engineered a lymph node “sinus-on-a-chip” adhesion microfluidic 
device that recapitulates the decreasing wall shear stress environment of the lymph node 
subcapsular sinus was engineered to interrogate the effects of wall shear stress magnitude 
and dissipation on human monocytic and metastatic cancer cell line adhesion. Wall shear 
stress levels within the microfluidic channel, which were quantified through COMSOL 
modeling of idealized human lymph nodes, recapitulated those of quiescent lymph nodes 
as well as lymph nodes that had remodeled both biophysically and biochemically due to 
inflammation or the presence of a tumor, which permitted the assessment of the effects of 
lymph node remodeling on cell adhesion. This analytical method revealed that structural 
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changes within the sinus and afferent lymphatic vessel alters the theoretical position at 
which cells can optimally interact with the floor of the subcapsular sinus, while 
biochemical changes through upregulation of adhesion molecules increases the overall 
extent of adhesion. Finally, the presence of immune cells with cancer cells further increases 
the adhesivity of colon carcinoma cells. implicate lymph node remodeling to regulate the 
location at which cells can optimally interact and/or within the subcapsular sinus and 
therefore potential mechanism of lymph node invasion. Concisely, this subcapsular sinus 
microenvironment mimicking microfluidic platform thus enables in vitro analysis of in 
vitro analysis and comparison of cell adhesivity as it relates to lymphatic remodeling during 
inflammation or in the presence of a tumor to provide novel insights into the poorly 
understood but clinically relevant process of lymphatic metastasis.  
6.2 Contributions to the Field 
Broadly, this project involves an integrated, multidisciplinary approach that 
combines microfluidic, biophysical, and biochemical techniques to provided fundamental 
insight into the basics of receptor-ligand biology and mechanisms of cancer metastasis, and 
in doing so, this work has contributed to numerous fields, including mechanical 
engineering, cancer biology, and immunology. The main contributions of this work to the 
scientific community is in the engineering of novel microfluidic platforms that can be used 
to elucidate pertinent biological problems, such as mechanisms of cancer metastasis. 
Although in vivo models may offer a more complex, physiologically relevant 
microenvironment to study metastatic extravasation, these platforms provide the unique 
capacity to probe the contributions of isolated molecules in cell adhesion in controlled 
microvasculature conditions. Individually, these novel systems, which have been made 
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available to others by publishing peer-reviewed journal articles and conference 
presentations, have impacted the field in the following ways. 
6.2.1 Microfluidic to Interrogate Subsets of Cells with Different Average Adhesive 
Behavior 
Chapter 3 of this work detailed the design of a cell-sorting adhesion 
chromatography microfluidic system that permits the collection of distinct fractions of cells 
based on their adhesion propensity to a functionalized substrate under hemodynamic flow 
mimicking microenvironments. The incorporation of a dynamic fluid flow environment to 
the cell-sorting microfluidic provides the unique ability interrogate the effect of 
physiological shear force on the adhesive behavior of cells, something that other, static 
cell-sorting techniques such as bead systems or fluorescent activated cell sorting (FACS) 
are not capable of probing. Elucidating adhesion of cells in the context of fluid shear stress 
is valuable because shear stress has been implicated in promoting cancer cell adhesion 
during the extravasation process.231,326,327 For example low fluid shear stresses, such as 
those used here, stimulate the upregulation of mechanosensitive molecules that lead to 
downstream enhanced adhesion of cancer cells.328 Furthermore, collisions between 
adherent and free flow LS174T cells during perfusion cause the free flow cell to interact 
with the adherent cell leading to downstream rolling adhesion behavior of the initially free 
flow cell.255,329 Importantly, this behavior may not be observed with beads or using FACS 
due to the static microenvironment without  the involvement of shear stress under which 
such sorting occurs. 
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Furthermore, currently, there are few methods to recover metastatic cancer cells 
and analyze their adhesive behavior in a high content manner. Distinctively, there are 
numerous advantages of this system over other methods of sorting and analysing large 
populations of cells (such as through the use of fluorescent-activated cell sorting). First, by 
incorporating high-speed videomicroscopy to the cell-sorting microfluidic, we are not only 
able to fractionate cells based on their average adhesive propensity, but we are also able to 
visualize and quantify the short time-and length-scale adhesion behavior of thousands of 
cells in a single experiment. Furthermore, the high-throughput nature of this system, 
coupled with high cell viabilities and recovery (over 80% and 90%, respectively), permits 
the enrichment of hundreds of thousands of cells in a single experiment, allowing facile 
post-perfusion analysis of the fractionated cell subsets. Notably, unlike interventional 
approaches that are used to study cancer cells, this system does not require a conjectural 
hypothesis of attributes intrinsic to adhesive propensity. Collectively, the features of this 
residence time-based, cell sorting adhesion microfluidic make it an ideal platform for 
studying biophysical and biomechanical mechanisms of long time- and length-scale cell 
adhesion, which can inform anti-metastatic cancer therapeutics and novel cancer cell 
biomarkers.   
6.2.2 Integrated Microfluidic to Juxtapose Short and Long Time- and Length-Scale 
Adhesive Propensity 
The first iteration of the cell sorting microfluidic platform describe in Chapter 3 
was limited in that it quantified the average velocity of cells and permitted the collection 
of only two fractions of perfused cells – interacting and non-interacting. Outstandingly, 
however, there is also a need to interrogate not only at quantity of adhesion, but also quality 
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of adhesion, as metastatic cancer cells have been shown to exhibit a reduced adhesion 
persistence to certain cell adhesion molecules.13,171 Furthermore, with respect to quantity 
of adhesion, there is a wide distribution of average rolling velocities exhibited by metastatic 
cancer cells, therefore necessitating a means of sorting cells based on long time-and length-
scale adhesion with greater resolution. As such, in the fourth chapter of this work, we 
integrated photoconversion technology, which permits the labelling of single cells based 
on their short time- and length-scale adhesion, with the cell sorting platform, and increased 
the resolution of fractionation by collecting up to three interacting cell populations. In 
doing so, for the first time, we were able to simultaneous quantify and compare short and 
long time- and length-scale adhesion of metastatic cancer cells to interrogate previous 
reports of reduced adhesion persistence and discern cellular molecular phenotypes that 
underlie persistent versus non-persistent behavior of metastatic cancer cell subsets. 
Succinctly, this platform improves upon former methods of interrogating metastatic cancer 
cell adhesion by enabling assessment of quality and quantity of adhesive behavior, and the 
use of such a platform can be used to identify distinguishing surface markers on highly 
adhesive and persistent phenotypes of cancer cells, which can be used to inform therapeutic 
targets that prevent extravasation of cancer cells without disrupting normal immune cell 
homing, or as a high-throughput method of analyzing the effect of adhesive-ligand 
targeting drugs or ligand knock-out on altering the rolling velocity and persistence of cells. 
6.2.3 Lymph node “sinus-on-a-chip” to Elucidate Mechanisms of Lymphatic Metastasis 
Chapter 5 of this work described the process of designing and implementing a 
lymph node “sinus-on-a-chip” microfluidic device that was incorporated with high speed 
videomicroscopy to visualize, quantify, and compare the adhesive behavior of monocytes 
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and two different metastatic cancer cell lines in models of healthy and dilated lymph nodes. 
While there are numerous parallel plate microfluidic devices to study the role of selectin 
mediated adhesion in hematogenous metastasis, similar systems to study the role of selectin 
mediated adhesion in lymphatic metastasis are currently lacking, despite the prominent role 
the lymphatics play in cancer metastasis.12,13,26,27,145,171 Using COMSOL to mimic 
lymphatic fluid flow from the afferent lymphatic vessel to the subcapsular sinus, the 
pathway many circulating tumor cells employ to invade the lymph node, we engineered a 
divergent channel design to model the wall shear stress profile that a cell infiltrating the  
the lymph node from the afferent vessel into the subcapsular sinus would experience. 
Importantly, we simulated not only the conditions of a healthy lymph node, but also the 
conditions of a dilated subcapsular sinus and dilated afferent vessel, as well as adhesion 
molecule upregulation through the addition of ICAM-1 or VCAM-1, as remodelling of the 
lymph node often occurs in the presence of a tumor. 
Unlike platforms to study metastasis through the circulatory system, this device has 
a decreasing wall shear stress that recapitulates the unique fluid flow profile within the 
lymphatic system, thereby allowing the interrogation of the effects of a decreasing wall 
shear stress on the adhesion mechanics and biophysical mechanisms of cells, an analysis 
that is not possible with current adhesion chromatography systems that mimic the 
microenvironment of hematogenous metastasis. Concisely, the novelty of our lymph node 
“sinus-on-a-chip” is that it enables, for the first time, the role of selectin-selectin ligand 
interactions of monocytes, cancer cells, and mixed monocyte-cancer cell populations in 
lymphatic extravasation to be interrogated under a variety of physiologically relevant wall 
shear stress and dilation conditions, which can be used to better understand the critically 
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under researched process of metastatic extravasation through the lymphatics, and the role 
of lymphatic remodelling in altering extravasation within the lymph nodes. 
6.3 Future Directions 
The work completed in this thesis provides new microfluidic platforms to study 
cancer metastasis, and these platforms will serve as the foundation for future directions of 
the work presented here, which should broadly focus on: (1) Verifying and optimizing 
microfluidic channel fabrication and functionalization, (2) increasing the breadth of cancer 
cell lines and adhesion molecules studied, and/or (3) implementing more complex design 
features into the microfluidic device to increase the accuracy of the recapitulated 
microenvironment under which cancer metastasis occurs.  
Relevant to all work completed in this thesis, a future project should compare the 
coating density of surface molecules (IgG, E-selectin, ICAM-1, VCAM-1, etc.) to the 
actual surface density of the molecules (ie. the adsorption and functionalization density of 
such molecules on the substrate of the microfluidic channels). Although we have quantified 
the coating density of the microfluidic channels and experimentally shown that no surface 
molecules are shed during perfusion experiments, we have yet to quantify or estimate what 
the actual surface density of functionalization molecules is along the substrate of the 
microfluidic channel. By estimating the surface density based on the functionalization 
molecules affinity for the substrate/molecule with which they are adsorbed/attached to, 
such as the affinity of IgG Fc specific to polystyrene or the affinity of recombinant E-
Selectin Fc chimera protein to IgG Fc specific, we can verify that our surface coatings are 
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comparable to physiological values and better compare experiments among different days 
or surface coating techniques.  
More specifically, each aim of the thesis can be expanded with the following work: 
6.3.1 Interrogating the Surface Molecule Profile of Subsets of Cells with Different Long 
Time- and Length-Scale Adhesive Propensities to Selectins 
To date, the scope of the cell sorting microfluidic designed in this thesis focused on 
fractionating LS174T colon carcinoma cells over E-selectin. Notably, P- and L-selectin are 
also implicated in rolling adhesion during the hematogenous metastatic adhesion cascade, 
and therefore, a natural extension of the work presented here would include fractionating 
metastatic cancer cells over P- and L- selectin and comparing the cellular molecular 
profiles of collected interacting versus non-interacting cell subsets to elucidate cell ligands 
that underlie differing adhesion propensity to P- and L-selectin. This is particularly relevant 
when thinking about one of the objectives of the Thomas lab – to identify novel biomarkers 
that can be targeted for anti-cancer metastasis therapeutics – as E-, P-, and L-selectin are 
all known to engage selectin ligands present on the surface of metastatic cancer cells, which 
have the potential to be unique targets that prevent metastatic extravasation without 
disrupting leukocytic homing.24,74,185  
Furthermore, in addition to interrogating functionalization with other selectins, the 
microfluidic should be used to interrogate the adhesive propensities of different 
populations of cell lines, including cells derived from primary human tumors, and to 
identify distinguishing cell surface markers between the interacting and non-interacting 
cell subsets of these populations of cancer cells. This would permit a more thorough 
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understanding of the biomechanical underpinnings and cellular surface marker 
characteristics of long time- and length-scale selectin-mediated adhesion outside the 
context of LS174T cells and probe the extent of patient to patient adhesion and phenotypic 
variability among tumor cells. Importantly, knowledge derived from these studies could be 
used to identify selectin ligands that may be universally present on a variety of metastatic 
cancer cells, which could inform targetable markers for a widely applicable cancer 
therapeutic.24,185,330 
6.3.2 Studying the Effects of Selective Selectin Ligand Inhibition and Qualifying Cancer 
Stem Cell Markers 
In chapter four, we presented the success of the using the integrated cell-sorting, 
photoconversion microfluidic platform to analyze, simultaneously, the mechanisms 
underlying short and long time- and length-scale adhesion and quantify the persistence of 
metastatic LS174T colon carcinoma cells over P-, E-, and L-selectin, particularly as it 
changes in response to enzymatic degradation of selectin ligands on metastatic cancer cells. 
As such, future work should leverage this platform to explore the effects of selective 
selectin-ligand inhibition on altering metastatic cancer cell adhesion and persistence. Using 
information gained from future work of the cell-sorting platform (as described above), 
which should identify additional tumor cell expressed selectin ligands implicated in 
adhesion across a variety of cancers and patient samples, cell populations that have the 
inhibition of relevant selectin ligands can be perfused through the integrated system to 
analyze the effectiveness of such inhibition in reducing adhesion or altering persistence. 
The ease of fabricating the channels, coupled with the short perfusion experiment times 
and wide-ranging options of post-perfusion analysis, an extensive combination of cell 
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populations, ligand inhibitions, and channel functionalizations can be interrogated in a 
high-throughput manner, permitting rapid testing of potential therapeutics, while also 
allowing a deeper understanding of the mechanisms by which known metabolic inhibitors 
that prevent metastasis work.81,331–333 
Moreover, the expression levels of CSC marker CD24, and coexpression levels of 
CD24 with other known selectin ligands, has been correlated with short and long time- and 
length-scale adhesion individually, but the juxtaposition of CSC marker expression as it 
relates to both velocity and adhesion propensity has yet to be interrogated.12,26 These 
experiments can be completed using the cell sorting, photoconversion platform, and would 
help complete CSC studies already completed in our lab. Additionally, given the general 
ambiguity in the field of cancer biology regarding common CSC markers between different 
cancers, the use of the platform should be extended to analyze how the expression levels 
of a variety of literature cited CSC markers in different metastatic cancer cell lines and 
patient derived tumor cells changes with regard to different adhesion propensities and 
persistences of collected cell fractions and/or photoconverted subsets. Together, the ideas 
outlined above would serve to further understand the functional effects of selectin ligands 
on adhesion behavior and persistence as it relates to cancer metastasis and inform a better 
understanding of CSC markers. 
6.3.3 Enhancing the Design of the Lymph Node “Sinus-on-a-Chip” to Better 
Recapitulate the Lymphatic Metastasis Microenvironment 
For the first time, we engineered an innovative microfluidic system to quantify the 
selectin-mediated adhesive behavior of cells in a physiologically relevant lymphatic 
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microenvironment. While this system has provided novel insight into the basic mechanisms 
of immune cell and circulating tumor cell extravasation through the lymphatics, it is limited 
in that it provides a simplistic model of the afferent lymphatic vessel and subcapsular sinus. 
The first iteration of the device served well to isolate only a few variables in the complex 
adhesion cascade, nonetheless, adding further structural details to the system will enable a 
deeper understanding of the biophysical and biomechanical effects of the lymphatic 
microenvironment and lymphatic remodeling on the ability of circulating tumor cells and 
immune cells to traffic and home to the lymph node. Therefore, future design iterations 
should be made that incorporate more structural features of the lymph node. For example, 
the subcapsular sinus has an array of vertical micropillars that are positioned in 6 – 20 µm 
intervals, dividing the space within the subcapsular sinus into smaller compartments.14,334 
Undoubtedly, these pillars may effect fluid flow through the subcapsular sinus, and 
therefore could be added to the lymph node “sinus-on-a-chip” to better understand the 
dynamics of cell movement through the subcapsular sinus. As another example, the 
pulsating flow through the afferent lymphatic vessel could be modeled, as the constantly 
varying fluid flow may affect the presentation of selectin ligands on the surface of 
circulating tumor cells, as fluctuating shear forces have been observed to increase the 
expression of cell adhesion molecules during other physiological processes.297,335–340 
Additionally, thus far, due to experimental setup limitations, we have modeled the 
wall shear stress profile of three lymph node conditions: (1) a healthy lymph node, (2) a 
dilated subcapsular sinus, and (3) a dilated afferent vessel diameter. These models have 
provided a noteworthy first look into the effects of remodeling on cell adhesion, however, 
due to the prevalence of co-occurring dilation of the subcapsular sinus and afferent 
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lymphatic vessel, a system that is capable of modeling this scenario should be fabricated 
and the adhesion of metastatic and/or immune cells in the model quantified.137,146,239 
Finally, as with future work for the other aspects of this thesis, the lymph node “sinus-on-
a-chip” should be used to elucidate the adhesive behavior of different cancer cell 
populations, patient derived tumor cells, and other immune cells (such as B-cells or tumor 
associated macrophages). Specifically, studying the different adhesion mechanisms 
between cancers that have a tendency to metastasize to the lymph nodes versus those that 
do not frequently form metastatic tumors may inform differences in cell adhesive behavior 
that underlies the propensity of some cells to extravasate through the lymphatics, for 
example MDA-MB-468 cells versus 468LN cells.341 Finally, additional co-perfusion 
experiments with cancer cells and monocytes should be performed to determine if 
monocyte augmentation of adhesion is consistent among different cancers. Collectively, 
extending the application of the lymph node “sinus-on-a-chip” to interrogate other cell 
lines and adding more lymphatic conditions to the design will serve to further bridge two 
main aspects of the Thomas lab – elucidating the role of the lymphatic system in cancer 
metastasis and understanding the biophysical and biomechanical underpinnings of cell 
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